Understanding Paramedic, Trial Network, and Patient’s Family Experiences in Emergency Research Clinical Trials by Lipman, Paula Darby et al.
 
 
 Understanding Paramedic, Trial 
Network, and Patient’s Family 
Experiences in Emergency Research 
Clinical Trials 
 
PROJECT 1:  EMS PROJECT – 
PARAMEDIC TRAINING AND SCOPE OF 
INVOLVEMENT IN CLINICAL TRIALS  
 
 
 January 31, 2020   
 
Prepared for: 
Strategies to Innovate EmeRgENcy 







An Employee-Owned Research 
Corporation® 
1600 Research Boulevard 






Table of Contents 
Executive Summary ...................................................................................................................................... 3 
1. Introduction ........................................................................................................................... 4 
1.1 Background ............................................................................................................................ 4 
1.2 Research Questions ................................................................................................................ 4 
2. Methods ................................................................................................................................. 5 
2.1 Protocol Design ...................................................................................................................... 5 
2.1.1 Qualitative Data Collection. .............................................................................................. 5 
2.1.2 Member Checking Survey Methods .................................................................................. 6 
2.1.3 Participant Characteristics. ............................................................................................... 7 
2.2 Integration of Findings ........................................................................................................... 7 
2.2.1 Data Sources...................................................................................................................... 8 
2.2.2 Data Management. ........................................................................................................... 8 
2.2.3 Data Analysis. .................................................................................................................... 8 
3. Development of Conceptual Model ...................................................................................... 9 
4. Results .................................................................................................................................. 11 
Member Checking Results .................................................................................................................. 11 
4.1 Implementation Context ...................................................................................................... 11 
4.1.1 Institutional Support and Leadership (Table 4)............................................................... 11 
4.1.2 Availability of Resources for Prehospital Clinical Trials (Table 5). .................................. 13 
4.1.3 Dedicated Research Staff and Champions (Table 6). ...................................................... 14 
4.1.4 Paramedic Involvement in Protocol Development or Modification (Table 7). ............... 15 
4.1.5 Motivating Paramedics by Providing Feedback on the Trial (Table 8). ........................... 16 
4.1.6 Conducting Trials in the Prehospital Setting (Table 9). ................................................... 17 
4.2 Learner Factors .................................................................................................................... 17 
4.2.1 Characteristics of Paramedics in Relation to their Field of Practice (Table 10). ............. 18 
4.2.2  Interest in and Perceived Value of Prehospital Clinical Trials (Table 11). ....................... 19 
4.3 Training Approaches ............................................................................................................ 20 
4.3.1 Training Approaches addressing Learner-level Factors ....................................................... 21 
4.3.1.1 Training Delivery Methods (Table 12). ............................................................................ 21 
4.3.1.2 Prehospital Clinical Trial Training Content (Table 13). .................................................... 22 
4.3.1.3 Refresher Training and Ongoing Learner Support Strategies (Table 14). ....................... 23 




4.3.1.5 Training Incentives (Table 16). ........................................................................................ 25 
4.3.2 Training Approaches addressing Institution-level Factors ................................................... 26 
4.3.2.1 Institutional Resources to Strengthen Trainings and Support for Prehospital Clinical Trials 
(Table 17). ....................................................................................................................... 26 
4.4 Environmental Factors ......................................................................................................... 28 
4.4.1 Evolution of the Paramedicine Profession (Table 18). .................................................... 28 
4.4.2 Stakeholder Engagement to Advance Research (Table 19). ........................................... 30 
5.  Discussion ............................................................................................................................ 31 
5.1. Study Limitations .................................................................................................................. 31 
5.2. Discussion of Findings .......................................................................................................... 32 
References .................................................................................................................................................. 35 
Appendices ................................................................................................................................................. 36 
Appendix A Focus Group Guide ..................................................................................................... 37 
Appendix B  Interview Guide ......................................................................................................... 45 
Appendix C Member Checking Survey ........................................................................................... 51 
Appendix D Focus Group and Interview Codebook ....................................................................... 59 










There is tremendous opportunity to learn from researchers and emergency medical services (EMS) 
personnel about approaches for implementing prehospital clinical trials, and for developing and 
delivering research training for paramedics.  Under the leadership of the Strategies to Innovate 
EmeRgENcy Care Clinical Trials Network (SIREN), paramedics and other EMS professionals were 
invited to participate in a mixed methods study to better understand how EMS paramedics are 




The study followed an exploratory sequential mixed methods strategy with three phases of research 
(focus group and interview data collection, member checking, and integration of findings).  Westat, a 
Maryland-based research organization, independently completed data collection, analytic, and reporting 
responsibilities in consultation with the SIREN project team.  A total of 51 individuals (22 paramedics 
and 29 others participated in either a focus group or interview, and, of these, 33 (70.2%) responded to 




Several factors were found to be associated with the context in which the trial is implemented, 
specifically institutional support and leadership, availability of resources, and strategies to involve 
paramedics throughout the research process.  Paramedics’ prior exposure and attitudes regarding the 
perceived value of research were indicated as influencing their experiences.  Training delivery methods 
identified as effective in building skills and confidence include in-person and hands-on training activities 
focused primarily on the specific trial protocol, refresher trainings, and access to reference materials 
and informed trial leaders and champions.  Institutional support to augment training and motivation 
include recognition of the role of paramedics, providing incentives and support, using templates that 
can be tailored to participating sites, and providing ongoing feedback on enrollment and other trial 
progress. 
 
Recommendations for Next Steps  
 
Specific recommendations for training design and conduct are summarized.  These findings and 
recommendations can be considered by researchers and others to address some of the barriers or 










There is tremendous opportunity to learn from researchers and emergency medical services (EMS) 
personnel about approaches for designing and implementing prehospital clinical trials, and for 
developing and delivering research training for paramedics. Participation in clinical research 
presents special challenges for paramedics and EMS agency personnel due to the unique nature of 
the prehospital environment.  Under an administrative supplement awarded to the Strategies to 
Innovate EmeRgENcy Care Clinical Trials Network (SIREN), paramedics and other EMS professionals 
were invited to participate in interviews and focus groups to better understand how EMS 
paramedics are prepared for their role and to capture their experiences related to prehospital 
clinical trials. Information collected from this endeavor will help EMS researchers identify best 
practices for involving and preparing EMS paramedics for their role in emergency care research and 
will contribute to shaping clinical practice in the emergency setting.   
 
The research was conducted in three phases1:  1) qualitative data collection (focus groups and 
interviews), 2) member checking, and 3) integration of findings and completion of analysis.  This 
report provides a summary of the research phases and results, describes development of a 
conceptual model, and presents recommendations for future research. 
 
1.2 Research Questions 
 
The research questions went through several iterations over the course of discussion among members 
of the research team.  Revisions to the questions were made to ensure that the data collection activities 
elicited findings that are useful, applicable, and that contribute to advances in the field of prehospital 
clinical research.  The final research questions were:   
 
 What factors and strategies are associated with paramedic engagement in prehospital clinical 
trials? 
 What methods and strategies have been used for paramedic training for prehospital clinical 
trials? 
 What are the challenges and barriers associated with paramedic engagement and training for 
prehospital clinical trials? 
 What are the recommendations to optimize methods and strategies to engage and train 
paramedics for prehospital clinical trials?  
  
                                                 
1 Westat, a research organization headquartered in Rockville, Maryland, provided qualitative services under 
subcontract. Westat independently completed data collection, analytic, and reporting responsibilities in 






2.1 Protocol Design 
 
The study followed an exploratory sequential mixed methods strategy that included three phases of 
research (Figure 1).  In Phase 1 (Qualitative data collection), focus groups were first conducted for initial 
exploration of topics and themes, followed by collection of data through individual interviews.   Focus 
group and interview participants were subsequently invited to provide feedback on select preliminary 
findings through a member checking survey (Phase 2), and results of both data collections were 
integrated in the final analysis (Phase 3). 
 
These phases are described in more detail below. 
 




2.1.1 Qualitative Data Collection.  Focus groups and interviews were conducted with individuals in 
one of two role classifications: (1) current paramedics and (2) other roles associated with clinical trials 
such as investigators, EMS medical directors and educators, and operational chiefs.  The purpose of the 
data collection was to assess attitudes, beliefs, and experiences associated with preparation for and 
conduct of prehospital clinical trials.  Focus groups were conducted initially, and findings helped to 
inform the content for the subsequent interviews. 
 
Sampling Method.  The qualitative sampling strategy – homogenous sampling – was intended to identify 
information-rich sources relative to their experience with prehospital clinical trials and with training of 
paramedics in particular.  The SIREN team used various methods to recruit an intentional group of focus 
group and interview participants perceived to represent key stakeholders based on their experience 
with clinical trials. This process included identifying investigators from the two prior networks (ROC - 
Resuscitation Outcomes Consortium and NETT - Neurological Emergencies Treatment Trials Network), 
email blasts, snowball (referral) sampling, and announcements at the 2019 National Association of EMS 
Physicians (NAEMSP) annual meeting.  The research team used a participant screener to confirm 
eligibility and identify focus group/interview times that were convenient for participants. The screener 
included questions regarding name, participant background, trial experience, and network affiliation.  












paramedics to gain a deeper understanding of the paramedic experience and sought to recruit an overall 
participant pool with balanced representation of ROC and NETT trials.  
 
Focus Group Approach.  Three in-person facilitated focus groups were conducted with key stakeholders 
at the 2019 NAEMSP annual meeting (January, Austin TX).  Constructed with an intent to capture 
perspectives relevant to the major steps of conceptualizing, designing and implementing prehospital 
clinical trials, participants were asked a series of questions to understand their experiences and to assess 
their perspectives on challenges paramedics face with protocol development and implementation, 
participant consent and enrollment, and training for prehospital clinical trials.  See Appendix A for the 
focus group guide.  
 
Focus group discussions were led by two trained facilitators who are members of the Westat research 
team.  A member of the research team was also present during all groups to manage logistics, 
honoraria, and the consent process.  All participants provided consent before the start of the session.  
The discussion was audio-recorded with permission of all focus group participants.  Focus groups were 
held in a private conference room and lasted two hours.  All participants were provided a $100 Visa gift 
card. 
 
Interview Approach.  Preliminary findings from the focus groups were used to develop a tailored 
interview guide (Appendix B) which addressed paramedics’ experiences with prehospital clinical trials, 
comfort and skills related to research, experiences with training and conducting specific trials, and 
environmental factors influencing paramedics’ engagement and participation in research.   
 
Interviews were co-led by two members of the Westat research team.  The purpose of the interview was 
reiterated, and all participants provided verbal assent and permission to record the discussion before 
the interviews were conducted.  Interviews were conducted and recorded via WebEx.  All participants 
were offered a $100 as honoraria. 
 
2.1.2 Member Checking Survey Methods.  A member checking process (Phase 2) was conducted as 
a means to determine the resonance of preliminary themes identified through analysis of interviews and 
focus groups.  Member checking enhances trustworthiness of data and enables triangulation of data to 
enhance understanding of the phenomena in question, leading to more valid and nuanced 
interpretations.  Specifically, the research team conducted a Synthesized Member Checking method 
(Birt et al., 2016), which summarizes themes across the data, and provides participants the opportunity 
to confirm or dispute and add clarifying comments to these themes. 
 
Twenty statements were selected that synthesized key thematic findings from the preliminary analysis, 
representing the following:  organizational context for trial implementation; paramedic characteristics 
related to attitudes, beliefs, and experiences pertaining to clinical trials; and training approaches for 
clinical trials.  The statements were included in a mixed data survey instrument (Creswell & Hirose, 
2019) that was administered to interview and focus group participants using a mixed methods 
integration strategy of connecting such that the respondents surveyed were those that participated in 
earlier data collection activities (Fetters et al., 2013).  Respondents were instructed to review each 
statement and indicate whether they agreed, disagreed, or had no opinion; and were also encouraged 
to provide comments, particularly if they disagreed or felt strongly about the finding.  At the close of the 
survey, participants were asked to provide their first and last names to enable tracking of survey 
responses and linking of the dataset with role (i.e., paramedic or other) and participant type (i.e., 





Completing the survey was estimated to take no more than fifteen minutes.  The survey was mobile 
optimized and programmed using SurveyMonkey®.  After excluding three participants because of 
missing or invalid email addresses, forty-eight participants were sent an initial email from 
SIREN@westat.com on November 18, 2019 that described the purpose of the data collection and 
included a URL to access the survey.  An additional participant was excluded because of an invalid email 
address, resulting in an analytic sample size of 47. A reminder email was sent to non-respondents eight 
days after the initial email. Survey data collection closed on December 2, 2019.   
 
2.1.3 Participant Characteristics.  A total of 51 individuals (22 paramedics and 29 individuals in 
other roles, including investigators, EMS medical directors and educators, and operational chiefs 
[hereafter referred to as “Others”]) others) participated in either a focus group or an interview during 
the Phase 1 qualitative data collection (Table 1). From these participants, 47 received an invitation to 
complete the member-checking survey and 33 participants responded to the survey, for an overall 
response rate (RR) of 70.2%.  One survey response was considered incomplete because the name of the 
respondent was missing, and therefore, was not included in the analysis.  Table 2 presents the Member 
Checking survey response rates, by role and Phase 1 participant type.     
 
Table 1. Number and Role of Phase 1 Participants (Focus Groups and Interviews) 
 
 Focus Group Interview Total 
Overall 32 19 51 
By Role 
Paramedic 11 11 22 
Other 21 8 29 
 
Table 2. Member Checking Survey Response Rates, Overall and by Respondent Role and Participant 
Type 






Overall 47 33 70.2% 
Response By Role 
Paramedic 18 13 72.2% 
Other 29 20 69.0% 
Response by Phase 1 Participant Type 
Interview 19 11 57.9% 
Focus Group 28 22 78.6% 
Note: Four paramedics were excluded from the member checking survey because of missing or invalid email 
addresses. 
 
2.2 Integration of Findings    
 
The analysts used a mixed data analytic strategy to examine the qualitative data and assess resonance of 
the findings quantitatively. The integration strategy for the member checking survey involved the 
process of building, that is, construction of items based on the qualitative results (Phase 1), and 




Fetters, 2020a). To provide a comprehensive understanding of the findings, the team used joint display 
analysis and presentation procedures (Phase 3) (Fetters, 2020b).  
 
2.2.1 Data Sources.  Multiple data sources were included in the analysis, as described in Table 3. 
 
Table 3.  Qualitative Data Collection and Member Checking Survey Data Sources 
 





 Notes taken by the 
interviewer or co-
facilitator during the 
interviews/focus groups 
 Notes were used to develop the codebook 
and preliminary coding discussions with 
facilitators and co-facilitator 
 Notes provided additional context and 
insights to coded text 
Focus group and 
interview 
transcripts 
 Transcriptions based on 
focus group and interview 
recordings  
 Transcripts were imported into NVivo 11 




 Quantitative and open 
text data from online 
survey  
 Endorsement of items were used to confirm 
themes, ensure that themes accurately 
represented participants’ views  
 
2.2.2 Data Management. For focus groups and interviews, all discussions were audio recorded with 
the consent of participants and were professionally transcribed verbatim. Co-facilitators and 
interviewers also took notes.2  All transcripts were anonymous and any names of individuals, facilities, or 
other descriptors that could compromise confidentiality were removed from the transcripts. Once 
validated, transcripts were posted on a secured drive where members of the research team could access 
the data for analysis. Using standardized procedures, transcripts were formatted and imported into 
NVivo 11 for analysis.  For the member checking exercise, data from SurveyMonkey® were exported to 
an Excel spreadsheet.  The spreadsheet was saved on a secured drive, only accessible by the research 
team.  Frequencies and percentages were calculated in Excel. 
 
2.2.3 Data Analysis. Broad content areas and themes of interest based on focus group and interview 
data were explored.  The broad content areas initially identified included Research Operations and 
Logistics; Research Training; Attitudes towards Research; EMS and Other Systems; and Other Relevant 
Discussion.   The initial identification of content areas and themes was meant to be as expansive and 
inclusive as possible so that the analysis would capture the breadth and depth of issues discussed.  In 
this manner, the content areas and themes emerged and evolved during data collection. Throughout the 
process, the research team met to discuss analysis progress, leading to the development of a codebook 
(Appendix D) to document the emergent concepts and themes.  Throughout the coding process, the 
codebook was refined as codes were merged, expanded, deleted, or divided. Previously coded text was 
recoded to reconcile variability. Research team members trained in qualitative data analysis methods 
utilized NVivo 11 (NVivo, 2015) to code the transcripts and retrieve text segments for the analysis.   
 
Coding Rules and Meetings.  Prior to the start of analysis, all coders met to discuss and agree on specific 
coding rules.  NVivo 11 is organized around nodes that are defined by emergent content areas and 
themes. Rules included how much text surrounding each node to code (e.g., coding at the beginning of a 
                                                 




sentence or paragraph, coding interviewer questions) in order to provide sufficient context to derive 
meaning. Coders also came to consensus on the organization and use of the codebook.  These rules 
allowed the research team to standardize the coding process. Coders met regularly to discuss the status 
of coding and triangulation of interpretations. Inconsistencies in coding were discussed and resolved 
through consensus.  
 
Coders collaborated with the research team to analyze and refine the coding process as follows:   
 Step 1.  Draft Codebook – based on high-level themes from the focus groups. 
 Step 2.  Confirm Codebook – select research team members reviewed the codebook against a 
set of focus group and interview transcripts to ensure that the codebook captured the breadth 
and depth of concepts in the transcripts. 
 Step 3.  Test and Refine Codebook – a subset of the research team reviewed a coded interview 
to assess the application of codes.  Inconsistencies or inaccurate application of codes were 
resolved and the codebook was further refined. 
 Step 4.  Active Coding – coded text was generated and distributed to the research team for 
review.  This process ensured that coded text accurately and consistently represented assigned 
codes.  
 
3. Development of Conceptual Model 
 
During preliminary analysis, emergent themes were organized into a conceptual model to understand 
the contributors that influence the implementation and conduct of prehospital clinical trials.  The model 
posits that there are multiple and bidirectional interactions among the domains and also accounts for 
external factors in the larger environment, all of which likely contribute to institution and learner level 
outcomes.   
 
The scope of this study was not to test the relationships among the domains, but to generate a model to 
organize the findings and to potentially guide future projects exploring topics pertaining to 
implementation of prehospital clinical trials.  Figure 2 illustrates this model, which includes domains 
identified through the analysis process, and which incorporates potential outcomes at the level of the 
individual (the learner) as well as the institution.  Results are presented by domain in the following 
section (Section 4).   
 
 Implementation Context – Organizational factors existing in the immediate environment where 
the prehospital clinical trial is being trained on and implemented. 
 Learner Factors – Paramedic characteristics including personal attitudes, beliefs, experiences, 
and skills in conducting prehospital clinical trials. 
 Training Approaches – Different methods and strategies to encourage successful uptake of 
clinical trial training goals. 
 Environmental Factors – Variables that influence the prehospital clinical trial environment 
overall but that are not likely to be directly impacted by training programs.  
 Potential Outcomes – Possible benefits of training approaches to both the individual learner 















Member Checking Results.  The member checking data, organized to reflect the attitudinal responses 
and related qualitative comments, were a data source for the analysis (Section 2.2.1, Table 3).  Percent 
agreement for each of the 20 statements on the Member Checking Survey was calculated and was found 
to range from 52% to 100%.  Respondents agreed with the majority of the findings.  Fifteen statements 
resulted in 90% or greater agreement among respondents (presented in Appendix Table E.1); of these, 
eight statements received 100% agreement.  For items with less than 90% agreement, the percent 
disagreement overall and by role was calculated, which confirmed general consistency in perspective, 
irrespective of role.  The mixed methods joint display of Appendix Table E.2 presents these five 
statements and illustrative comments.  All qualitative comments provided by respondents for these five 
statements were incorporated in the final results (Section 4).   
 
Results are presented by model domain, with illustrative quotes presented in italics in tables 
accompanying the findings.  Subthemes, where found, are presented in bold text in the tables.  
Illustrative quotes add background and richness to the findings and sources are identified by data 
collection mode (Interview = I, Focus Group = FG, Member Check = MC) and attributable participant role.   
As themes in the analysis are interrelated, cross-references to other relevant sections are provided. 
 
4.1 Implementation Context  
 
The Implementation Context domain pertains to the organizational context in which the clinical trial is 
conducted that influences paramedics’ experiences and attitudes, and directly or indirectly impacts 
training and support for the anticipated or implemented trial.  The focus group and interview discussions 
identified a range of factors pertaining to the organizational context in which clinical trials are 
conducted. These factors in the implementation context are likely associated with the conduct of 
successful trials and may function to reduce reluctance of paramedics to participate in specific trials, as 
well as to reinforce interest and skills needed to be fully engaged in research more generally.  Many of 
these comments were the result of reflections on what participants thought affected paramedics’ 
comfort and skills with regard to participation in prehospital clinical trials.  Training, a critical element in 
building the skillset and level of comfort for trial participation, is addressed in Section 4.3, with themes 
pertaining to the institution-level found in 4.3.2. 
 
Broad and interrelated themes in this domain include the importance of institutional support and 
leadership (4.1.1), availability of resources (4.1.2) and presence of dedicated research staff or those who 
serve as study champions at the local level (4.1.3).  Participants also expressed the value of 
incorporating paramedics’ input in both the development of the trial protocol and modifications 
following implementation (4.1.4), as well as on providing feedback on the progress of the trial to keep 
paramedics informed and motivated (4.1.5).  Finally, the broader context of the prehospital setting and 
the challenges of conducting trials under those circumstances were also discussed (4.1.6). 
 
4.1.1 Institutional Support and Leadership (Table 4).  Participants discussed how stakeholders in 
the EMS system in which the trial takes place demonstrated their support for prehospital clinical trials.  
This theme, particularly voiced by participants who were in leadership and education roles, suggests 
that institutional efforts to communicate with paramedics to keep them informed and to have visible 




paramedics’ experience and intentions.  These efforts, which typically include key individuals such as 
medical directors, set the stage by recognizing the complexities of clinical research and by creating a 
culture in which paramedics are expected and encouraged to support research.   
 
This concept was explored in the Member Checking exercise with the following statement: “Informing 
paramedics of a possible pending trial is more likely to engender interest and engagement.”  The 
additional information provided through member checking qualitative feedback suggests that timing of 
this information is critical, as in “It is important not to get them excited and then not deliver. The 
deflation they feel at missing an opportunity is worse than them not knowing they almost got the 
opportunity” (MC- Other), and “Wait until the trial is funded and at least 90% ready for implementation 
to inform them about it. I don't inform them until it is ready to deploy, as it really doesn't matter to line 
providers until that point” (MC- Other).   However, timing of the announcement is also related to the 
opportunity for paramedics to potentially participate in trial design (see Section 4.1.4), as demonstrated 
by “earlier contact allows them to have a voice and hopefully help with buy-in” (MC- Other).  
 
Table 4.  Institutional Support and Leadership 
 
Importance of EMS agency support in building a culture for research.   Perspectives on the value of 
agency support for the implementation of a prehospital clinical trial were expressed particularly by 
individuals in the non-paramedic group, which included medical directors and paramedic educators.  
Efforts at the broader agency level can take different forms depending on the agency, but should 
reflect the agency’s genuine commitment to research. 
 
We probably failed the trial on our side by not doing enough promotion of the trial internally. And I think that’s 
probably a disconnect between our medical director and the organization, because I think there was a few of us 
that were, for lack of a better term, really trial champions…really ensuring that esprit de corps on the research 
exists and it stays with the project I think is probably very important. (I- Other) 
 
So it does create that – creating that culture is – takes a lot of sort of commitment, which also means that, you 
know, you’ve got to have dedicated academic folks who have got projects going and basically continuing to 
engage them, because they do like to be on the cutting edge. I will agree that systems that really like research, 
part of what drives it is they like to be on the novel edge of what you’re doing.  (FG- Other) 
 
So what’s happened is because of my role as an EMS commissioner, I’ve been able to leverage my – you know, 
my interest in doing research along with, you know, the connections I’ve made, the relationships I’ve had. I’ve 
been able to leverage those to get pre-hospital research kind of more higher visibility within the EMS agency. So 
I’m always a champion for research. (I- Other) 
Leadership buy-in and presence is a critical element of the implementation context.  Often the 
commitment of the EMS agency is expressed by individuals in leadership roles who promote or 
represent the particular trial and the value of building the evidence base more generally.  Thus, an 
important element of the implementation context is the presence of visible and committed 
leadership, a role often played by the medical director or study PI. 
 
So it’s very clear, if you want to do research within the – you need to, number one, have the EMS medical 
director as your advocate. If the EMS medical director is not your advocate, you’re going to get nowhere. And 
then next it does EMS medical director have the clout to get the different battalion chiefs and the different 





I think it falls upon the medical director and the administrators just to kind of make the case for why the 
participation is important, and once you provide that up front education, you do get a little more buy in. It just 
may not come as naturally, say like a doctor, they know, you know, research is part of their job.  (I- Other) 
 
I think when there’s enthusiasm coming from their leadership [paramedics are] always on board… (I- Other) 
 
4.1.2 Availability of Resources for Prehospital Clinical Trials (Table 5).  Limited resources at EMS 
agencies often restrict opportunities to conduct prehospital clinical trials, or complicate efforts to 
sustain a successful trial.  Participants expressed that EMS leadership are often unable to commit to 
implementing prehospital clinical trials due to limited budgets, staffing, timelines, and competing 
priorities.  Additionally, EMS agencies may be required to pay for paramedics’ time to participate in 
protocol trainings, placing more strain on limited resources. Thus, for some EMS agencies, research is 
often not viewed as a priority.   Subthemes identified in the focus groups and interviews include 
challenges associated with lack of resources and the benefit of having access to resources throughout 
the duration of the trial.  Also, see Training Approaches (Section 4.3) regarding additional discussion 
related to resources and training. 
 
Table 5.  Availability of Resources  
 
Challenges created by lack of resources for research.  Lack of resources at the agency level impacts 
the continued investment required to conduct the trial, as well as capacity to provide sufficient 
training for paramedics.  This theme was particularly captured during the focus group discussions 
from the perspective of non-paramedics, who expressed frustration with the range of resource 
requirements for research (e.g., time, equipment, training funds).   
 
It also takes resources. That’s like – I mean, honestly, most EMS managers are bogged down by the day to day 
fires that are created by a lot of different variables. And then to have – To say like okay, well, we’re going to take 
some of your time, and your resources, and your paramedics’ like focus, and say we’re going to do a live trial, 
not everyone has that ability. You also usually need an academic center pretty near the hub too…Like I mean, the 
task of doing a rural study, I can’t even imagine what that would be for the EMS agency on that side.  (FG- 
Paramedic) 
 
Every study I’ve been involved in, this is like universally under budgeted and underrepresented. And it’s very hard 
when you’re – particularly when your budget constraints are tight and your – you need the equipment and you 
need the – you need to pay for the regulatory investment, and you need to pay for your investigators and for 
your research infrastructure, like your RAs who are doing the consents and obtaining the data in the ED, EMS 
becomes an afterthought, and you know, maybe there’s a little money in there for training, but it’s very difficult 
to – Very difficult to sell that as part of the grant. (FG- Other) 
 
If you’re trying to do a study on a skeleton research staff, it’s going to be hard, because then you have to ask 
more from the EMS program. (FG- Other) 
 
So for our side [the challenge] is getting the EMS agencies to participate, finding time, because training time is 
training dollars, you know, so we provided the training but they provided the people, which meant that the 
agencies were paying for them to go to this training. And whenever you’re talking about training, you’re talking 
about dollars out of someone’s budget. (I- Other) 
Access to resources throughout the trial supports implementation.   Given that patient enrollment in 
a prehospital trial is often a relatively rare event, it is especially critical that resources be allocated to 
provide the tools and information throughout the trial, to supplement any trainings offered and to 




to assist with recollection of the procedures, or can be in the form of reliable access to real-time 
support.  This is also related to themes addressed in Training Approaches (4.3). 
 
So using those prompts, that’s what they’d do. And many of them thanked me over and over again because they 
don’t remember all the steps. So everybody carries a pocket card, if they don’t like the pocket card, they carry 
their app on their phone. (I- Other) 
 
We have 24/7 hotline that the paramedics, we give them that number at the training. So at any point at any 
time if they have a question about the protocol or inclusion, or exclusion, or anything, they can call us at 2:00 in 
the morning, and any human being highly trained in the protocol will answer the phone and answer their 
question. (I- Other) 
 
4.1.3 Dedicated Research Staff and Champions (Table 6).   Leadership and agency commitment to 
research is often evidenced by the presence of dedicated research staff or study champions.  
Respondents stated that EMS agencies that have been successful with conducting research often utilize 
dedicated staff devoted to research studies, research training, and quality improvement (QI) studies.  
These staff can include research assistants, nurses, or study coordinators, who function to simplify the 
research environment and paramedic experience during the conduct of the trial.  The presence of study 
champions, in addition to other factors, has an impact on paramedics’ comfort and skills with research 
participation.  
 
Table 6.  Dedicated Research Staff and Champions 
 
One approach to facilitating trial implementation is to provide staff, such as nurses or administrators, 
who can be a resource to the paramedics and others over the course of the study.  However, 
providing this infrastructure can be both challenging and costly.  Also valuable are the individuals 
either within the EMS agency or among the paramedic team who either opt to be advocates for the 
trial or are encouraged to do so by investigators and others. Study champions in particular can 
provide paramedics with informal access to information pertaining to the trial and motivate trial 
participation.   
 
Also, what hasn’t gotten discussed yet is the trial came in, and they hired a study nurse, and they actually hired 
two of them, so they could, you know, -- There would always be one available. They had to get credentialed into 
the hospitals to be able to come in, access the facility, go into the ED, and then ultimately access the patient 
charting. (I- Paramedic) 
 
I’ve got my daily operations to worry about. So having like dedicated staff that’s not being paid by the EMS 
agency is actually a good way to separate those things. And when you look at the successful EMS agencies and 
research…they pour most of their resources into QI and training, and they have dedicated staff that cannot be 
pulled from their trucks for other things. That doesn’t happen in a lot of other agencies (FG- Paramedic) 
 
We were successful because we had nurses contacting the paramedics regularly and so having the research 
infrastructure…when we had our nurses doing regular visits with cookies and donuts and just forming 
relationships, paramedics were much more open to the on the fly education, and got more buy in. (I- Other) 
 
So if a paramedic gets befuddled – and this happens throughout our province, they simply call in and this – we 
call them almost champions too, but they’re not – it’s not their job. They’re there to try and remedy this. So they 





…find a few champions in your organization that are into it, and will listen, and understand what [inaudible 
20:36] for, and then they go to their peers and say this is why this should be important to you. And they’re more 
willing to listen to their peers than they are the guy sitting in the glass palace, right? So you find those few 
people that are really into it…then they tend to come around because they’re listening to each other.  (FG- 
Paramedic) 
 
4.1.4 Paramedic Involvement in Protocol Development or Modification (Table 7).  Participants 
also emphasized the value of considering the paramedic role throughout trial design and 
implementation.   Engaging paramedics at all phases of the research not only impacts their commitment 
to the trial but also can ensure that the design is pragmatic and approximates the standard of care (see 
related theme in 4.1.6).  Paramedics with research experience may be engaged as the trial is being 
designed, and trial monitoring approaches can incorporate constructive feedback from participants 
which may lead to protocol modification.  However, successful uptake of these strategies requires 
agency commitment and vigilance, as well as resources. 
 
Table 7.  Paramedic Involvement in Protocol Development or Modification  
 
The value of engaging paramedics was recognized as critical when planning the protocol.  Methods to 
solicit ongoing feedback, mostly informal check-ins or encouragement to report on what is or is not 
working in the field, were also components of effective trial implementation.  These efforts help to 
ensure that the expectations for the trial are aligned as closely as possible with standard EMS 
routines to minimize the burden on the paramedics. 
 
…in our area, the paramedics are the authors of protocol… We had people from around the country that are like 
how did you get this protocol written like this where it’s aggressive over here, but very simplistic and kind of, you 
know, cautious on this end? And it was – It’s paramedic driven.  (I- Paramedic) 
 
I personally think that EMS personnel need to be involved with the genesis of any research idea pretty much at 
step one – step two if not step one, and a bunch of us have followed that lead.  You’ve got to treat [paramedics] 
like part of your investigative team, and they will identify all sorts of problems with your protocol before you 
even get started. (FG- Other) 
 
We even went so far as to making sure that the control medication, if you will, was the same type of control 
medication as what we carry on the unit. So even though it’s the same medicine, and it’s labeled the same, there 
was no difference in those two vials, and those guys are used to seeing, oh, that’s the blue vial with the red top. 
Yep, same one. And it becomes a muscle memory thing, and they’re not worried about screwing something up. 
(I- Paramedic) 
 
So we actually changed our approach to our next study. A couple things. One is paramedics don’t want to spend 
time on the phone doing a formal consent process. They want to go, go, go. So we found a compromise, which is 
we no longer do the 10 minute on the phone going through the consent form with the paramedics. That really 
got on their nerves. They really gave us a lot of flack for that. (I- Other) 
 
He [one of the medical directors] will actually step in [and say] hey, you guys know who I am. I have a question. 
What problems are we running into?  And just to every paramedic that’s sitting here, what issues do we have, 
and if there’s an issue we can address it. Say, hey, there was a shoulder strap that came with it. That needs to  
go. It’s in the way. Okay, perfect. Those are now coming off. So he basically can kind of do an intermittent kind 






4.1.5 Motivating Paramedics by Providing Feedback on the Trial (Table 8).  Monitoring of the 
trial can provide useful information to share with participants to keep them informed of trial progress, 
as discussed above.  Furthermore, in addition to reinforcing the agency’s commitment to the trial, 
information on recruitment and other key trial milestones can educate paramedics about the process 
and outcomes of research.   
 
However, some participants observed that paramedics are more inclined to remain engaged and 
invested in the trial if they believe that efforts to monitor compliance with the protocol are not punitive.  
This was explored during Member Checking with the following statement:  “Some paramedics may be 
less inclined to participate in research due to concerns about making mistakes.”   Comments from 
respondents qualified this statement, as per the following which emphasizes the importance of training:  
“They’ll be more likely to participate willingly when they’re trained-and feel the trial is well organized, 
optimized clinically and procedurally-and they understand the purpose” (Paramedic) and “Maybe in 
some trials at other departments but our department makes sure that instructions are on hand and 
practice has been provided.” (Paramedic).   Other comments suggest awareness of this issue and 
approaches to address it, including:  “…and that is a management responsibility to understand their 
employees and manage them when implementing a trial.” (Other) and “If properly educated of their role, 
this is not a concern for the majority of paramedics involved in clinical trials.” (Other).    
 
Table 8.  Motivating Paramedics by Providing Feedback on the Trial 
 
Participants in both roles provided specific feedback on useful information to share and on the 
importance of keeping paramedics informed of the progress of the trial.  Often an underlying theme 
of these strategies is the provision of ongoing appreciation for paramedics’ efforts and an emphasis 
on how critical they are to the success of the trial (see 4.2.2).  Appropriately crafted messages can 
also help alleviate concerns about making “mistakes” in the field by emphasizing how investigators 
appreciate the input and can learn from these challenges, thereby reinforcing a non-punitive culture 
for the conduct of research. 
 
Here’s how many patients we have enrolled. Here’s how many patients were screened and did not get enrolled. 
You know, you guys are doing a great job. Here’s kind of where we are in the grand scheme of numbers. So he 
keeps everybody pretty abreast of …where the study is. (I- Paramedic) 
 
So it is easy for me to get up there and say you guys are rock stars…You have already changed medicine and 
how we care for our patients and improved patient outcomes across this country. You have. Every one of you 
that has enrolled a patient into a trial or helped to, you have impacted the way we care for patients and have 
improved outcomes. (I- Other) 
 
And if they make a mistake, we never scold them. We simply say thank you. We’ll learn from that. They’re 
usually horribly embarrassed….I mean, it’s a blaming game where they’re always worried they’re going to make 
a mistake, and we’re saying no, you did your best. Everybody makes mistakes. We just learn from that.  (I- 
Other) 
 
…when the research team makes it clear that this is not going to be a discipline process. So hey guys, yes, we 
really can’t have you making like, you know, errors that are very, you know, deliberate, and we can’t have you 
doing unsafe acts on patients, and here’s how we’re going to mitigate that. But if for some reason something 
happens or you drop the box, and it shatters, or you drop the medication and it shatters, no big deal, we’ ll just 





4.1.6 Conducting Trials in the Prehospital Setting (Table 9).  As introduced above, there are 
challenges with conducting research in the prehospital setting that influence the strategies and methods 
that can be implemented within the agency to support and conduct trials.  These immutable influences 
in the broader implementation context, expressed particularly in the focus groups, include challenges to 
conducting research in the prehospital setting that impact paramedics’ comfort level and may be 
challenging to address in typical training strategies and approaches. 
 
Table 9.  Conducting Trials in the Prehospital Setting  
 
Adding a research protocol to the context of emergency are in the prehospital setting, which is 
typically unpredictable and chaotic by nature, can impact the standard work flow and negatively 
impact paramedics’ comfort and intentions.  Keeping research protocols as close to routine practice 
as possible, and promoting a positive culture, which acknowledges these challenges (as described 
above), can positively impact learner and institutional outcomes.  
 
You got familiarized with it yourself and say, hey, I think this may fit the criteria…and you’re sitting there and 
you’re second guessing it, and sometimes you can miss the window of opportunity to deliver something that 
someone needs, you know? … these are not frequent events and they’re a little bit different from what you’re 
familiar with and maybe a different work flow. (Paramedic) 
 
Maybe something as simple as wording. Some of the studies we’ve done, they have very specific wording in the 
protocol that’s written because it’s very clear and it makes a great deal of sense, which you then try to translate 
at 3:00 in the morning in the dark, doesn’t translate nearly as well [inaudible 11:38] what does that mean?... 
And you do something different. (FG- Paramedic) 
 
You know, there’s so much variability in the pre-hospital setting or even in the emergency setting. I mean, you 
can’t think of every situation. You can’t have a script for everything that’s going to come up. (FG- Paramedic) 
 
The things that improve the buy in is the more pragmatic the study is, the more the study is in keeping with our 
normal practice, the more likely they’re going to buy in.  When you design a study that has multiple 
interventions to be done, the likelihood of that going well is really poor….if you have a whole bunch of new 
procedures that are specific to this particular study, your compliance is going to be way lower than it would 
normally. (FG- Other) 
 
And I think it has to be simple. It has to be very clear and straight forward. The thing you ask them to do has to 
be very limited and very well defined. And it can’t be onerous. (FG- Other) 
 
 
4.2 Learner Factors  
 
Participants were asked to reflect on how paramedic characteristics, including personal attitudes, 
beliefs, experiences, and skills, may affect their experiences and comfort with the conduct of prehospital 
clinical trials.  In addition to the two broad themes discussed below, the model incorporates prior 
experience with clinical trials as a relevant factor.  However, as all participants in this study had 
experience with prehospital clinical trials, this theme was not explicitly explored.  Two broad themes 
were identified in focus groups and interviews pertaining to paramedics’ characteristics associated with 
general interest in research (4.2.1), and specifically how paramedics perceive the value of prehospital 





4.2.1 Characteristics of Paramedics in Relation to their Field of Practice (Table 10).  All 
participants contributed to the discussion of how typical traits, inclinations, and backgrounds of 
individuals currently in the field of paramedicine may influence factors associated with participation in 
research.  These were often expressed in the context of understanding why a paramedic may or may not 
be interested in research or inclined to view it as a component of his or her profession, which can be 
useful in the design of training approaches to maximize paramedics’ comfort and skills with 
participation.  Characteristics identified include general predisposition that may have led individuals to 
the practice of paramedicine, enthusiasm for new or novel experiences, and the impact of generational 
or cohort differences.     
 
Table 10.  Characteristics of Paramedics in Relation to their Field of Practice 
 
Influence of prior experience and predisposition on attitudes toward research.  Participants 
described perceived traits of paramedics that either drew them to paramedicine, or were relevant to 
having an understanding of or interest in research.  Some of these comments, expressed by both 
groups, may reflect traits of more typical paramedics that are perceived to impact attitudes toward 
research, such as interest in helping others, and expectations for understanding the rationale behind 
protocols.   
 
In my opinion, a good paramedic embraces the aspect of helping people. You know, and anything that you can 
do is a plus, so if we can give them pain medication or I mean, you have to have an attitude of service, in my 
opinion, to make a good paramedic, you know? The attitude of service, and not the attitude of, you know, being 
bothered. (I- Paramedic) 
 
Paramedics are generally willing to do – a bigger workload or a difficult challenge if they understand it and it 
makes sense…if it doesn’t make sense, or it’s poorly deployed, or it’s just stupid, they’ll break it or they’ll kill it. (I- 
Paramedic) 
 
…they’re really not sophisticated in understanding the depth of how research is done…I mean, a lot of EMTs and 
folks will move mountains and do really complex, you know, almost unthinkable work…and they will do it well 
and very accurately if they understand the why. (I- Other) 
 
I think most paramedics are very mechanical in their thinking. They’re not very analytical as far as trying to look 
at analyzing what the reasons that they’re doing things, so I think it really – the most important thing is just 
learning that [inaudible 14:53] expectation specifically. If that makes sense. (I- Other) 
Interest and preference for new experiences may be relevant to the conduct of prehospital clinical 
trials.  There were several themes pertaining to whether or not paramedics’ predisposition for change 
and new experiences is related to participation in research. The data suggest that some paramedics 
are driven by preference for novel or new experience, whereas other are more protocol-driven.  In 
some cases, general disinterest in one’s job, or “burnout,” was also discussed as a factor which can 
impact paramedics’ inclination toward the additional expectations regarding a clinical trial.     
 
It’s like a change almost, like you know, sometimes people fight change, so they’ve got the attitude of well, why 
am I doing this, why is it up to me, right.  So there’s the odd person like that.  It’s not as many, but I just think on 
a personal level, we’re just – want to try new things and be involved in things and it’s learning as well. (I- 
Paramedic) 
 
…that’s totally new to them, but they love it, because they say they’re doing something different. They’re now 
doing something that might help somebody’s brain, and they’re getting to do something that’s hands on. 





They’re a really unique group that foundationally are protocol driven. So they’re very much driven by specific 
step by step protocols. So as a whole, you’re dealing with a workgroup that is very scripted, and if you leave it for 
too much interpretation, then you can end up corrupting the project, right? Does that make sense? (I- Other) 
 
…they view participation in these studies as a change in work environment, where now there’s a new skill that I 
have to perform where there’s this new thing that I have to do, and they balk at that almost unanimously… 
because that’s a change in our environment. (FG- Paramedic) 
 
There is a small group that is not interested in taking the extra few minutes or whatever it takes to do the 
training, and extra few questions, so there is – that can be tough to get buy in from those.  (FG- Other) 
 
I have found a lot of people, because of burnout and whatnot that just comes along with the job, they – you 
know, they’re like I don’t want to participate in those things, I don’t get paid any extra money…and I’m just a 
puppet and I’m just tired of doing trials, because you’re kind of tired of doing the job too, so.  That affects some 
people’s attitude toward these things.  (I- Paramedic) 
Paramedic cohort as a potential factor influencing trial interest and experience.  Some of the 
comments linked paramedic age and job seniority to interest in participating in clinical trials.  
Participants explained that younger cohorts are more likely to have received education on research 
methods as part of their training, which they felt contributes to a culture change in some EMS 
systems; also see related discussion on changes to the field of paramedicine in Environmental Factors 
(Section 4.4). 
 
The only thing I can think of for the handful of studies where, you know, four or five studies where we’ve gotten 
pushback from specific individuals is they’re closer to retirement, and they tend to be older or have longer tenure 
there. (I- Other) 
 
I think you’ve got to remember most paramedics, especially the older ones, received no education or very little 
education in research methodologies, and so as the profession moves more towards an evidence based medicine 
sort of model, getting more paramedics hands on experience with doing research gets them to understand that 
process better. (FG- Paramedic) 
 
…We’re turning over. We’re an older service. We’ve got a lot of 40 year old people retiring, a lot of young kids 
coming straight out of college, and they’re more invested in research, and they’re chomping at the bit to get 
involved in some of this stuff, so I think there’s a little bit of a cultural change with the education for medics 
coming up.  (FG- Other) 
 
4.2.2  Interest in and Perceived Value of Prehospital Clinical Trials (Table 11).  Focus groups and 
interview participants were asked to elaborate on what paramedics found interesting or rewarding 
about research.  Paramedics especially stressed the relationship between research and advances in 
patient care, and also the general importance of prehospital clinical research to ensure that the most 
evidence-based approaches are practiced. 
 
Table 11.  Interest in and Perceived Value of Prehospital Clinical Trials 
 
Research in the context of improving patient care.   Many participants appreciated that research can 
lead to advances in the treatment of patients by providing evidence that may lead to protocol 
changes in the field.  This understanding of the longer-term goal of research was described as a 





As a professional paramedic, as a practitioner of paramedicine, we all want to advance the field. We want to do 
the most correct, best practices out there…So I think participating in these studies where we find the kind of – 
the old way is not necessarily the best way anymore helps us advance our field and gain knowledge and make it 
better for our patients out there. (I- Other) 
 
I think it’s an important part to see the future of where we’re going and what we’re going to be doing.  Most of 
the paramedics want more tools to help our patients, so participating in trials is a good way for us to shape our 
own future.  (I- Paramedic) 
 
…from my perspective it makes us better to participate in these. We’re getting information on kind of the cutting 
edge stuff a lot earlier than it’s getting published, so I think it’s important for our people to participate just 
because it makes us better at providing clinical care.  (FG- Other) 
 
It’s important to us because we feel like we’re part of a group that’s learning or trialing things that are going to 
hopefully improve patient outcome and I think we all want that in the long run.  So it’s kind of fun also to be like 
hey, I was part of that study and you know, help make a difference maybe, or maybe not...  (I- Paramedic) 
 
We really think this is going to make a difference in patient outcomes and patient care or we wouldn’t be doing 
it. (I- Paramedic) 
Importance of paramedicine research in the prehospital setting.  There were several themes related 
to the recognition that, in order to improve patient outcomes, potentially life-saving emergency 
medicine techniques need to be tested specifically in the prehospital setting.  Awareness of the 
importance of this setting for clinical trials will increase buy-in from all stakeholders (e.g., hospitals in 
particular) and help to advance the field of paramedicine as a whole.   
 
It also creates buy in from the field perspective that they’re an active participant in, you know, changes in care 
or protocol changes that are coming up, whereas before it’s things that maybe extrapolated from in hospital 
studies that, you know, doesn’t work in the pre-hospital environment. We don’t know unless we try it.  (FG- 
Paramedic) 
 
…if it’s all done in the hospital and it’s not employed or evaluated in the field, we’re missing a real critical piece. 
(I- Other) 
 
It helps the average paramedic, average EMS provider to understand that there’s more to it than just providing 
the care on the vehicle, or like at the patient side. You know, it shows that there’s career development options, 




4.3 Training Approaches  
 
Drawing on the conceptual model, the domain of Training Approaches addresses the methods and 
strategies to encourage successful uptake of clinical trial training goals.  Participants were asked to 
reflect on their experiences to address a series of questions about training practices and recommended 
strategies for developing and implementing successful training programs for prehospital clinical trials. 
Topics raised by the participants align with the conceptual model domain, Training Approaches, as they 
describe different methods and strategies focused on the learner’s needs and influences (4.3.1) and on 
those strategies aimed at promoting institutional uptake of clinical trial training goals (4.3.2). Many of 
the themes that emerged relate to those described in the Implementation Context (Section 4.1) and 




influence factors within those domains. As posited by the conceptual model (Figure 1), the interplay of 
these three domains (Implementation Context, Learner Factors, and Training Approaches), in addition to 
the influence of the environment, may ultimately affect prehospital clinical trial training outcomes. 
 
4.3.1 Training Approaches addressing Learner-level Factors 
 
4.3.1.1 Training Delivery Methods (Table 12).  During focus groups and interviews, participants 
described training methods that support learners’ mastery of competencies for successful prehospital 
clinical trial participation. Useful methods include delivery of the training in person (versus web-based), 
incorporating hands-on activities and other interactive approaches that promote active learning, and 
repetitive training to impress new skills and protocols in learners’ minds.  
 
Table 12.  Training Delivery Methods 
 
In-person training is important for gaining buy-in and engaging learners. Participants noted the 
value of in-person training, either alone or as a complement to web-based training, to gain buy-in 
from paramedics and stimulate learning. Compared to remote or asynchronous training approaches, 
in-person training encourages paramedic participation in training. Classroom-style discussion and in-
person group activities can help solidify training material, while providing opportunities for learners 
to ask questions and raise concerns.  
 
Oh, I guess the biggest thing would be face to face service. I mean, that’s the best thing, because when you do it 
online, or you know, have it as a continuing education that, you know, people say do on a computer, they’re just 
going to ignore it. I mean, they’re just going to say, excuse me, even if it’s mandatory, they’re going to just cook 
through it, you know, just to get it done. (I- Paramedic) 
 
I think that the initial training can be online, but if there isn’t that in person follow up component of it the 
paramedics will either lose interest or not follow through. (I- Other) 
Hands-on training activities help build learners’ confidence. Participants noted that hands-on 
training experiences engage learners while improving their skills and self-efficacy with clinical trial 
protocols. Although hands-on training is generally preferred among paramedics, participants in other 
roles reported that available resources often drive selection of training methods.  
 
Face to face and tactile is the best way to go to get to EMS providers. (FG- Paramedic) 
 
What do they value? They all like hands on. They all like operating something that they haven’t done before 
using a pump.  (I- Other) 
 
Yeah, the training was…only half the day.  It was really good and to the point when we were learning how to use 
the pump.  Again, the pump was easy and they made us do it with our eyes closed, so we could just do it by feel 
so we were really comfortable with it, which was great.  (I- Paramedic) 
 
Actually, he came to each firehouse …and…told us how to administer it, told us about the protocols, told us 
about the study. You know, he opened it up. He let us touch it. You know, because to me, most firemen learn 
best by actually being hands on. So he actually, you know, let us touch it, let us see it, you know, let us have our 
understanding of what it was going to be, and you know, that was it. (I- Paramedic) 
 
If we could have had them actually work a patient that was a simulation of a traumatic brain injured patient, I 




know, they saw what we wanted them to do, then they actually did it. I think that would have helped…We would 
have needed two hours, so it’s that balance between how much time do you have, how much time are they 
willing to give and do you have the facilities, the equipment to do that kind of training. (I- Other) 
  
I think it depends on the complexity of what it is, but I know when we were rolling out like high performance 
CPR, and obviously even like teaching it, I find that unless – by doing it, it was like totally – you had to go and do 
it a couple times and stuff, so I mean, certain things I think are really critical to do the simulation for. (FG- Other) 
Repetition of training material supports learning retention and learners’ comfort with the protocol. 
Focus group and interview participants discussed the role of repetition during training to impress new 
protocols upon paramedics and improve their comfort. Particularly for complex protocols, it is 
important to provide sufficient protocol training and repetition of critical components so paramedics 
feel comfortable implementing the protocol in the field. 
 
This is what you need to focus on, and when you went through the video training or the PowerPoint training, 
those were the three things that were continually hit on over and over that repetitive, that repetition makes a 
big, big difference. (I- Other) 
 
… the more training somebody has, the more comfortable they’re going to be giving the medication or dealing 
with that medication…if you come in and do kind of repetitive training on that and keep like pounding it into 
their heads a little bit of this is when you give it, this is why we’re doing it, then you know, they’ll be a lot more 
comfortable doing it. (I- Paramedic) 
 
4.3.1.2 Prehospital Clinical Trial Training Content (Table 13).  Participants reported that prehospital 
clinical trial trainings generally focus on the information essential to paramedics, with an overview of 
the trial’s purpose and research concepts briefly covered as part of the overall training curriculum. 
Tailoring training content to the learner’s clinical knowledge base and using familiar language can help 
gain the attention of learners and support their grasp of new concepts.  
 
Table 13.  Prehospital Clinical Trial Training Content 
 
Prehospital clinical trial trainings focus largely on the specific protocol. Prehospital clinical trial 
trainings emphasize what paramedics need to know to take part in the study, including the protocol 
and the rationale for the study. Research methods and ethics are often included in the training at 
some level, although non-paramedic participants reported that paramedics’ appetite for detailed 
research education is generally low. 
 
So it was a package, a curriculum package. It was designed to introduce the trial, the logic for the trial, patho 
physiology of stroke. We added also stroke prevention in there. Some of the – Well, obviously most of the 
researchers are heavy into public health also. And then the mechanics of the trial. Here’s the protocol. (I- Other) 
 
About 300 medics are going to carry out the protocol. I just want them to know the basics. This is why. This is 
how you do it. (FG- Other) 
 
He kind of gave us what we call like a 10,000 foot view of the study, and then he said but I want to talk about the 
– like this is the moral and ethical considerations and kind of how clinical trials worked, so that was in the same 
continuing education session that he went into that first. (I- Paramedic) 
 
Other than sometimes the more advanced paramedics want more literature, more understanding of what 




them references that they can go to to read up on more information. But as far as undertaking the trial, I give 
them what’s necessary with some handouts. (I- Other) 
 
Oh, I had to do EFIC training for all 400 paramedics, which is doing it 35 times, the Belmont report, beneficence. 
(laughs) We’ve all done that every year training. That was really a lot of work, and no one liked it. (FG- Other)  
Tailoring trainings to paramedics’ clinical knowledge base and delivering the training in “their 
language” supports paramedic understanding and engagement. Paramedics’ training uptake may be 
improved when the training content takes into account the language, experiences, and learning style 
of paramedics. 
 
And one of the girls who was there training us, I know that she’s really quite smart (laughs) and she said I was 
reading this and I know it was put together by a neurologist, but I didn’t understand any of it, so here’s the meat 
and potatoes of it.  And they just dumbed it down to our level, which was great. (I- Paramedic) 
 
So the training has to be directed towards the type of individual and you know, it’s – well, I’m that type of 
individual. I need to see images. Words kind of don’t sync in as well. (I- Other) 
 
I’m out there all the time. I’m interacting with paramedics, answering their questions, and when they talk to me, 
they know they’re talking to somebody they can speak the same language. (I- Other) 
 
The other thing that we found was that paramedics doing the training was far superior to – Nurses or docs doing 
the training. We involved paramedics very early in our training curriculum, and got their input and incorporated 
it into our program, and that made all the difference in the world, because the medics just – a medic speaks the 
language to another medic that a physician or a nurse just doesn’t, so that worked really well for us. (FG- Other) 
 
 
4.3.1.3 Refresher Training and Ongoing Learner Support Strategies (Table 14).  Prehospital clinical 
trial refresher trainings and ongoing instructional strategies were key discussion topics in the focus 
groups and interviews. Although refresher trainings are not uniform, participants communicated the 
importance of continually refreshing paramedics on the trial for successful protocol implementation 
over time.  Participants also reported additional strategies to provide paramedics with ongoing trial 
assistance and motivate their continued participation. These strategies include providing paramedics 
with trial reference material and access to telephonic assistance for trial-related questions. 
 
Table 14.  Refresher Training and Ongoing Learner Support Strategies  
 
Refresher/booster training sessions can improve protocol implementation (e.g., protocol 
deviations, low enrollment) and motivate paramedics. Focus group and interview participants 
discussed the importance of refresher or booster training sessions on protocol implementation and 
sustained paramedic participation. When the volume of cases is low, refresher trainings may be 
especially useful to maintain paramedic awareness of the trial.   
 
We’ve found that refresher training is very, very important in terms of protocol adherence and keeping them on 
track… (I- Other) 
 
…data was now becoming instantaneous for us for the first time so we could see the trends and we could get 
instant follow up, so if a crew was out of protocol or outside of the… guidelines, for one, we had the follow up 
from the hospital right away, and now I could go back, look at the chart and say, hey, this is where there are 
mistakes. And once we saw trending mistakes, we would block out a next training of EMS training would go 





And it’s also dependent on how frequently they actually do the calls. So hey, if I’ve done four [Trial name] calls, I 
may not need retraining. I haven’t done a [Trial name] call for a year or two. Probably be a good idea. (I- Other) 
Reference material and access to trial-informed individuals (e.g., investigators, nurse educators) for 
assistance can help paramedics overcome uncertainties and address training gaps. Participants 
reported various strategies to support paramedics in their ongoing implementation of the protocol, 
including reference cards and placards, online resources, and access to PI and/or others for questions. 
Non-paramedics described the intent of these strategies to remind paramedics of the protocol and 
help them through uncertainties, especially if the paramedic lacked training for the prehospital 
clinical trial. Some paramedic participants noted that strategically placed protocol reference cards can 
help trigger their recall of the trial, and appreciated having access to PIs and/or other trial-informed 
individuals for questions. 
 
I think for the most part once we got our little reference cards it had parameters as far as what you need to do, 
as far as you know, the blood pressure or this or that. Once we had those available, I mean, in most cases I 
remember the reference cards either being on the monitor thing…so you can look at it and say, hey, we’re doing 
this. They either had that there or if it was a drug trial they had something on the drug box so when you went to 
get a drug out of the drug box you could remember, you know, which trial you’re doing it. I mean, I think that 
helps. (I- Paramedic) 
 
The difficulty of course, as I’ve say, is maintenance of competency, as every six months we have to review it, but 
we’ve got placards that hang beneath the pump. I call them 3:00am cards. When it’s 3:00am in the morning this 
tells you step by step what you’re supposed to do. (I- Other) 
 
And then there are certainly those that don’t get the training that they should, and that’s why we have all of 
these, you know, pocket cards and EPOS physicians and paramedic specialists and all of that. Paramedic 
specialists are the ones that sit in dispatch working on single response vehicles or are there to answer calls from 
the field. (I- Other) 
 
The other thing that I think was vital…is that accessibility to the PI or somebody that they can call to say when 
those gray area situations come up that they don’t have an answer for, what do I do. Can I call somebody, can I 
get in contact with somebody to get an answer to that question?  (FG- Paramedic) 
 
4.3.1.4 Training Rollout (Table 15).  In focus groups and interviews, participants commented on 
challenges that arise when there is a significant time lag between the prehospital clinical trial training 
and initiation of the trial, and when there are varying levels of training exposure among paramedics 
within an organization. 
 
Table 15. Training Rollout  
 
Time lags between training and trial initiation may negatively affect paramedics’ ability to recall 
and implement the protocol effectively. Participants discussed the impact of time lags on 
paramedics’ implementation of the protocol. Significant time lags between the training and trial 
initiation can negatively affect learners’ retention of training information, affecting their ability and 
confidence to implement the protocol effectively.  With regard to impact on training specifically, non-
paramedic participants discussed the budgetary implications when a second training is necessary to 
re-train participants because of extended time gaps between the initial training and the trial.  






What affects their comfort?  Hm.  Well, again, it’s length of time between training and rolling out what we will 
be doing. (I- Paramedic)   
 
But the problem is we do a lot of planning and ramping up and say, okay, we’re ready to start on September 
first, so we’re going to do our training in October or August. And then we get everybody trained, and then…two 
weeks goes by, a month goes by, 12 weeks goes by, 16 weeks goes by, everyone’s forgot about everything. We 
burned through all the money for overtime for the initial training, and now we’ve got – So sometimes that is 
unavoidable, but it creates a complete nightmare. (FG- Other) 
Non-uniform paramedic training for specific clinical trials within organizations can create challenges 
for paramedics in the field and affect the trial. Participants reported that inadequate prehospital 
clinical trial training among paramedics and organizational training gaps can result in protocol 
implementation issues, and may place burden on paramedics who have received the training.  
 
I think the one super failure that we realized, I think it was just because we had so many other things going on, 
and there was probably a two or three year break in our training specifically for [Study name], and we’d actually 
like – through QI we noticed that there was, hey, why aren’t these guys doing this, and we brought it back in and 
some of the guys had never had the initial training. Some guys didn’t even know we were still doing the study at 
all, and that – that was the huge kind of breakdown… they realized if you’re not continuing education every 18 
months your members completely lose track of everything. (I- Other) 
 
I guess the drilling that we get in the classroom, it helps, but it’s just one time a month until the trial goes in or 
actually goes, you know, into effect, but like I said, if you don’t go to those classes, that could be the challenge of 
it all. (I- Paramedic) 
 
…so all of a sudden, they get scheduled to work on your car and they don’t have the training.  So it makes it a 
little more difficult because you’re running the whole show, whereas if I’m with my partner who’s trained, she 
could be getting the [trial equipment] set up while I’m on the phone… (I- Paramedic) 
 
4.3.1.5 Training Incentives (Table 16). Focus group and interview participants discussed the use and 
effectiveness of training incentives. Specifically, non-paramedic participants commented on the use of 
incentives to help drive learner engagement in training activities; however, respondents to the Member 
Checking Survey indicated that incentives may not be the most essential element for motivating 
paramedics. Respondents clarified that paramedics appreciate food and money provided, but training 
incentives are generally not necessary.  
 
Table 16. Training Incentives 
 
Providing paramedics with food at trainings and monetary tokens of gratitude are appreciated but not 
critical to garner paramedic participation. Non-paramedic participants noted the benefit of providing 
food at in-person trainings and using other types of incentives as a strategy to boost paramedic 
engagement. In Member Checking, however, paramedics commented that providing food is a nice 
touch, but other types of prizes (e.g., gift cards) are not necessary for motivating paramedic 
participation. 
 
So you know, every quarter we would have somebody from [the network], [inaudible 57:34] would come down, 






Paramedics really like food. You have to bring food to every training if you want them to be your friend. I mean, 
that’s like on a check list. It’s really important that you feed them. (I- Other) 
 
So at the end of the month when everybody had replied and we had a whole bunch of different agencies – EMS 
agencies participating, we drew a name from each agency, and they got something kind of cool, like an iPod 
shuffle or a $50 gift card – Visa gift card or something that would up the ante for them to respond and read that 
message, and I think it was really, really, really helpful. Protocol deviations went down for the first two weeks 
always after we sent that message. (I- Other) 
 
I think there will always be some that are motivated through various incentives, however, I don't think they are 
critical to garner participation. (MC- Paramedic) 
 
Food is always good. Prizes, much less so. If they need to be compensated to participate, that negates the 
altruistic aspect of research. (MC- Other)  
 
 
4.3.2 Training Approaches addressing Institution-level Factors 
 
4.3.2.1 Institutional Resources to Strengthen Trainings and Support for Prehospital Clinical 
Trials (Table 17).  Interview and focus group participants described how EMS institutional resources 
can be leveraged to promote successful training programs using approaches that endorse collaboration 
with internal agency leadership and external stakeholders, such as hospital and fire systems, 
institutional review boards (IRBs), and unions.  Participants described benefits of the multi-system 
approach including the prevention of knowledge and communication gaps and consistency of protocol 
implementation across sites. As expected, most of the responses about the use of institutional resources 
were made by participants who serve in roles other than paramedics, given that many in the sample, 
such as training managers and principal investigators, have experience coordinating and implementing 
successful training programs. 
 
Table 17.  Institutional Resources to Strengthen Trainings and Support for Prehospital Clinical Trials 
 
Involve peer champions in the trainings.  Staff members within the EMS organization who are 
motivated and/or experienced in conducting prehospital clinical trials can be engaged to promote 
trainings and research study participation or be trained to train others (i.e., used in a train-the-trainer 
model). 
 
I know who my champions are, my paramedic champions. So I talk to them before I go into that first day of 
training and say, “You guys, what do you think? How is this going to be received? There’s this really cool study 
we’ve got an opportunity to participate in. Your leadership wants to do it, but I really wanted your opinion.” So if 
you feel like you’re empowering the champions…, they also have influence and can get excited. And sometimes 
we train the trainer with those champions so it’s peer to peer training instead of me. (I- Other)  
 
There’s kind of two ways I think of getting things done in an EMS agency or a fire department, and one is getting 
the administration’s buy in and the medical director’s buy in. But sometimes they have other things going on 
and they’re just like I can’t add one more thing to my plate. So sometimes it’s easier to find some paramedics in 
the organization that you know, that you’re comfortable with, that you can kind of sell them, and then they 




Demonstrate leadership buy-in and support for training.  Training programs for prehospital clinical 
trials can be more successful when the managers and other leaders of EMS organizations are 
supportive of research. 
 
In my experience I think training is absolutely critical to the paramedics, and certainly in our situation I do all the 
training, mainly because I’m the PI, and what I’ve learned over the years with paramedics is they like to hear it 
from the horse’s mouth. You send in a coordinator. You send in someone else. They’re not going to buy in, and 
they’ve really enjoyed that, and they commented specifically on the fact that that’s why they’re doing research, 
because you’re engaged enough to actually speak to us about it. (FG- Other) 
I had an in-service training which is basically all of the members go to our central training locations at our 
training bureau, and then [the PI] came in. He led the training and then he had fellows…there to say, “We’re on 
board. We know what you’re doing.”…They did a great job of saying we’re all on board. …Any question that we 
had, we could ask him directly. We had plenty of ed opportunities. Our supervisors, you could call them and say, 
“I’ve got a question about this trial.” (I- Paramedic) 
So for our side, [the challenge] is getting the EMS agencies to participate, finding time, because … whenever 
you’re talking about training, you’re talking about dollars out of someone’s budget. …So trying to get a big 
organization…to come on board, it took us a while to get that to happen, almost I want to say close to a year, 
because they’ve got… 2,000 practitioners out there that we needed to talk to. So it was getting them on board 
and then getting into their training cycle was a little bit difficult. (I- Other) 
Use standardized templates that can be tailored to site training needs.  Trainings for prehospital 
clinical trials should include common methods, messages, implementation format and frequency to 
encourage a system-wide approach, and include templates for tools that can be tailored to site 
specifics.  When asked to comment on this theme during the member-checking exercise, only 82% of 
the respondents agreed. Member Checking respondents provided comments stressing the 
importance of tailoring training programs to local needs.   
 
You can have some messages or key points that everybody needs to be trained on, but how those are delivered I 
think needs to – you need to have trust in people that are doing the training, that they know their agencies, they 
know their medics, and they know what’s going to be best and what will work. Everybody does it a little 
different. (I- Other) 
How can you replicate studies when no system is the same? It’s very difficult to get some of those replication 
when logistically or the way that systems set each other up organizationally, culturally, the structure of it, it’s all 
different. Who are they funded by? Municipality, county, the fire department, public health department. I mean, 
that creates different organizational behaviors and structures that also create a lot of barriers for research in 
EMS and drive different cultures, because they have different goals. I mean, they’re different missions. I mean, a 
fire based EMS system has a way different mission than a public health like funded EMS system. (FG- Paramedic)  
You know, there’s so much variability in the pre-hospital setting or even in the emergency setting. I mean, you 
can’t think of every situation. You can’t have a script for everything that’s going to come up. We kind of tried to 
think of as many things for this trial, and there’s been a few things come up that we never imagined were going 
to happen, so I think you just have to teach … what are the core values of the study and then kind of give them 
the freedom to you know, make a common sense decision and always err on the side of, you know, being ethical. 
(FG- Paramedic) 




Give contemporaneous feedback to motivate paramedic engagement with the study.  As discussed 
above as part of the Implementation Context (4.1.5), institutional resources should be allocated to 
provide study updates (e.g., enrollment).  This theme was particularly endorsed by the non-
paramedic participants. 
 
…I think face time was important, ongoing, and just sort of keeping them informed of how things are going or 
where the opportunities lie. (FG- Other) 
 
But yeah, annually there would be an update, and along with the update would be well, you know, here’s how 
many cases we’ve enrolled right now and we haven’t had any problems or anything like that. (I- Other) 
 
So – and the other problem too with the research is there’s not that instant gratification, like the [Name] Trial, 
we didn’t have any kind of information back for, boy, I think a year maybe. (I- Other) 
 
…things that came from the research group that were meant to be as kind of like token ‘thank yous’ for 
participation … a lot of that wasn’t necessary from the line providers’ perspective as much as maybe seeing how 
getting a better insight and recognition that individual providers were contributing to the development of 
sciences probably would have been more important and gave more buy-in than the stipends for participating in 
the training. (I- Other) 
 
And also, if you kind of followed up and said, ‘Hey, this is where the trial’s at. This is how it’s going. This many 
people have shown improvement. … and the people that haven’t shown improvement, here’s why.’ If you keep 
people more involved, I think they’d be more willing to do it. (I- Paramedic) 
 
4.4 Environmental Factors  
 
As per the model, Environmental Factors are variables that influence the prehospital clinical trial 
environment overall but that are not likely to be directly impacted by training programs.  A range of 
environmental factors may influence the success of prehospital clinical trial training programs. These 
factors intersect with paramedicine and research at a community and societal level, and as such, 
paramedics and EMS leadership do not necessarily have actionable control of them. Focus group and 
interview discussions uncovered two factors within the larger setting of the prehospital environment 
that may indirectly influence paramedic participation in research - the evolution of the paramedicine 
profession (4.4.1), and the role of stakeholders in advancing research within the field (4.4.2).  
Respondents of both role types (paramedics and others) provided feedback related to this domain.  
 
4.4.1 Evolution of the Paramedicine Profession (Table 18).  The impact of the movement toward 
a license/degree-based profession was discussed, including the potential influence on newer cohort’s 
research knowledge and the conduct of prehospital clinical trials (see 4.2.1 for discussion of cohort 
differences). For example, requiring paramedics to obtain a bachelor’s degree is likely to create 
opportunities for paramedics to learn about research methods, research design, data collection, public 
health, behavioral health, and to internalize their role in research prior to entering the paramedic 
profession. The majority of these sentiments were expressed by participants representing “other” roles, 
several of whom were originally trained in paramedicine. 
 
Table 18.  Evolution of the Paramedicine Profession 
 
The field is advancing the scope of paramedicine training to include advanced education. 




paramedics are increasingly joining the field with advanced education and skills, and that their 
increased role in research demonstrates a general acceptance that the field is expanding. 
 
We are developing an advisory for [EMS councils] right now that talks about elevating the credentialing for 
paramedics to a more formalized university-level degree program for moving from certification to licensure in 
the paramedic field. So a paramedic would need to have a bachelor’s degree to be able to practice. (I- Other) 
 
The traditional concept was …that the medical director practices the medicine and that the paramedics and 
EMTs basically carry out the protocols. It’s actually [the EMTs and paramedics who] practice the medicine, and I 
think that’s where the mindset is changing. That they actually are independent practitioners. They independently 
treat patients. They function under a set of standing orders, but they have their own licenses. They have their 
own training, their own certifications, and I think that’s the mindset that we’ve been trying to change for the last 
at least five, ten years, and I think so that’s probably this technician-clinician difference is making them more of 
a clinician than they think they at least – and getting that mindset into their thinking. (I- Other) 
 
One of the things that we’ve been trying in my career to do is elevate the paramedic to a level of being a 
professional – considered a medical professional in the same level as a, you know, physician, nurse, dentist, 
pharmacist, and you know, basically bring them in to that realm of healthcare provider. And I think we’ve done a 
good job and honestly, the paramedics that are out there now, almost all of them have advanced education…I 
think the current cohort very much considers themselves…a part of the medical healthcare profession. (I- Other) 
Added value of advanced education and research experience. Participants described how the 
benefits of more extensive training programs leads to better quality of research and improved patient 
health outcomes. Participants (particularly paramedics) expressed their beliefs that employers will 
expect paramedics to have degrees and other indicators of advanced education, and in return, 
paramedics will expect to be compensated commensurate with their increased skills and knowledge. 
 
I think paramedicine is a very, very new profession, and I think certainly when I teach our paramedics, the buy in 
in terms of moving the profession forward I think is very, very key. There’s very little evidence for so much of 
what we do in paramedicine early on, and I think with the randomized trials you add science to the profession, 
and you move that profession forward. And I think that gets a lot of buy in from the paramedics, for sure. (I- 
Other) 
 
So when I got a graduate degree in education I was one, if not the only advanced graduate-degree paramedic in 
our system. It helped – It opened a bunch of doors for me, and it makes me appreciate research. It makes me 
appreciate everything so much better. ...So we would like to get more of that. (I- Other) 
 
So when …we elevate the entire practice of paramedicine to be more in line with nursing and the doctors out 
there…there is room in the curriculum to be able to talk about studies and data and what our role is in those 
studies. (I- Other) 
 
I know one time here … they were trying to make the paramedic like an associate’s degree or something, make it 
even like pre-requisites as far as anatomy, physiology, and all this other stuff. That’s all fine and well and 
everything, but I mean, you could go to school same amount of time it is for all that and get your medic or you 
could go to nursing and make, you know, twice the money. So I mean, it’s kind of a money thing on that. (I- 
Paramedic) 
 
Well, in the near future, we are going – moving away from like a one year program to a two year program for 
paramedics, so it’s going to be a longer and broader education.  And I think once you do that, you get people 
who are more used to a learning environment…. But I think there will be buy-in and I think at that time, people 
might be interested in how the research is done, because they may have taken that stats course or something 





4.4.2 Stakeholder Engagement to Advance Research (Table 19).  EMS agencies work alongside a 
variety of organizations to implement prehospital clinical trials, with varying levels of experience, 
interest, and resources available for research.  These variations across settings impact the 
implementation context directly or indirectly and can make implementation difficult when priorities or 
resources conflict, or when organizations have differing needs and goals for their involvement in 
research.  Themes related to stakeholder engagement include demonstrating commitment to working 
across different agencies and institutions, and to guidance for developing networks of institutions 
committed to research that can potentially reduce barriers to engagement for all relevant partners.   
 
Table 19. Stakeholder Engagement to Advance Research 
 
Work with and across diverse EMS systems.  Participants described the range of characteristics 
across EMS agencies and other organizations involved in implementing clinical trials that must be 
considered when developing training programs and determining how to standardize training 
information while maintaining flexibility for site-specific needs; see Training (Section 4.3). 
 
I would say just having many, many points of view or input, having different departments with different 
structures like – Just coming at it from different points of view as far as, you know, size, amount of medics, 
utilization of medics in the department, you know, I guess you need to take all that into account when you’re 
doing a study like that. (I- Paramedic) 
 
It would be really easy to roll out the same training for every single agency. But if you don’t individualize that to 
the agency or the group of paramedics you’re talking to based on their previous experience in clinical trials or 
maybe they have none. An agency who has never participated in research at all is going to have to be trained 
very differently than an agency who has participated in three exception trials. …You can have some messages or 
key points that everybody needs to be trained on, but how those are delivered I think needs to – you need to 
have trust in people that are doing the training, that they know their agencies, they know their medics, and they 
know what’s going to be best and what will work. Everybody does it a little different. (I- Other) 
 
How can you replicate studies when no system is the same? Like you know, it’s very difficult to get some of those 
replication when logistically or the way that systems set each other up organizationally, culturally, the structure 
of it, it’s all different. Who are they funded by? Municipality, county, the fire department, public health 
department. I mean, that creates different organizational behaviors and structures that also create a lot of 
barriers for research in EMS and drive different cultures, because they have different goals. I mean, they’re 
different missions. I mean, a fire based EMS system has a way different mission than a public health like funded 
EMS system. Or a private company… Continuity is different, especially like on these multi-site pre-hospital trials. 
It’s very difficult to try to make those generalizations between those sites. (FG- Paramedic)  
 
From a creative sort of standpoint from the get-go would be developing the trainings. I was able to … create the 
program in such a way … that information translates across all those [sites]. When I say A, does that mean A in 
Idaho or no, because they use Z there. So I mean, even before it even gets rolled out to the people, there are 
challenges that you have to sort of think about and be able to overcome those as well. (I- Other) 
Develop, engage, and train networks of institutions committed to research.  Participants described 
the importance of having an established research infrastructure in place before beginning clinical trial 
implementation and for garnering support from leaders of all key institutions.  Participants in 
leadership and educational roles who are more actively engaged in institutional-level collaboration 
also described communication gaps and other frustrations dealing with organizations (e.g., unions, 
fire departments, and city councils) collaborating on clinical trials who are not aware or were not 





I think the first step to avoid any political conflict when you’re introducing a trial to an EMS agency is to sit down 
with the leaders first and say, ‘Here’s what we want to do. This is what it’s like to be involved. This is how much 
time it’s going to take. This is what we can compensate you. This is how long it’s going to last.’ And just be really 
transparent with that leader and have that leader make a decision, yes we want to participate or no, we don’t.  
(I- Other) 
 
The unions are important, but one thing we’ve been really successful with in getting buy-in is so fire chiefs report 
to a mayor and city council, so we were heavily involved in the rescue trial. When that publication came out, you 
know, we went before the city council and really – ‘Thanks to the leadership of the fire chief. We were able to do 
this study here, and these are the results.’ And ‘Thank you, Mr. Mayor. Thank you, City Council.’ And so we go 
right to the politicians and get buy in from them, and I think when we did that several years ago now, that set a 
great foundation to … encourage the fire chief to value research and that stuck a little bit. (FG- Other) 
 
I worked in other systems around the country where you’re getting a lot of private systems, and those open up 
lots of different things. You know, union contracts, and labor constraints for how people are trained, and how 
people are paid, and all of these stratified layers of restriction, that it comes down to you just want to get good 
training. …I think one of the early challenges is really getting in earlier with the administration, understanding 
good MOUs on what timeline looks like…those were challenges that were not recognized as fully by the line 
providers, but it was certainly a challenge that was recognized by management that you run into these labor 
agreement challenges that are just frustrating when you try to just do the research. (I- Other) 
 
Our system is that all patients are transported by ambulances. There is the fire department too. We get along 
with all of them. But [if] we can’t get there fast enough, the fire department responds first. So … we needed their 
engagement. We needed their help. We needed them not to do things or to do things. So we had to make sure 
everybody’s engaged. … So we’ve got to make sure that everybody is on the same page and they all know what 
each other’s responsibilities are. (I- Other) 
 
To do these types of trials it takes someone who knows the intricacies of EMS and knows their system well, … It 
probably took about a year and a half just to get buy in from the community, so at the same time we’re talking 
to paramedics, we’re talking to the hospitals, the critical care physicians...we needed to get all the neurologists 
and those individuals on board so they would support it because it – yeah, it only takes one prominent physician 
or nurse saying this is not good to really derail a study. (I- Other) 
  
5.  Discussion 
 
In this section, limitations of the study are presented, followed by a summary of key findings organized 
by research question (1.2).  Note that the final research question explicitly addresses recommendations 
to optimize methods and strategies to engage and train paramedics for prehospital clinical trials.  
 
5.1. Study Limitations  
 
There are several limitations of this study that impact interpretation of the findings.  First, and by design, 
the study was largely exploratory and required drawing on prior experiences with training for and 
implementation of clinical trials.  Given the emphasis on identification of lessons learned, all individuals 
have had prior experience with clinical trials in the prehospital setting.  This criterion for involvement 
has the potential to emphasize the perspective regarding, for example, factors that may or may not 
contribute to paramedics’ interest in research. Paramedics who have not participated in trials, and who 




Future research exploring barriers to participation or perceived barriers should consider recruiting 
paramedics who have declined, or have not yet been invited to participate in a trial, or those known to 
be disinterested. Second, this qualitative study employed an intentional sampling strategy designed to 
identify information-rich sources with relevant prehospital clinical trial experience.  It is not intended to 
be representative of the entire population of stakeholders, but this approach is appropriate for 
generating transferrable findings.  That is, the findings would likely have relevance broadly without 
making any specific claims about the full details or any particular emphasis across the findings. Third, 
there is some potential for recall bias.  Participants were asked to reflect on their training and trial 
implementation experiences from trials that may have concluded several years prior to data collection.  
However, the information that they retained, regardless of whether it represented the full breadth of 
their experiences, may be the most important relative to their current views about participation in 
research and likely has little impact on the themes under discussion.  Finally, as this information is self-
reported, social desirability may have filtered participants’ reports. Steps taken to mitigate this risk 
included taking precautions to avoid expressing any particular view by the researchers in the 
construction of the interview guide, the efforts to explore the full range of opinions, and the use of an 
independent data collection entity (Westat) which has no particular stake in the study findings.  
 
The conceptual model provided is a preliminary attempt to represent factors influencing participation in 
and success of prehospital clinical trials, with an emphasis on paramedic training. While appropriate for 
examining the breadth of opinions relative to the participants in the study, the sampling approach used 
does not allow for stratification on variables (e.g., type of EMS agency, type of trial, etc.) which may 
have relevance to the setting in which the trial takes place. Due to these limitations, further exploration 
of contextual factors, coupled with a quantitative approach to assess the generalizability and 
importance of specific factors, could enhance understanding about factors and strategies associated 
with paramedic engagement in and training for prehospital clinical trials. 
 
5.2. Discussion of Findings  
 
The findings provide information to address the research questions underlying this qualitative study, 
namely: 
 
 What factors and strategies are associated with paramedic engagement in prehospital clinical 
trials? 
 What methods and strategies have been used for paramedic training for prehospital clinical 
trials? 
 What are the challenges and barriers associated with paramedic engagement and training for 
prehospital clinical trials? 
 What are the recommendations to optimize methods and strategies to engage and train 
paramedics for prehospital clinical trials?  
 
These findings have been organized through a conceptual model (Figure 1) to comprehensively illustrate 
the overarching domains of relevance, and the breadth of relevant factors. Many of the themes from 
this study pertained to the organizational context in which the trial is conducted and the training for the 
trial takes place.  Participants, particularly those in leadership and educational roles with personal 
experience facing some of the challenges, emphasized the importance of agency support for prehospital 
clinical trials, which is evidenced by visible leadership and which uses a range of strategies to reflect the 




supporting trials is availability of resources, which is often a challenge for EMS agencies due to limited 
budgets and competing priorities. Lack of resources at the agency level impacts the continued 
investment required to conduct the trial, as well as capacity to provide sufficient training for 
paramedics.  Given that enrollment in prehospital trials is often a relatively rare event, it is especially 
critical that resources be allocated to provide the tools and information throughout the trial, to 
supplement any trainings offered and to provide support for paramedics.  Another contextual factor 
associated with trial success is the presence of dedicated research staff or study champions, who 
function to simplify the research environment and paramedic experience during the conduct of the trial.  
The presence of study champions, in addition to other factors, has an impact on paramedics’ comfort 
and skills with research participation by providing informal access to information pertaining to the trial 
and motivating trial participation.   
 
To advance the field of prehospital research, it is critical that the contexts in which trials take place are 
prepared to engage paramedics in all phases of the research.  Consideration of the paramedic role 
throughout trial design and implementation not only impacts commitment to the trial but also can 
ensure that the design is pragmatic.  Employing methods to solicit ongoing input on what is or is not 
working in the field, and providing periodic updates on trial enrollment, were also recommended.  A 
positive culture for research more broadly and adequate training for specific trials, can reinforce 
paramedic engagement, as per this comment from a paramedic who provided this feedback during the 
member checking exercise, “[Paramedics are] more likely to participate willingly when they’re trained-
and feel the trial is well organized, optimized clinically and procedurally -- and they understand the 
purpose.”  Given the challenges of conducting trials in the prehospital setting, efforts to monitor 
paramedics’ compliance with the protocol should be conducted using non-punitive approaches that 
incorporate ongoing appreciation for paramedics’ efforts.   
 
The findings also reflect observations on how paramedic characteristics (learner factors), including 
personal attitudes, beliefs, experiences, and skills, may affect their experiences and comfort with the 
conduct of prehospital clinical trials. These characteristics include the general predisposition that led 
individuals to the practice of paramedicine, enthusiasm for new or novel experiences, and the impact of 
generational or cohort differences.  Paramedics, the findings show, perceive research in the prehospital 
setting to be valuable because it can identify evidence-based approaches to patient care that advance 
the field of paramedicine.  
 
Awareness of important learner factors, such as the perception that paramedics are motivated by 
helping others and by understanding the purpose and goals of the trial, can contribute to more effective 
design of training curricula for clinical research conducted by EMS agencies.  Focus group and interview 
participants were asked to draw on their own experience to reflect on training methods and strategies 
that support learners’ mastery of competencies for successful prehospital clinical trial participation. 
Those in the non-paramedic group were more likely to emphasize that training options and 
opportunities are impacted by availability of resources, and to observe that current cohorts of 
paramedics are typically disinterested in learning about research methodology.  The timing of training 
relative to implementation, combined with refresher trainings and ongoing learner support strategies, 
were considered critical for successful protocol implementation over time.  Although incentives are 
typically offered and can help drive learner engagement, additional feedback from the member checking 
exercise indicated that they are appreciated but not essential, as per this comment from a paramedic, “I 
think there will always be some [paramedics] that are motivated through various incentives, however, I 





The findings also reflect variables that are part of the larger prehospital clinical trial environment, which 
may influence the paramedic experience as well as the success of training programs.  These topics were 
discussed chiefly by participants in leadership and educational roles. In particular, the evolution of the 
paramedicine profession was acknowledged as a potential factor influencing future cohorts’ knowledge 
and experiences with clinical research methods. Paramedics are increasingly joining the field with 
advanced education and skills, and with an enhanced expectation that they will be involved in clinical 
research in the prehospital setting.  Recommendations to encourage institutional and stakeholder 
engagement were also identified, including working with and across diverse EMS systems to build a 
network of institutions committed to and capable of conducting research successfully in the prehospital 
setting.   
 
Specific recommendations for training design and conduct are presented in Table 20.   Framed by the 
preliminary conceptual model (Section 3), these findings and recommendations can be considered by 
researchers and others to address some of the barriers or challenges to paramedic involvement in 
prehospital clinical trials.   
 
Table 20.  Recommendations for Training  
 
To the extent possible, provide trainings for prehospital clinical trials in person 
Incorporate hands-on activities into the training program 
Ensure the prehospital clinical trial training is commensurate to the complexity or newness of the protocol 
Engage paramedics in the development of the training program 
Tailor the style and content of trainings to the paramedic audience 
Conduct ongoing refresher training sessions, especially for trials with low volumes of cases 
Provide paramedics with easy access to protocol reference material and trial experts 
Aim to minimize the time lag between initial training and trial initiation 
Provide adequate training to all paramedics who may have an opportunity to enroll patients 
Involve peer champions 
Provide feedback to paramedics on enrollment and study outcomes  
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EMS Experience Project/Aim 
 
------------------------------------------------------------------------------------------------------------------------------- 
EMS Project Focus Group:  Paramedic Training and Scope of Involvement in Clinical Trials 
SIREN Subproject #1 
 
Focus Group Preamble 
Thank you for taking part in this focus group. We are delighted that you have agreed to join us.  I am 
[FACILITATOR NAME] and will be facilitating today’s discussion. This is [CO-FACILITATOR NAME], who 
will be taking notes so we can refer to them later if we have any questions.  We are part of a team of 
researchers led by Dr. Robert Silbergleit at the University of Michigan and others involved in the SIREN 
Network. 
[CO-FACILITATOR] and I are from a research organization, Westat, located in Rockville, MD.  We are 
working with SIREN to better understand the range of research practices currently used to involve and 
prepare EMS paramedics for their roles in clinical trials that enroll subjects in the prehospital setting. 
The goal of today’s focus group is to get your thoughts and opinions about the experiences of 
paramedics and EMS directors involved in these trials. We recognize that many of you are not 
paramedics, so we will be asking for your thoughts on their experiences.  We will also, however, be 
asking for your own experiences and perspectives based on your role in prehospital research. 
Information collected from this discussion and others will help SIREN identify best practices of involving 
and preparing EMS paramedics for their roles in emergency care research, and help to identify 
challenges, unanswered questions, and clarify what needs to be studied empirically.   
Before we continue, I want to stop and see if you have any questions about what I have said so far. 
Answer any questions. 
Okay, now I’d like to go over a few “housekeeping” guidelines.  
In a focus group, it is really important that you express yourself openly.  There are no right or wrong 
answers. We want to know what you think. I am here to guide you, but you should feel free to 
express your opinion and discuss among yourselves. If you would like to add to an idea, or if you have 
an idea that is different from someone else, feel free to jump in. You do not need to wait for me to 
call on you to talk, but of course, only one person should speak at a time. 
I want to remind you that your participation in this discussion is voluntary and you can choose not to 
respond to any question for any reason.  Do I have everyone’s consent to participate?  Obtain verbal 
agreement. 
Also, we ask you to keep what will be discussed today within this group and not share it with others 
who are not participating. This is to make everyone feel comfortable sharing their honest opinions 




We will be recording this discussion today as a back-up to make sure our notes are correct.  Your input 
will be kept confidential, and what you say will not be linked to your name in any report. The recording 
will be destroyed after we have analyzed the discussions.  If at any time you do not want your 
comment to be recorded, please let [NAME] know and we will turn off the recorders while you are 
speaking.  
Do I have your permission to record our discussion? Obtain a verbal agreement. 
Please silence your cell phones and other electronic devices. You might also notice that I may repeat 
or ask questions about some of the comments that you make throughout the discussion today. I will 
do this not only to ensure that we capture everything that is said in the group but also to confirm that 
I understand what you have said. 
Are there any questions before we get started? Answer any questions. 
Introduction 
Let’s first go around the room and have each of you state your first name and role (e.g., 
paramedic, EMS director, research investigator. When you introduce yourself, briefly please tell us 
about your experience doing clinical trials in the pre-hospital setting and what types of pre-hospital 
studies you’ve been involved in. 
1. In what ways is participating in clinical trials something you think is an important part of paramedics’ 
jobs? 
Probes: 
● To your knowledge, have paramedics participated or heard about how the results of a 
prehospital trial have impacted or led to a change in the care provided in the 
prehospital setting? 
 
2. From your perspective, what about participating in trials do you think paramedics find most difficult 
in terms of protocol implementation and other procedures? 
Probes: 
● Logistical challenges (executing key steps, communicating with hospital/study staff, 
ensuring consistency)? 
● Lack of EMS voice/perspective during protocol development? 
● Protocol implementation (e.g. confirming eligibility, a particular procedure?) 
● Enrollment (e.g., recognizing that a patient is eligible, identifying which study to enroll 





● For those of who you are not paramedics, what do you find most difficult about 
participating in prehospital trials?  
 
3. Can you tell us about a time when it was uncomfortable to enroll a patient into a prehospital trial 
and what made it uncomfortable? 
Probes: 
● Ethical considerations (e.g. audio recording, protecting patient confidentiality, concerns 
about the study)? 
● Consenting 
● Determining eligibility 
● Family/LAR communications 
● Have you heard about whether some medics avoid enrolling people because they are 
uncomfortable with it?  
 
EFIC Studies 
4. In EFIC trials, where consent is not required prospectively, how are decisions made about when 
consent may be feasible versus when it is not? 
Probes:  
● Describe a time when consent feasibility in an EFIC trial needed to be determined.  
● Describe a time when “no objection to research” needed to be obtained from a family 
member available prior to enrolling a patient into an EFIC research study? How was it 
done? 
 
5. Can you tell us about any particular experiences (positive or negative) you have had with patients or 
families in EFIC studies?  
Probes: 
● When you/paramedics are enrolling a patient in an EFIC trial, how do you/they 
communicate with the family member/others present? 
● In what ways do you/paramedics adjust how you act because family members or other 
people are observing you? 
● For those negative experiences you described, what do you think could have prevented 
them (e.g., changes in training/your own behavior, changes in the protocol, changes in 






Now I’m going to ask you some questions about exception from informed consent or EFIC studies.  
6. When you have been involved in prehospital studies that require consent, tell us about the consent 
process for these studies.  
Probes: 
● How is this different than the screening and enrollment process for EFIC studies? 
● What do you think matters most about doing consent processes in the prehospital 
setting (e.g. keys to success, biggest areas for failure/problems)? 
● What are people’s (patients’ or families’) reactions to being asked for consent? 
● Are there particular types of studies that you think cause problems/challenges from the 
perspective of consent? 
● Are there challenges to the consent process specific to non-EFIC studies that we haven’t 
already talked about? 
 
General 
7. What would you like the researchers developing prehospital protocols to know or take more into 
consideration?  
Probes: 
● Challenges with enrollment, consent, etc.  
● Need to consider paramedics’ competing priorities.  
● Impediments to clinical roles.  
 
Training to be involved in Clinical Trials 
Now that we’ve heard about the challenges of conducting clinical trials in the prehospital setting, let’s 
discuss the types of training and tools that would help mitigate those challenges.  We’d also like to hear 
about any topics you’d like training on that are not currently available. 
8. Can you tell us about the kinds of training you/paramedics have received to be involved in a clinical 





● Protocol implementation (e.g., enrollment procedures, inclusion/exclusion criteria, consenting 
process)? 
● Communicating with family members/others? 
● Research ethics (e.g., GCP/HSP)? 
● General research (e.g. design, studies)? 
 
9. Thinking back to some of the negative or uncomfortable situations you experienced in prehospital 
research, were you provided with adequate/appropriate training for circumstances such as these? 
Probe: 
● What recommendations do you have to improve or create trainings that would prevent or 
mitigate these occurrences?  
 
10. What would make the clinical trial training experience better for you/for paramedics from your 
perspective?  
Probes:  
● Involve paramedics in training design?  
● More/better training tools (e.g., scripts, reminder cards)? 
● More/better training formats (e.g., web-based, hardcopy, instructor-led)? 
● Realistic training expectations (e.g., time commitments, compensation) and refresher sessions 
(e.g., frequency, duration)?  
11. Have there been training tools you found especially helpful to paramedics and what about these 
tools were so helpful? 
Probe: 
● Content 
● Format (e.g.  
● Logistics, mode of delivery  
● If you/your organization has developed training tools for clinical trials, are you willing to 







Thinking back to our discussion, does anything else come to mind that you think might be important?   
➢ Dr. Silbergleit, do you have any follow-up questions you would like to ask or clarifications you’d 
like to make at this time? 
Thank you for participating.  You have all worked hard and we have learned a great deal from you.  We 
appreciate your help with this important topic. 
[NAME] will distribute your gift card and ask that you sign the form to document that you received this 




















EMS Experience Project/Aim 1 
INTERVIEW GUIDE (MASTER) 
Paramedic Training and Scope of Involvement in Clinical Trials (SIREN Subproject #1) 
 
Interview Guide Preamble 
Thank you for agreeing to participate in this interview.  I am [INTERVIEWER NAME] and will be facilitating 
today’s discussion. This is [CO-INTERVIEWER NAME], who will be taking notes so we can refer to them 
later if we have any questions.  She may also ask questions to ensure all the necessary topics are covered.  
As you are aware, we are from Westat, a research organization headquartered in Rockville, MD, and are 
part of the team of researchers led by Dr. Robert Silbergleit at the University of Michigan and others 
involved in the SIREN Network.  [Add brief description of SIREN Network here and in introductory email 
from Westat.  May also add detail about gift card here and in introductory email from Westat.] 
We are talking with you and others to better understand how EMS paramedics are prepared for their 
role in clinical trials in the prehospital setting. The goal of today’s interview is to learn your thoughts and 
opinions about the experiences of paramedics involved in these trials.  We will be asking you to reflect 
on your own experiences and provide your perspective based on your role in this type of research. 
Information collected from this discussion will help EMS researchers identify best practices for involving 
and preparing EMS paramedics for their role in emergency care research.   
Before we continue, I want to stop and see if you have any questions about what I have said so far. 
Answer any questions. 
Okay, now I’d like to go over a few “housekeeping” guidelines.  
We hope that you are comfortable expressing yourself openly, as there are no right or wrong 
answers. I want to remind you that your participation in this discussion is voluntary and you can 
choose not to respond to any question for any reason.  Do I have your consent to participate?  
Obtain verbal agreement. 
We will be recording this discussion today as a back-up to make sure our notes are correct.  Your input 
will be kept confidential, and what you say will not be linked to your name in any report. The recording 
will be destroyed after we have analyzed the data.  If at any time you do not want your comment to be 
recorded, please let me know and we will turn off the recorder.  
Do I have your permission to record our discussion? Obtain a verbal agreement. 
Are there any questions before we get started? Answer any questions. Turn on recorder. 
Introduction  
In today’s discussion we are going to address several topics, including your own experience, and 




conducted in January at the NAEMSP Conference, in which you or your colleagues may have 
participated.  We will also be asking you some targeted questions pertaining to your experience 
and perspectives regarding [Trial name here].   
First, I would like to understand your personal experience with clinical trials research more 
generally.  I understand that your role is [paramedic, EMS director, research investigator, research 
coordinator].   
1. Please briefly describe your clinical trial experience in the pre-hospital setting and the studies 
you’ve been involved in. We are interested in experiences that you would consider either 
positive or negative. 
Probes: 
● In your experience, what makes a pre-hospital clinical trial go well (i.e., what is the 
“secret sauce?”  (e.g., previous positive experiences, leadership, team chemistry, 
motivators/incentives) 
2. What do you consider to be the challenges or barriers to clinical research in the pre-hospital setting?  
Have you encountered these barriers? 
Probes: 
● Lack of resources (e.g., time for training and for protocol development, staffing) 
● Protocol complexity 
● Lack of/low involvement of trial champion 
● Regulatory challenges 
● Insufficient training (EMS or otherwise) 
● Lack of EMS voice/perspective during protocol development 
 
Paramedic Experience 
Now I’d like to move to a focus on the experience of paramedics. 
3.  In what ways is participating in clinical trials an important part of your job/a paramedic’s job?  What 
do you find/think paramedics find interesting or valuable about participating in research? 
Probes:  
● Knowing that trial results lead to change in care provided in the prehospital setting 
● Requirements/expectations (e.g., of EMS directors/managers) 
● Wanting to feel “part of something bigger” 




4. What do you think affects your/paramedics’ comfort and skills with regard to clinical trials? 
Probes:  
● Individual-level:  Years of experience, prior background, educational background, 
understanding of research methods, appreciation of the value of trials in improving 
emergency care 
● Patient-level:  e.g., mistrust, language/health literacy, social conflict 
● Institutional-level:  Type of institution (e.g., fire department, etc.) in which trial is taking 
place, presence of a champion, effective leadership, shifting priorities, earmarked funds 
● System-level:  EMS systems, change in public awareness, advances in the profession 
● Nature and complexity of the trial, including adequacy of training and other support 
5. What approaches or strategies can help with these issues [regarding comfort and skills]? You can 
speak from your own experiences, from what you’ve heard from others in the field, or from what 
you have read.  
Probes: 
● More engagement of the EMS director [requires resources, more like for a multi-site?] 
● Reduce complexity of protocol, if possible 
● Design protocol to mediate conflict or “hesitation” between providing acute care and 
enrolling the patient 
● Availability/accessing of research coordinator 
● Stronger foundation in research methods; different educational requirements 
● More participation of EMS in protocol development 
● Additional training (both “soft” skills re: dealing with LAR, and technical/methods skills), 
including refresher training 
● More recognition of paramedics’ role 
Targeted Trial [FRONTIER, IMMEDIATE, Ketamine] 
6. Now I am going to ask questions that pertain more directly to your experience and role on XXX trial.  
I understand that this trial was conducted from [xx date to xx date] and focused on xxx.  Please 
describe your role in this research. 







Can you tell me anymore about this?  Is anything incorrect or missing? 
Probes: 
 Was there any step that you found to be particularly critical or less critical?   
8. It is my understanding that this trial was particularly unique because [FOCUS].  Can you describe 
more about this [if haven’t already]?  
9. What was the most difficult situation for you/for the paramedics in this trial?  Can you describe a 
situation that worked well? 
10. What training did you/paramedics receive for the XXX trial?  Please describe the training or 
resources that were provided. 
Probes: 
 How were you/are paramedics prepared for this types of [difficult and positive] situations 
[described above]? 
 What did you think you/paramedics were or weren’t prepared for?   
11. Can you tell me [more} about how the training or resources were delivered or provided to you/to 
paramedics? 
Probe: 
 Were you/paramedics able to complete the training as planned?  Did you/they have any 
particular challenges (e.g., timing, your schedule, etc.)?  
 What aspect of the training worked best for you/paramedics? 
12. If you have received/developed training for other pre-hospital trials, how did the training for XXX 
trial compare? 
13. What would you recommend to improve paramedics’ training for clinical research?  Can you think of 
anything else we haven’t covered that would make the EMS training experience better?   This could 
be related to content, format, or delivery. 
Environment and Context 
For our last topic I’d like to ask you to think about organizational or policy-level issues that may 
influence the future of EMS participation in research, or emergency care clinical research more 
generally.   Several of these topics came up during our focus group discussions. 




15. Among your colleagues, have you noticed any movement toward professionalization in the field of 
paramedics (i.e., licensed/degree, paramedicine) and, if so, how may this impact the role of 
paramedics in research?   
 
16. Are there any other circumstances in the broader environment that may influence the future of EMS 
participation in research, e.g., public awareness of the value of this type of research for trauma 
care? 
17. As a final question, do you have any thoughts on how a research network such as SIREN can help 
address the issues we’ve discussed today?  (e.g., accumulating and disseminating best practices, 
communicating with policy makers and other decision leaders, etc.) 
Thank you for participating.  We appreciate that you have taken the time to discuss your perspectives on 
this important topic.  We will be developing a summary report that will be shared with you via email for 






















The NIH would like to know about paramedics' experiences with prehospital clinical trials. 
 
This survey asks for your feedback on preliminary findings from focus groups and phone 
interviews conducted with EMS professionals. Your participation in this survey is requested 
because you participated in either a phone interview or focus group. It should take 15 minutes 
or less to complete. 
 
Your responses are confidential and all results will be reported in the aggregate. We will ask for 
your name for survey tracking purposes. Your participation and responses will have no bearing 
on your EMS agency, work on prehospital clinical trials, or NIH funding. If you have any 
questions or concerns about this exercise, please contact Dr. Paula Darby Lipman at 
PaulaLipman@Westat.com (301-279-4555). 
 






SECTION 1: Important Methods or Strategies Associated with Paramedics' Engagement in 
Prehospital Clinical Trials 
Please review each statement and indicate if you agree as to whether the statement fits with 
your experience in the field, disagree or have no opinion. If you feel strongly about any 
statement (especially if you disagree), please add your thoughts in the Comments field for the 
relevant statement(s). 
1. Paramedics generally like participating in procedures that will benefit patients and improve 






2. Paramedics are motivated when they understand the clinical relevance of the trial, rather 






3. Paramedics may like clinical trials that offer opportunities to try something new, 






4. Paramedic input on trial design, or feedback on existing protocols, improves the quality of 

















6. Paramedics may be more willing to be engaged in research when there is evidence of buy-








7. Attitudes about the value of research in general among EMS providers may impact 






8. Some paramedics may be less inclined to participate in research due to concerns about 










9. Paramedics are less willing to complete clinical trial tasks if they think that it will interfere 






10. Engaging stakeholders including EMS medical directors, union leaders, and other agency 







SECTION II: Important Methods or Strategies Used for Paramedic Training in Prehospital 
Clinical Trials  
 






12. Training methods that support active learning (e.g., simulations, scenarios, and hands-on 











13. Incentives (such as food at trainings, gift cards, and lottery-based prizes) help promote 






14. Tailoring the content of trainings to paramedics' clinical knowledge base and delivering 







15. Peer champions can be engaged to promote trainings and engagement in the research 

















17. Trainings should be standardized across sites, include a system-wide approach, and 








18. Time lags between training and trial initiation may negatively impact paramedics' ability 






19. In-person refresher/booster training sessions can improve protocol implementation (e.g., 






20. Research training should be included as part of paramedic continuing education, should 











SECTION III. About You 
 
We are requesting your name for survey tracking purposes. We will keep your responses 
confidential and only report aggregated results. 
 
21. Please provide your name 
First Name _______________ 
Last Name _______________ 
 
 
22. Thank you for your input on this topic. Please let us know if you have any additional 




















SIREN Aim #1 Codebook 
 
 
Parent code Child code Grandchild 
code 






 Discussion of including EMS when developing protocols at 
the beginning or throughout the development process; 
EMS provider involvement improves 
design/implementation 
Includes the idea of “buy-in” of the 
process, relying on EMS expertise 
Strategies Examples of strategies to ensure EMS involvement when 
developing protocols 
 
Protocol design  Discussion of designing protocols that are simple, limited 
deviation from routine care processes, feasible process 
and equipment, integrating protocol in workflow, EMS 
provider reference for simple protocols, also during 
discussion of EMS “style” and that they are used to step-




Discussion of EMS obtaining consent in protocol, 
challenges of obtaining consent, and enrollment  
Includes discussions of EFIC, 
teleconsenting 
Research personnel  Comments about dedicated research staff (e.g., site 
coordinators), can include discussion of need or cost of 
having dedicated staff, difficulty with training several staff 
but enrollment is low or sporadic 
 
Other  Include other discussion related to research operations 
and logistics 
Includes discussions of community 
consultation, recruiting from 





 Discussion of including EMS when developing trainings at 
the beginning or throughout the development process 
 
Strategies  Examples of strategies to ensure EMS involvement when 






Parent code Child code Grandchild 
code 
When to use code Comments 
Basic protocol training  Comments about protocol-specific trainings, strategies to 





 Comments about training for research methods, research 
design 
 
Ethics training  Discussion about ethics trainings, human subjects 
protection 
 
Training format  Discussion of types of training formats, modes, delivery   
Training topics  Comments about including topics beyond protocol-
specific trainings, including obtaining consent, 
communication  
 
Training schedule  Discussion of timing of training (closer to protocol 
implementation), booster sessions, timing of training 
affecting motivation, bureaucratic delays 
 






 Comments about difficulties with participating in 
trainings, timing, competing priorities 
 
Lack of training 
resources 
 Discussion of challenges faced due to a lack of training 
resources or discussion of the resource deficit itself 
 





General interest in 
research 
 Discussion about interest in conducting research in 
general or theoretically, participating in journal clubs, 
buy-in and understanding contribution of research 
Includes discussion of generating 
study ideas, equipoise between 
clinical care and research, 
considered an honor to be included 
in research; 
Also includes the negative (the 
feeling that research is burdensome, 





Parent code Child code Grandchild 
code 
When to use code Comments 




Examples of how generational differences affect interest 




Examples of how level of experience in the field affects 





Examples of how level of exposure to research affects 
interest in conducting research 
 
Comfort with research   Discussion about comfort and skills with conducting 
research  
 
Value of participating 
in research 
 Includes discussion of how EMS research makes 
translation more relevant to the EMS providers, 
improvement of EMS provider skills, strategies to 




Discussion of how research, results of studies can 
improve care, patients in studies get better care, 
engaging EMS providers in research will improve care, 
research improves EMS systems and how these are a 
valuable incentive to participating in research, discussion 
of outcomes (patients’ clinical outcomes, EMS proficiency 
outcomes) 
 
Strategies Discussion of strategies to increase EMS’ buy-in for 
participating in research, such as research education, 
providing clinical feedback, feedback on status on project 
 
Reluctance for EMS to 
participate in research 
 Includes comments about challenges with obtaining 
informed consent, delays in implementation, difficulty 
staying current on research protocols, alternative 
engagement in research (e.g., QI) 
 







Parent code Child code Grandchild 
code 
When to use code Comments 
Includes discussion of general EMS 
traits (e.g., those who are “good” 
and want to help patients however 
they can including doing research; 
those who are “bad” and just want 
the thrill of the fire/emergency) – 
See also “Interesting Quotes” for 






 Comments about the need for standardization of EMS 
systems, certifications 
 
Diversity of EMS 
systems 
 Discussion of various types of EMS systems with different 
funding mechanisms, priorities 
 
Stakeholders  Comments about the importance of champions, 
motivated leadership, institutional support for EMS, 
hospital staff, includes reverse of no buy-in from 
institution 
Could include positive feedback to 
paramedics from hospital staff 
Resources  Discussion of resources in EMS systems (opportunities or 
resources available within the system) 
 
Barriers  Discussion of challenges or barriers in EMS systems  
Engaging paramedics   Discussion of importance of engaging paramedics in 
research endeavors, respecting paramedics (beyond 
including them in protocol development and design) 
Includes discussion of leadership, 




 Discussion about professional opportunities and/or 
movement toward developing a licensed/degree-required 
field of study 
 
Other  Include other discussion related to EMS systems  
Parking Lot EFIC  Any discussion of EFIC studies Code comments to these codes, but 
we may not analyze Regulatory   Any discussion of regulatory processes, challenges, 
especially in relation to EFIC studies 






Parent code Child code Grandchild 
code 
When to use code Comments 
Interesting 
Quotes 
  Code any interesting quotes, can be double-coded with 
above quotes 
Give EMS credit for their skills; 
Discussion of general EMS traits 




















Appendix Table E.1. Member Checking Results – Theme Statements with Greater than 90% 




Theme Statement % Agree 
Implementation 
Context 
Paramedic input on trial design, or feedback on existing protocols, improves 
the quality of the study and ensures the protocol will be feasible to 
implement in the field. 
100% 
Paramedics may be more willing to be engaged in research when there is 
evidence of buy-in from all stakeholders, and when there is a clear trial 
champion. 
97% 
Engaging stakeholders including EMS medical directors, union leaders, and 
other agency leaders mitigates potential challenges in implementing 
prehospital clinical trials.  
94% 
Learner Factors Paramedics generally like participating in procedures that will benefit 
patients and improve clinical care 
100% 
Paramedics are motivated when they understand the clinical relevance of the 
trial, rather than by the research process per se. 
100% 
Attitudes about the value of research in general among EMS providers may 
impact implementation of the prehospital clinical trial.     
100% 
Paramedics are less willing to complete clinical trial tasks if they think that it 
will interfere with patient care. 
97% 
Paramedics may like clinical trials that offer opportunities to try something 






Leadership buy-in or a culture supportive of research helps to improve the 
success of training uptake.  
100% 
Peer champions can be engaged to promote trainings and engagement in the 





In-person training is critical for gaining buy-in and engaging paramedics. 100% 
Time lags between training and trial initiation may negatively impact 
paramedics’ ability to remember and implement the protocol effectively. 
100% 
In-person refresher/booster training sessions can improve protocol 
implementation (e.g., protocol deviations, low enrollment) and motivate 
paramedics. 
100% 
Training methods that support active learning (e.g., simulations, scenarios, 
and hands-on training) generally work better at engaging paramedics than 
methods relying more on passive learning. 
97% 
Tailoring the content of trainings to paramedics’ clinical knowledge base and 
delivering the training in “their language” supports paramedic understanding 
and engagement. 
94% 







Appendix Table E.2. Member Checking Results - Theme Statements with Less than 90% Agreement 



































They’ll be more likely to participate willingly when they’re 
trained-and feel the trial is well organized, optimized 
clinically and procedurally-and they understand the 
purpose (Paramedic- agree) 
 
But there are a hundred other reasons they may be less 
inclined....fear of retribution for a mistake; fear of 
liability, resistance to change, etc. There will be a variety 
of interest levels, and that is a management 
responsibility to understand their employees and 


















Incentives are good for showing appreciation but do not 
offset the time commitment (Other- disagree) 
 
Food is always good. Prizes, much less so. If they need to 
be compensated to participate, that negates the altruistic 























Depends on the EMS agency, many paramedics do not 
care about research and will tune this out. May be good 
for some interested individuals. (Other- disagree) 
 
Paramedics should be regularly engaged with the 
importance of research and clinical trials in CME offerings. 
If the research training is part of a current trial the 
paramedics are involved in, regular refreshers will help 
reinforce important concepts and benchmarks for the 
trial. (Other- agree) 
 
Key word is piggy back - separate the trial and procedural 
training from the research education/training Don’t 




















Consistency is important but tailoring is needed since EMS 
systems in the US are not uniform (Other- agree) 
 
As with any clinical research, there will be variability in 
clinical practice and operations across sites which may 
hinder standardization. Prior to training, it is important to 


























of a possible 
or pending 












It is important not to get them excited and then not 
deliver. The deflation they feel at missing an opportunity 
is worse than them not knowing they almost got the 
opportunity (Other-disagree) 
 
Wait until the trial is funded and at least 90% ready for 
implementation to inform them about it. I don't inform 
them until it is ready to deploy, as it really doesn't matter 
to line providers until that point. (Other- agree) 
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Over the past decade, investigators associated with the Resuscitation Outcomes Consortium (ROC), 
a network of regional clinical centers that conducted experimental and observational studies of 
out-of-hospital treatments of cardiac arrest and trauma, and the Neurological Emergencies 
Treatment Trials (NETT) Network, which aimed to improve outcomes of patients with acute 
neurologic problems through research focused on the emergent phase of patient care, have 
accumulated a wide range of experiences with regard to the ethics and conduct of exception from 
informed consent (EFIC) trials, including implementation of strategies for community consultation 
and public disclosure, and other aspects of transparency and compliance.  Synthesizing these 
experiences and developing a model operational procedures document for the implementation of 
EFIC can provide a valuable resource for investigators conducting emergency care research, can be 
used to inform future EFIC studies conducted by the Strategies to Innovate Emergency Care Clinical 
Trials Network (SIREN) investigators, and may serve as a foundational document for broader use in NIH-
funded research. 
 
1.2 Purpose  
 
The overall project focuses on the policies, practices, and accumulated experiences related to EFIC, with 
a particular emphasis on goals and methods for community consultation and public notification.   An 
expert panel method was used to gather specialized input and perspectives on the topics introduced 
through two documents developed by the SIREN team.  The sample of experts was invited to provide 
written feedback on the draft documents and to participate in a facilitated expert panel discussion to 
provide additional insights into topics pertaining to EFIC.  The expert panel, comprised of individuals 
representing the expertise and knowledge that exists through ROC, NETT and SIREN experiences, was 
convened via a web conference to help illuminate and explore the range of opinions, to identify gaps, 
and to provide critical feedback regarding possible recommendations and future courses of action.   
 
This report details the process and results of the expert panel method, conducted in three research 
phases1:  1) written feedback on two documents which were prepared by members of the SIREN team, 
2) participation in a facilitated panel discussion to discuss the utility of the documents and the specific 
topics pertaining to EFIC, and 3) integration of findings to provide actionable feedback for document 
revision and to identify gaps for further exploration.   
 
1.3  Description of the SIREN Deliverables 
 
In response to the passage of the EFIC regulations, the U.S. Food and Drug Administration (FDA) 
developed and disseminated the Guidance for Institutional Review Boards, Clinical Investigators, and 
Sponsors EFIC Requirements for Emergency Research.  The guidance is intended to determine the safety 
                                                 
1 Westat, a research organization headquartered in Rockville, Maryland, provided qualitative services under 
subcontract. Westat independently completed data collection and analysis, in consultation with the SIREN project 
team, which included developing procedures for data management, development of the expert panel discussion 
guide, and facilitation of the panel discussion. 
3 
 
and effectiveness of FDA-regulated products (e.g., drugs, including biological drug products, devices) in 
emergency setting EFIC trials.  EFIC investigators and IRBs, however, have found that the regulatory 
intent and specific goals of community consultation (CC) and public disclosure (PD) are difficult to 
interpret and implement.   EFIC researchers employ a variety of methods to define and engage with 
communities and have varied perspectives on the best ways to report on and determine adequacy of CC 
and PD activities.  SIREN was charged with developing two documents that identify best practices or 
clarify areas where further debate or research is needed.   
 
The first document was a scoping review of the literature on implementation of community 
consultation and public disclosure for emergency research using EFIC [lead author:  Neal Dickert, MD].  
The purpose of the scoping review was to: 
 
“...review the published empirical, conceptual, and policy literature related to community 
consultation and public disclosure for EFIC. Where possible, the goal is to identify best practices 
that can be communicated to the emergency research community in order to improve both the 
efficiency and quality of the conduct and review of community consultation and public 
disclosure.  Where best practices cannot be identified, the aim is to clarify areas where further 
debate or research could help to develop them.”  (Scoping Review, p. 1)            
 
The second document presents model operational procedures (MOP) for the implementation and 
review of NIH sponsored multicenter clinical trials with EFIC for emergency research [lead author: 
Robert Silbergleit, MD].  The document is intended to: 
 
“…provide a model process and procedures that can be used as starting point for 
implementation of clinical trials using Exception from Informed Consent for Emergency Research 
(EFIC) in NIH funded multicenter clinical trials.  The process and procedures described can and 
must be adapted to the specific needs and details of any future trials.  The materials provided 
were developed and informed by both thorough review of the accumulated scholarship related 
to EFIC, and other lessons learned through practical shared experiences of prior NIH funded 
emergency care researchers.”  (MOP, p. 1) 
2 Methods 
 
The project used a sequential strategy with three phases of research (Figure 1). In Phase 1 (expert panel 
review of documents), experts were sent two documents with instructions to complete the review. 
Feedback from this phase was used to identify topics for the subsequent facilitated expert panel 
discussion (Phase 2). Results of both data collections were integrated in the final analysis (Phase 3). 


















Expert sampling was used to identify a group of individuals with relevant experience, expertise and 
familiarity with the fundamentals of EFIC.  The sample was composed of experts representing at least 
one of three key stakeholder perspectives: (i) EFIC investigator or researcher, (ii) Bioethicist/Ethicist, 
and/or (iii) Central Institutional Review Board (CIRB)/IRB affiliate.  There were no honoraria for 
participation in either the document review or facilitated expert panel discussion activities.  
 
Appendix A provides the list of invited experts, their affiliations, the perspective they represented, and 
their participation in the project. 
 
2.2 Phase 1: Expert Panel Document Review  
  
The first phase of the project was to invite the expert panel to review the two draft documents and 
provide written comments on specific sections of the documents and in general.  
 
Data collection.  The SIREN team confirmed that the goal of the review was for the experts to consider 
whether the findings or interpretations expressed in the documents accurately reflected their expertise 
and experience with EFIC and their familiarity with the literature.   As Document Authors (Drs. Dickert 
and Silbergleit) were interested in capturing feedback on specific sections of text using a low-burden 
approach, each document was formatted with editable text boxes corresponding to sections for which 
feedback was requested.  The original text of the documents was protected from editing. 
 
All experts invited to participate in the panel were sent an email with both documents attached and 
detailed instructions on how to provide feedback (see Appendix B: Scoping Review and Appendix C: 
MOP).  In particular, experts were asked to provide input on sections where they felt revisions or more 
detailed explanations were required or where they saw gaps in descriptions of EFIC procedures and 
interpretations.  The experts were also invited to provide general comments at the end of each 
document.  
 
Experts were instructed to return their written feedback (i.e., draft documents containing their feedback 
in text boxes, saved with their initials) via email within two (2) weeks.  A reminder was sent three days 
prior to the due date.   
 
Phase 1
• Expert Panel Document Review
Phase 2
• Expert Panel Facilitated Discussion
Phase 3
• Integration of Findings
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Data Management. The Westat team developed an Excel spreadsheet and assigned a number to each 
document’s comment box and a unique ID for each respondent.  As documents were received, the 
Westat team extracted statements from comment boxes and entered them into the applicable cell in 
the Excel spreadsheet.  The reviewed documents were also saved on the secure project drive as source 
materials.  The Excel spreadsheet containing all reviewer comments was uploaded to the SIREN project 
drive for access by Document Authors and other SIREN team members. 
 
The Westat team summarized the key points from the Excel spreadsheet and created summary tables 
for review with the SIREN team.  The summary tables included feedback that offered new aspects of a 
concept or divergent points of view, as well as suggestions considered “actionable” (e.g., revised words, 
suggested restructuring).  Duplicative feedback was combined (and not weighted by amount), and 
feedback that indicated agreement with the text or concept was not included.  The SIREN team used the 
summary tables to guide decisions regarding topics for further exploration in Phase 2.  
 
2.3 Phase 2: Facilitated Expert Panel Discussion   
 
The second phase of the project was to convene a facilitated expert panel discussion to explore a 
selected set of topics generated from the Phase 1 document review feedback. The discussion was 
conducted via web conference and hosted by Westat. 
 
Data Collection.  A link to a scheduling poll for the facilitated discussion was included in the initial email 
to the expert panel when requesting the document review. The email explained that the facilitated 
expert panel discussion was intended to be an opportunity to further explore the topics presented in the 
documents.  
 
The SIREN working group identified topics for discussion based on the Phase 1 document review and 
developed a semi-structured guide to facilitate the discussion (Appendix D: Facilitated Expert Panel 
Discussion Guide).  Westat generated an agenda and distributed an Outlook meeting invitation with a 
WebEx session link to everyone who was invited to participate in the expert panel, including those who 
did not submit document reviews.  
 
The 2-hour facilitated expert panel discussion was led by a trained facilitator from the Westat team.  
Three other members of the Westat team and several SIREN working group members were in 
attendance to take notes and provide technical and content-specific assistance, as needed.  All 
participants were notified that the facilitated expert panel discussion was being recorded to which 
participants verbally agreed.  Participants were reminded that the purpose of the discussion was not to 
reach consensus or to discuss the basics of EFIC, but to explore the challenges and lessons learned of 
EFIC research.   
 
Data Management.  Two members of the team from Westat independently took detailed notes during 
the web conference, which were compared subsequently to reconcile any inconsistencies.  The notes 
were then compared against the list of facilitated discussion attendees and the recording, to fill in any 
missed discussion and speaker names.  The notes were not formally transcribed but capture the 
majority of what was said by participants.  
 
The Westat team created a tracking sheet to identify expected facilitated discussion attendees and 
monitor their participation in the web-based discussion.  The tracking sheet was updated after the 
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facilitated expert panel discussion to revise attendee list and update affiliations, as needed.  The Westat 
team shared the tracking sheet with the SIREN team for review and confirmation of panel member 
details (see Appendix A: Expert Panel List). 
 
2.4 Phase 3: Integration of Findings  
 
The SIREN team, and Document Authors in particular, used multiple sources from the Phase 1 document 
review to develop the discussion guide for the Phase 2 facilitated expert panel discussion.  As described 
in Section 2.3 above, the SIREN team used the summary of feedback from each document review to 
decide which topics to address in the expert panel discussion.  The Document Authors then reviewed 
the complete set of reviewer comments in the Excel spreadsheet and selected four topics that required 
further discussion and clarity from the panel. 
 
The Westat team created a first draft of the facilitated expert panel discussion guide, including main 
questions and probes for the four topics selected from the Phase 1 document review results.  The 
Document Authors reviewed and provided input on the draft guide, honing the probes to address the 
heart of the challenges and how to provide guidance.  The guide was finalized and a notes document 
was developed to capture comments under all relevant questions. 
 
To expedite the document revision process (to be conducted by Document Authors subsequent to this 
report), the Westat team conducted a secondary level of review of the Phase 1 Expert Panel Document 
Review Summary Tables.  Comments were classified to reflect instructions to reviewers to identify 
where revision or clarification is needed, and where there are gaps, as follows.   
 
 Revision - refers to comments about edits, wording, terms used, or reorganization of sections of 
the document. 
 Clarification - specific suggestions for elaboration or different information about a topic 
introduced in the document 
 Gap - refers to the absence of a relevant, substantive topic or information missing from the 
document 
 
The Phase 2 Facilitated Expert Panel Discussion Notes were also reviewed and analyzed independently 
to capture the main themes and related nuances expressed by the experts during the discussion.  In 
particular, text related to engaging diverse communities, FDA EFIC guidelines, and methods and goals of 




3.1 Participant Characteristics 
 
Eleven of the 29 experts (38%) invited to participate in the document review submitted written 
comments on at least one of the two documents (one expert only provided feedback on the MOP).  
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Sixteen experts2 (of the 22 invited) attended the Phase 2 facilitated expert panel discussion (via 
WebEx)—seven of whom had also submitted written comments on the documents in advance.  There 
was vigorous discussion among attendees, with seventy-five percent of participants (12/16) contributing 
at least one comment. See Appendix A for details about expert panel participation. 
 
3.2 Summary of Phase 1 Expert Panel Document Review Feedback 
 
This section summarizes the feedback specific to each document, particularly pertaining to feedback 
classified as clarifications on information provided in the review, or possible gaps reflecting a topic or 
concept that is either absent or not fully addressed.  See Appendix E: Phase 1 Expert Panel Document 
Review Summary Table for all feedback on both documents, including suggestions for revisions. 
 
Scoping Review.  As described in Section 1.3 above, this document reflected a review of published 
literature related to CC and PD activities for EFIC.   One expert reported having no revisions to this 
document, and a second expert only returned feedback on the MOP.  Thus, the assembled feedback 
represents input from a total of nine experts.  Several highlights were identified, with the majority 
focusing on CC:   
 
 Clarify that CC and PD should occur during protocol development. 
 Address how and when CC and PD activities occur at national vs. local levels. 
 Describe whether CC results vary by trial focus (e.g., cardiac arrest, TBI). 
 Emphasize that community consultation is intended to reflect the importance of establishing trust 
and respect within the community. 
 Include data on how and whether protocols are amended based on CC results. 
 Include additional detail on acceptance rates by CC method and rates of opt-out use.  
 Address challenges with PD, including the inability to reach entire communities. 
 Include more information on how to define the “community,” how to incorporate both qualitative 
and quantitative approaches for CC, and improve definitions of the purpose of each method. 
 Add text pertaining to transparency in CC and PD and consider restructuring the paper to align with 
FDA regulations. 
 
MOP.  Also described in Section 1.3, this document is intended to provide a model process and 
procedures helpful for implementing clinical trials using EFIC.  Based on review of accumulated 
knowledge and lessons learned through experience of NIH funded emergency care researchers, and 
using a specific trial on TBI as illustration, the information is intended to be adapted based on the 
specifics of the trial.  Feedback was received from all eleven experts; however, there were no comments 
associated with two sections of the document - “Reporting public disclosure activities” and “Data safety 
monitoring board.”  General feedback on the MOP included the following: 
 
 There is not enough information for the document to be a study protocol, but it is too specific to TBI 
studies to be a general guidance document about EFIC. 
 The flow of the document is unclear. 
                                                 
2 Several of the experts were unable to participate in the project.   Two web conference attendees, who joined the 
discussion in place of invited experts unable to attend, are included in the total count of experts present during the 
facilitated expert panel discussion. 
8 
 
 Additional language is needed regarding historical racism, effect on research ethics, and the need 
for more inclusion in community consultation activities.  
 
The majority of the feedback on sections addressing regulatory criteria and protections for EFIC reflect 
suggestions for revision or clarification.  A higher volume of substantive feedback was accumulated in 
sections pertaining to CC and PD principles and the associated “menus” of methods and approaches.  
Highlights of this feedback are summarized below: 
 
 Community consultation and public disclosure principles: 
o Include historical context of racism and patient enrollment without consent. 
o Balance discussion of geographic communities vs. racial/ethnic/age composition of patient 
population. 
o Include recommendations on the appropriate persons to conduct CC and PD activities. 
o Address expectations regarding intended reach of methods and other outcomes. 
o Emphasize value of continuous engagement throughout the trial, and address how feedback 
is captured and its potential impact on the conduct of the trial. 
 Menu of methods: 
o Improve integration and cohesion of these sections with the associated sections discussing 
principles. 
o Clarify the basis for recommendations, e.g., mix or number of activities. 
o Consider incorporating methods to leverage social media and public relations expertise and 
methods. 
o Elaborate on advantages and disadvantages of each approach, including measures of impact 
(consider including a grid of pros and cons for each method). 
 
3.3 Summary of Phase 2 Facilitated Expert Panel Discussion 
 
The following section presents findings from the EFIC Facilitated Expert Panel Discussion.  As previously 
stated, the purpose of the web conference was to expand on the expert document reviews on the 
Scoping Review and MOP.  Given the ambiguity of the FDA guidance for EFIC requirements, the goal of 
the discussion was not to reach consensus among experts, but rather to identify the range of 
perspectives, experiences, and understanding of the goals, methods, and guidance to develop and 
implement CC and PD activities.  In addition, a number of comments specifically targeted advice for 
improvements to the MOP.   
 
The range of themes and subthemes expressed during the facilitated discussion (See Appendix F:  Phase 
2 Expert Panel Facilitated Discussion Notes) are presented in the following sections.  Each section 
represents larger categories of discussion that either emerged from the facilitated discussion or were 
specifically queried.  Subthemes, a description of these subthemes, and participant comments3 are also 
included to provide context.  
 
Engaging Diverse Communities  
 
                                                 
3 As proceedings of the EFIC Facilitated Expert Panel Discussion were not formally transcribed, these are 
considered “comments” rather than “quotes.”   
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The FDA EFIC guidance document describes “’the community in which the research will be conducted’ to 
mean the geographic area, e.g., hospital or other facility, or city or region, where the hospital or clinical 
investigator study site is located” (pg. 25).  Several comments from the Phase 1 document review 
indicate that researchers are also interested in ensuring that diverse communities are engaged in the 
community consultation and public disclosure process.  Other feedback addressed the need to include 
language on the importance of protecting patients’ rights and the historical context of racism and 
patient enrollment without consent.  Several participants stated that engagement of diverse groups 
should be proportional to the community demographics; an alternative suggestion emphasized that 
outreach should reflect the demographics affected by the disease/condition of interest. Others 
suggested that diverse groups should be specifically engaged to address injustices that these groups 
have faced. In order to expound on these recommendations, questions asked during the web 
conference focused on the topics of engaging diverse communities, definitions of “community” and 
which communities to include.  
 
Table 1.  Engaging Diverse Communities 
 
Subtheme: Description Participant Comment 
Mirror diversity of 
community:   
Emphasis on outreach to 
diverse groups that are 
reflected in the community 
It is more important to mirror the community in which you are doing 
consent…some people do a blanket approach to include all minorities, 
but if that doesn’t mirror the local community, and one can put in a lot 
of effort, it doesn’t really make sense. 
 
You need to start with the study you are doing and understand your 
expected ethnic distribution of the population that will participate in 
the study and address those groups within your community 
accordingly. 
Mirror diversity of 
community affected by 
disease or condition:  
Emphasis on outreach to 
diverse groups that are 
affected by the 
disease/condition  
I think it depends on the scientific goals of the research and what the 
disease or condition is of study, which minority groups will be most 
affected.   
 
It is essential that minority communities in fact be sought out. 
Investigators do not know their own blind spots…From BOOST study 
experience with Advarra, we found that we targeted people accessible 
to us, we reached a largely educated African-American community. 
When we gave education levels to Advarra, the IRB asked us to target 
an uneducated African American cohort because that is actually a huge 
portion of the population that was likely to be enrolled in study. We 
were not aware of that blind spot. 
 
FDA Guidance for EFIC Requirements for Emergency Research 
 
Although there were no specific questions asked during the facilitated expert panel discussion regarding 
the FDA guidance for EFIC requirements, several experts discussed this document from both the 
investigator and IRB perspectives.  Comments suggested that the FDA guidance was difficult for IRBs and 
investigators to interpret and execute.  Additionally, CIRBs may not have enough understanding of the 
local community to tailor the guidance as needed.  Others implied that although the guidance is 





Table 2.  Guidance for IRBs and Investigators to Implement Community Consultation and Public 
Disclosure Activities  
 
Subtheme: Description Participant Comment 
Explicit regulatory 
guidance: Comments 
regarding challenges for 
IRBs and CIRBs to follow 
and implement the FDA 
guidance  
Challenge with articulating what we ought to be doing with no 
regulatory guidance on this…it would be very helpful for IRB for there 
to be some sort of guidance, because the FDA regulations are 
understandably extremely vague. 
 
Central IRB, may not know the local community, may not be able to 
provide guidance.  It’s a challenge for IRBs to walk the line between 
telling the community that they may not be doing an optimal job and 
respecting the local knowledge.  
Flexible, broad regulatory 
guidance:  Comments 
regarding ensuring that the 
FDA guidance is flexible 
and broad to apply to 
various communities  
The challenge in writing guidance on broad regulations is to allow a 
broad array of different options that are suitable for particular studies. 
FDA regulations and guidance are largely permissible for a large array of 
community consultation and public disclosure activities, which I think is 
advantageous.   They’ve identified certain principles that are important 
to guiding those activities, but they are not proscriptive.   
 
I think it’s a double-edged award.  In 1995, FDA specifically didn’t 
mandate certain approaches because every community is different, and 
there are different approaches that are most appropriate for that local 
population.  So, they were intentionally vague. I raise consciousness of 
group to be careful re: what is mandated or said about what people 
have to do—it’s a wide world and every community is different.  What 
is optimal for one community might not be optimal for another 
community.  
Guidance on modifying 
protocols after community 
consultation:  Discussion of 
how and when to modify 
IRB-approved protocols 
after receiving feedback 
from community 
consultations 
In the era of CIRBs (e.g., BOOST 3 trial), it feels disingenuous to do CC 
when protocol is IRB approved and essentially fixed in local context. 
Conducting CC when there is no means to radically change the protocol 
or impact the CIRB’s broad assessment of the protocol. There should be 
some element of CC done centrally before going to local communities, 
or it could be done in a number of representative local communities as 
part of IRB deliberations. 
 
The 2nd issue is the IRB’s protocol approval before communities seeing 
it. FDA says that IRB has authority to change protocol based on CC 
feedback data, but not sure how that is handled.    
 
My concern is when we have a protocol through IRB, the community 
decides they don’t like something and we change it.  Do we go back to 
community and let them know it’s been changed. They may have more 
opinions about that [change]. Do you go back to them a second time? 
 
We have to expect any protocol will be modified down the road-- it’s 
the nature of research.  CC is different from the ongoing responsibility 
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Subtheme: Description Participant Comment 
for PD, you need to look at it with common sense perspective.  If 
initially you describe the protocol in a certain way, and modifications 
don’t change fundamental nature of the research, then I don’t think 
you need to go do another CC or look to re-consent people, depending 
on how the whole thing is framed.   
 
Community Consultation Goals, Methods and Metrics 
 
During Phase 1, expert reviewers provided comments on the MOP and Scoping Review documents 
pertaining to methods used for CC.  Reviewers, however, did not elucidate their thoughts about the 
reasons for employing specific methods, or the goals of CC.  As these goals are not clearly described in 
the FDA guidance and clinical trial investigators may not have experience conducting CC methods or 
reporting metrics, participants were queried on these topics during the facilitated expert panel 
discussion.   Participants stated that the goals of community consultation include improving the study 
protocol, promoting transparency, and building trust.  In terms of CC methods, experts suggested 
several activities to engage key stakeholders, stressed the importance of conducting activities in the 
community setting, emphasized the value of using multiple methods, and pointed to the need for 
adequate metrics on CC activities. 
 
Table 3. Community Consultation Goals, Methods and Metrics 
 
Subtheme: Description Participant Comment 
Community Consultation Goals 
Improve study protocol:  
Community consultations can 
provide invaluable suggestions 
to improve the protocol and 
communication to the public 
In literature… the ability to potentially modify materials based on 
community feedback.  The community may offer suggestions 
regarding what is clear or it’s important to understand this or that 
aspect. Which is valuable. We are into our science; the 
communication piece to the public sometimes needs adjustment. 
Promote transparency: 
Community consultations can be 
conducted to ensure 
transparency between the 
research team and community 
members 
One of the goals of both CC and PD is promotion of transparency.  
Another is promotion of trust between research institution and 
research community/catchment area - those potentially part of 
research, where subjects will be drawn…One reason to drill down 
further into diverse/minority communities is the promotion of 
trust and the promotion of transparency.  These two are 
potentially linked. 
Build trust: Community 
consultations can be conducted 
to promote trust between the 
research team and community 
members, particularly among 
groups that have been 
disenfranchised by research 
Another [goal] is promotion of trust between research institution 
and research community/catchment area - those potentially part 
of research, where subjects will be drawn.    
 
Making the decision to reach out to communities that don’t have a 
voice typically in our public square, and who are less likely to be 
the ones to go look at a website about health care issues or fill out 
survey on a website, is a way to build trust for future by meeting 
with those communities-- maybe even disproportionately to their 
overall presence in the community-- is a good way of addressing 
past oversights.  Jeremy Sugarman calls it research justice.  How to 
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Subtheme: Description Participant Comment 
make up for past behavior? Respectfully make this effort to drill 
down into communities that have been abused. 
 
Another advantage to think about with targeting African-American 
groups or other ethnic minorities, it gives people safe space to 
think through their opinions, deep ethical questions, what type of 
trials should we do without consent…it’s hard to think through all 
of the nuances. A lot of people don’t have well-formed views.  
Think through in your mind with others that look like you and 
share some of your values from the same community. 
Community Consultation Methods 
Collaborate with community 
leaders: Identify and collaborate 
with key leaders and 
stakeholders in the community; 
important to receive their buy-in  
Once we’ve identified the community we need to engage, then it’s 
important to identify leaders of those communities and start 
there…It’s important to identify the leaders of those communities. 
 
We have seen really engaging and creative ways to reach out to 
communities, from meeting with chaplains and going out to 
religious groups. One site talked to Spanish interpreters at 
hospitals to figure out how to reach community, they said here is a 
community leader- go for a walk with him. PI went for a walk in 
the community and met with leaders. 
Meet community members 
where they live:  Conduct 
community consultations 
outside of the academic setting, 
and where the target population 
frequents 
It’s important to go into the community—and not expect 
minorities or individuals to come to CC activities but to go into 
their communities in a way that reflects the importance of certain 
sites or community events for them, e.g., barbershops in Black 
communities and maybe churches, and so forth. 
Continuous engagement with 
community partners:  
Establish relationships with 
community partners prior to 
research conduct to build trust; 
relationships can be continued 
after study ends to ensure 
strong partnerships for future 
studies 
When research is being done, it’s typically done through an 
academic institution. It’s important to have good relationships 
with patients in clinical and therapeutic settings, before 
researchers wants to “enroll patients in study in this way…” Some 
of the way has to be paved with the institution’s relationship 
already with the community. 
Utilize community research 
advisory panels:  Seek guidance 
from patient and community 
advisory panels to inform 
community consultation 
methods, as well as to assist 
with public disclosure methods 
Through our CTSA, there are research advisory panels.  One is 
based in African-American neighborhood. Couple EFIC studies 
used that group as part of community consultation. 
 
One question we are asking folks in CC, we have patient advisory 
councils – ask them how can we do PD better?  Having the first 
step of in-depth panel on how you can do the broad outreach. 
Have a panel guide you on your broad outreach.  Can guide you on 
how to do it better.  E.g., one member is on the board of previous 
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Subtheme: Description Participant Comment 
TBI survivors and she will connect us to that group to publicize 
about the study.  CC can set up your PD. 
Importance of multiple 
methods:  Utilize multiple 
methods to maximize the 
strengths and balance out 
weaknesses of approaches.  
Examples include focus groups 
and other face-to-face 
approaches (which provide rich, 
interpersonal data and may be 
used to build trust) versus 
surveys and other broader 
methods (which provide more 
diverse data, but less depth and 
opportunities to develop trust). 
Each approach has strengths and weaknesses. One-on-one 
interactions with community are terrific, but Personal 
[approaches] only reach so many people. RDD [random digit 
dialing] has a strength.  Black community is 26% but only 20% 
responded in RDD, you can weight to assure 100% ethnic 
coverage, and weighted samples that directly reflect the ethnic 
distribution you are targeting, and no other approaches can do 
that, but there are downsides – e.g., no one-on-one interactions. 
I’d advocate for multiple approaches to maximize the strengths of 





Community Consultation Metrics 
Need to develop adequate 
metrics:  Determine the most 
effective ways to demonstrate 
that CC activities have achieved 
CC goals.  
Metrics, make sure that it’s not institution based but community 
based 
 
How to ensure receiving high quality community data that leads to 
positive changes, better quality data in protocols 
 
Public Disclosure Goals, Methods, and Metrics  
 
During Phase 1, expert reviewers provided feedback on the MOP in terms of the methods of public 
disclosure, but were less informative about the goals and metrics of this process. Similar to the CC topic, 
facilitated expert panel discussion participants were asked to expand on their perspectives about 
feasible, realistic goals for PD and best practices to implement PD announcements.   
 
Table 4. Public Disclosure Goals, Methods and Metrics 
 
Subtheme: Description Participant Comment 
Public Disclosure Goals 
Promote transparency:  Public 
disclosures can be conducted to 
ensure transparency between 
the research team and 
community members 
Easier to say what is NOT the goal, than what is the goal.  State the 
goal is not community informed consent. It’s not a referendum on 
the study. Explicitly state that – it was in document.  Be 
transparent.  Not possible to disclose every possible risk and have 
everyone see it or understand it, given what everyone is paying 
attention to in the media. It wouldn’t be feasible. Can’t reach 
everyone or document that you have reached them. 
Build trust:  Public disclosures 
can be conducted to promote 
trust between the research team 
and community members, 
particularly among groups that 
One of the goals of both CC and PD is promotion of transparency.  
Another is promotion of trust between research institution and 
research community/catchment area - those potentially part of 
research, where subjects will be drawn.    
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Subtheme: Description Participant Comment 
have been disenfranchised by 
research 
Public Disclosure Methods 
Centralized public disclosure 
mechanism:  Utilize the 
centralized study infrastructure 
to disseminate public disclosure 
on a national level; 
infrastructure and resources are 
not readily available to 
investigators  
Most [studies] have a central coordinating center with website for 
local sites…Seems like our national organization could have EFIC 
general info that is patient and media friendly so not such a 
foreign concept…normalize it, so people see that it has been tried 
nationally for 30 years and is not a foreign concept. 
 
Compared to CC, which should be done locally, it seems there is 
opportunity to emphasize central PD a bit more.  The NIH sponsors 
EFIC studies – they are excellent at disseminating info about 
health, seems good way to have central resources in general for 
EFIC that could be leveraged for all EFIC studies.  Surgeon General 
disseminates information on health.  A resource that could be 
there but is not for local investigators. 
Develop feedback mechanism: 
There is a gap in feedback 
mechanisms for public disclosure 
methods to address questions or 
concerns from community 
“CYA” – there is no feedback loop, maybe a radio or newspaper 
ad. Like a checkbox. There is a need for delineated mechanism for 
feedback -- phone number, email, probably several different 
mechanisms.   Gotta be multiple mechanisms for feedback, may 
not have access to email.   
Public Disclosure Metrics 
Difficult to demonstrate public 
disclosure outcomes:  Efforts to 
conduct public disclosure should 
be documented and are more 
important than measuring 
outcomes of disclosure activities 
as it is not possible to reach 
everyone in the community  
The process is what is important rather than trying to measure an 
outcome.  I think it’s about a good faith effort. I think it’s more 
about the process than trying to measure the outcome.   
 
Not possible to disclose every possible risk and have everyone see 
it or understand it, given what everyone is paying attention to in 
the media. It wouldn’t be feasible. Can’t reach everyone or 
document that you have reached them. 
Measure public disclosure 
activities with social media 
metrics:  Social media metrics 
can be easily assessed to 
understand the reach of public 
disclosure announcements 
Two thoughts re: metrics.  Modern age with social media, it is 
much easier now, e.g., Twitter account can see how many people 
viewed tweet. Through other social media platforms, it’s much 
more feasible to get a sense of how many eyes have seen your PD 
announcement.   Opportunity to start collecting data on what is 
common or the norm for PD activities.   
 
General Comments on the MOP Document 
 
Although participants were not explicitly asked for feedback on the MOP during the facilitated expert 
panel discussion, several experts provided comments on how the MOP can be used to provide guidance 
to IRBs and investigators. Other comments addressed how the MOP can be improved upon to increase 









Table 5. General Comments on the MOP Document 
 
Subtheme: Description Participant Comment 
Adaptable EFIC guidance 
document:  Advantage that the 
document provides guidance 
that can be tailored to the local 
community  
FDA guidance identifies reaching out to community leaders might 
be a good idea when doing CC. I’ll echo what others have said-- 
the challenge in writing guidance on broad regulations is to allow a 
broad array of different options that are suitable for particular 
studies. FDA regulations and guidance are largely permissible for a 
large array of CC and PD activities, which I think is advantageous.   
They’ve identified certain principles that are important to guiding 
those activities, but they are not proscriptive.  That is one of the 
advantage of docs such as the MOP, and including a wide array of 
activities. It’s a real strength of the document.  It can be a resource 
for IRBs and investigators. 
Clarify the role and 
responsibilities of the CIRB and 
local site: Suggestion to 
elucidate the roles and 
responsibilities of the CIRB and 
local sites, particularly when the 
CIRB may not understand the 
community’s needs 
CIRB does not abrogate needs of local communities. There are 
people who are trying to lay this out. But, this would be a great 
document to do that. The local sites’ responsibilities isn’t well 
articulated in many places.  
Expand the table of community 
consultation and public 
disclosure methods:  
Expand on the community 
consultation and public 
disclosure method tables so that 
IRBs and investigators are able 
to select from these “menus” 
These menus [reference to MOP document] should push not just 
2—but maybe 3 or 4 from each “column” – so there is wide spread 
of activity even though it may challenge the sites and address 
complementarity people are mentioning.  Also the menu - credit 
to Rob et al., good effort – is a superb shortcut but needs to be 
fleshed out regarding what the options mean.  Even within each 
section, here is what we think the best way to do it… Maybe 
language that says, this just isn’t aspirational, describe floor and 
ceiling.   Increasing the variety of activities that sites use can 
address the comments about each method having strengths and 
weakness. 
 
4.  Conclusion 
 
Although it has been over 20 years since enactment of the EFIC regulations, investigators, study teams 
and IRBs continue to find it a challenge to interpret and implement the requirements for CC and PD.  The 
purpose of the SIREN project is to develop and disseminate two documents – a scoping review and a 
model operations procedures document – to advance the field’s understanding of these important 
topics.  Experts (EFIC investigators/researchers, ethicists, and CIRB/IRB affiliates) provided feedback on 
these documents (Phase 1) and participated in a facilitated discussion (Phase 2) to further elucidate the 




The following sections present recommendations for the MOP (Section 4.1) and future research 
considerations (Section 4.2) based on synthesis of findings from Phase 1 and Phase 2.   
 
 
4.1 Recommendations for the MOP  
 
The expert panel provided several suggestions for refinement of the MOP based on their past 
experiences and knowledge of community consultation and public disclosure.  Themes that are 
potentially actionable and appropriate for inclusion in the MOP are presented in Table 6.   
 
Table 6.  Phase 1 and 2 Recommendations for the MOP  
 
Consider providing options on engaging diverse communities; consultation with community can 
help determine which recruitment options are most appropriate for the local environment  
 Mirror diversity of community 
 Mirror diversity of community affected by disease or condition 
Provide guidance on modifying protocols after community consultation 
Include description of best practices for authentic community engagement 
 Collaborate with community leaders 
 Meet community members where they live 
 Continuous engagement with community partners 
 Utilize community research advisory panels 
 Importance of multiple methods 
Develop feedback mechanisms for all types of public disclosure announcements  
Measure public disclosure activities via social media metrics  
Clarify the role and responsibilities of the CIRB and local site 
Expand the table of community consultation and public disclosure methods 
Leverage public relations expertise to package and disseminate the documents, to ensure 




4.2 Considerations for Future EFIC Research  
 
The most common observation expressed by the expert panel was the important contribution this 
project will make to the field of EFIC research.  Members of the expert panel described challenges they 
experience interpreting and implementing clinical research through the EFIC regulatory pathway and 
the gaps that the FDA guidance does not address, leading to areas of uncertainty among researchers, 
CIRBs, and local sites.  The experts explained that the solutions to the challenges they describe, which 
require collaboration of stakeholders representing a variety of social, organizational, scientific, and 
other communities, will not be achieved overnight.  The following themes represent areas for EFIC 
researchers and other stakeholders to consider as they embark on future studies: 
 
 Defining community.   Experts expressed the continued need for the field overall to explain how 
to define and target the communities related to the EFIC trial being implemented; how to best 
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collect feedback from these communities; how to present feedback to local and central IRBs; 
and how to incorporate CC feedback into trial design and implementation.  
 Clarifying goals for public disclosure.  Experts noted that the goals of PD still remain ambiguous, 
but suggested that methods include broad and expansive efforts at the national level as well as 
targeted and in-depth strategies at the local level.  Details for how these two-pronged strategies 
are operationalized will require additional examples from researchers and their experiences.   
 Addressing historical racism.  Experts gave feedback in both phases of the project to 
acknowledge historical racism in relation to research ethics, and the need for efforts to improve 
inclusion in CC and PD activities.   
 Assessing effectiveness of methods.  Experts described the need for more detail in applying and 
measuring impact of the varied methods used for CC and PD activities.  Some suggested the use 
of a grid of pros and cons for each type of consultation method or other ways to guide 
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1. Save this document to your local computer with your last name at the end of the file name.   
2. Read through each section of the document and consider whether the findings or interpretations 
reflect your expertise and experience with EFIC and your existing familiarity with the literature.  
Particularly, please provide input on sections you feel require revisions, more detailed explanations, 
or where you see gaps. 
3. Enter your comments in the closest text box to the right of the corresponding section.  Make 
observations and comments only where you feel you have something of value to add.  You do not need 
to comment if you think the relevant concept has been well captured. 
4. Save this document with your comments and email it to LizJansky@westat by January 31, 2020.  




Scoping review of literature on Implementation of Community Consultation and Public 
Disclosure for Research Using Exception from Informed Consent for Emergency Research. 
Introduction 
United States regulations that allow an exception from the requirement for informed consent (EFIC) 
for certain clinical trials in the context of emergency settings are central to advancement of care for 
acutely ill, incapacitated patients.  Prior to the passage of these regulations in 1996 (21 CFR 50.24), 
there was no clear regulatory provision to allow clinical trials in emergency settings where consent is 
impracticable.  The EFIC regulations contain a number of important provisions.  Most obviously, they 
require that it be impracticable to conduct the proposed trial by only enrolling individuals who can 
provided informed consent or who have a legally authorized representative (LAR).  In addition, the 
regulations place restrictions on approvable risk, require a prospect of direct benefit for enrolled 
subjects, and limit the use of EFIC to life-threatening conditions for which existing therapy is 
unsatisfactory or unproven.  They are also notable for requiring two forms of community engagement; 
community consultation prior to approval and initiation of a study; and public notification or disclosure 
prior to and during the study.  To date, the EFIC regulations are the only U.S. research regulations to 
require community engagement. 
In the more than 20 years since passage of the EFIC regulations, investigators, IRBs, and regulators 
have gained substantial experience interpreting and implementing this regulatory structure.  
Determining precisely which studies qualify for EFIC, what constitutes an “unsatisfactory or unproven” 
standard of care, and what constitutes impracticability of informed consent can all be difficult.  
However, the most well-recognized challenge for IRBs, investigators, and study teams has been 
interpreting and implementing the requirements for community consultation and public disclosure.  As 
noted previously, this is the only type of research for which these activities are required by regulation.  
In this context, a heterogeneous set of practices have emerged.  There are different methods of 
defining and engaging with communities, different definitions of adequacy, and different views of how 
to report and interpret community consultation feedback.  This can be especially intimidating for 
investigators and IRBs who lack experience with EFIC. On the other end of the spectrum, IRBs and 
investigators with substantial experience conducting EFIC have settled into practices that may or may 
not be grounded in evidence or informed by the work of other groups. 
The purpose of this scoping review is to review the published empirical, conceptual, and policy 
literature related to community consultation and public disclosure for EFIC. Where possible, the goal 
is to identify best practices that can be communicated to the emergency research community in order 
to improve both the efficiency and quality of the conduct and review of community consultation and 
public disclosure.  Where best practices cannot be identified, the aim is to clarify areas where further 





We used a structured search, in collaboration with an informationist, in order to identify literature 
related to the conduct of EFIC research. We used scoping review methodology, which aims to 
synthesize and characterize relevant literature around a topic.1  This approach was chosen, because 
this is a heterogeneous body of literature incorporating both conceptual and empirical work and 
highly-variable methods. The complete initial list of search terms is provided in Box 1. Terms were 
designed to capture literature related to consent in emergency research, EFIC research, and the 
conduct of community consultation and public disclosure for emergency research. We also included 
terms that covered several common conditions or clinical contexts for which EFIC research is 
commonly conducted; these include resuscitation, cardiac arrest, and traumatic brain injury.   
Box 1- Search Terms 
  
efic OR 'exception  from  informed consent'  OR  'final  rule'  OR 'waived informed  consent'  OR 'waiver of 
informed  consent'  OR  'waiver of consent'  OR  'waived consent'  OR  'delayed consent'  OR  'deferred 
consent' OR 'community  consultation'  OR 'community  consent'  OR  'public disclosure' OR 'public 
notification'  OR 'public deliberation' 
AND  
'emergency'/de  OR  emergency  OR  'emergencies'/de OR  emergencies OR 'consciousness'/de  OR 
consciousness  OR conscious  OR 'unconscious'/de  OR  unconscious  OR 'unconsciousness'/de  OR  
unconsciousness OR 'resuscitation'  OR  trauma  OR  'brain injury'  OR tbi OR 'traumatic  brain injury'  OR 
'coma' OR comatose OR 'heart arrest' OR  'cardiac arrest' OR 'emergency  treatment'  OR 'emergency  
medical services' OR 'emergency  health service' OR 'brain injuries'  OR  'research in emergency  settings’ 
 
  
In order to capture relevant aspects of the academic literature, our search included EMBASE, HEIN 
Online (a source for legal materials and legislative pieces), PubMed, and Web of Science. As 
displayed in Figure 1, the initial search identified 1719 references, including 995 duplicates. After 
removing duplicates, there were 446 articles from EMBASE, 30 from HEIN online, 470 from PubMed, 




Figure 1- PRISMA Chart 
  
 
Titles and abstracts of the full 
sample were screened initially by 
KM, with additional screening by CS 
and ND, resulting in 318 articles 
related to EFIC for full text review. 
From these 318, we selected articles 
with content specifically focusing on 
Community Consultation or Public 
Disclosure. These articles 
represented the following categories 
of primary content: empirical reports, 
descriptions of process/approach, 
opinions/policy/ethics pieces, and 
attitudes of IRBs, investigators, and 
providers. These categories simply 
represent primary “types” of articles; 
there was overlapping content 
across categories.  Empirical reports 
of CC results, for example, 
frequently included descriptions of 
processes and approach for the 
conduct of CC. A total of 83 papers 
were ultimately eligible for data 
extraction.  
A standardized data extraction tool 
was developed iteratively by the 3 
reviewers and reviewed by the entire research team.  The extraction tool was built using Google 
forms and captured key domains within each category of article. For example, in empirical reports of 
community consultation activities, information extracted included method of consultation, type of 
study for which consultation was conducted, form of assessment conducted and key questions or 
domains of assessments, population targeted, and key insights or implications described. Among 
ethics and policy papers, we extracted key content such as views of the value and purpose of 
community consultation, views regarding definitions of “community,” and views of particular methods 
of community consultation or public disclosure. In each category, there were open-ended fields for 






We grouped findings from this review under three main themes, Community Consultation Reports, 
Public Disclosure, and Conceptual or Policy-Focused Literature on Community Consultation and 
Public Disclosure, 
Community Consultation Reports 
In all, 31 articles reported results of community consultation processes conducted for EFIC trials.  
Among these, the most common consultation process used was meetings with existing groups, 
followed by town-hall meetings, in-person surveys and interviews, and random-digit dialing (Table 1). 
The most frequent population involved in reported community consultation activities was the general 
public (59% of activities from 18 articles).  This was followed by current/former patients with the 
condition under study, patients in emergency departments, neighborhood/geographic groups, and 
members of support groups.   
 
Survey Data  
The most frequently used form of assessment reported as part of 
community consultation was a survey.  Surveys were sometimes 
administered as stand-alone consultation activities (e.g. at a 
community event) or at the end of a group meeting or interview.  
Qualitative reports and summaries were often not provided in detail 
within published reports.  Because they are typically provided to the 
IRB by investigators, these methods of assessment are likely under-
represented in published literature.  Among surveys, a variety of types 
of questions were asked to elicit views of participants.  The four most 
common questions focused on personal acceptance of being included 
in the proposed EFIC trial, personal willingness to enroll/be included 
in the proposed trial (without specific reference to EFIC), general 
acceptance of the proposed EFIC trial, and acceptance of the conduct 
of the trial in the community (without specific reference to EFIC). 
Samples of each type of question are included in Table 2. 
 
Personal Acceptance of EFIC Enrollment  
Reported acceptance of personal EFIC enrollment was generally in 
the range of 64-85%, consistent with a previously published 
systematic review (Table 3).  There were outliers, including one study 
that reported an acceptance rate of 51%2 and one that reported a 
92.5% acceptance rate.3  Because this domain was the most 
commonly and most consistently assessed, it provides the most 
helpful cross-study comparison.  Other domains utilized more 
heterogeneous wording across reports, making cross-report 
comparisons difficult.   Moreover, some questions in other domains 
lack clear validity or focus.4  For example, answers about willingness 
to be enrolled in a proposed trial without specific reference to EFIC 
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are challenging to interpret, because it is not clear whether 
respondents understand that enrollment would occur without 
prospective consent.  Similarly, small variations in wording related to 
acceptance of trial conduct within a “community” appear to result in 
substantially discordant answers without a clear difference in 
content.5,6   
Across the range of reported studies, several patterns were observed 
of note regarding predictors of acceptance (Table 3).  There was 
variable impact based on demographic factors. Some studies 
reported slightly increased support among respondents who were 
younger and reported higher income.  Some studies also reported 
decreased personal EFIC acceptance among minority respondents 
as compared to Caucasian respondents.  In some reports, there was 
increased acceptance among respondents with personal connections 
to the condition under study (such as a patient or a family member of 
a patient affected by the condition under study), though this was not 
uniform. One report found the reverse association,7 and another 
suggested that this relationship was modulated by race, with African-
American respondents’ views not demonstrating this relationship.8 
Range and Impact of Consultation Method 
Several subthemes were observed across reports in terms of 
experiences with particular methods of community consultation.  
Meeting-based and other more interactive methods were observed to 
be associated with higher rates of personal acceptance (though more 
variable) than survey-based or other less interactive methods, such 
as random-digit dialing.4,6,9-11  It has been commonly reported that 
open public meetings or “town hall” meetings have very low 
attendance; this was less commonly reported in community 
consultation efforts involving attendance at meetings of existing 
groups.12 Focus groups and interviews, not surprisingly, involve more 
dialogue and interaction.   
In addition to a variety of ways to conduct the consultation itself, 
multiple approaches were reported for selection and recruitment of 
community consultation participants.  As mentioned previously, some 
reported consultation focused specifically on individuals with specific 
connections to or risk for the condition under study.  Even within 
more population-based, quantitatively-focused consultation efforts, 
there were a variety of strategies reported that were designed to 
selectively involve individuals felt to be important target populations 
(e.g. those who represent likely enrollees).  These strategies include, 
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for example, survey administration within emergency departments and zip code-based sampling 




Inconsistent Metrics  
Some reports included assessments of efforts and resources 
necessary to conduct community consultation.  These were not, 
however, routinely reported or reported using consistent metrics 
across studies.  It was commonly reported that the yield of town hall 
meetings, relative to the efforts of the study team, was very low.  
Numbers of respondents were, not surprisingly, substantially higher 
among more quantitatively-focused efforts. Some reports cited the 
rapidity with which strategies such as random-digit dialing could be 
conducted; this method was also reported to involve appreciable 
expense, due to the need to contract with a survey firm.11,15  More 
interactive efforts were reported, on the other hand, to require more 
time on the part of the research team.2,16 
Public Disclosure Reports 
A broad range of public disclosure methods was reported.  Traditional approaches include the use of 
press releases, public service announcements, and media appearances (not associated with cost to 
the team), paid advertisements in print, broadcast media, or other forms (purchased by the team), 
use of in-hospital posters, flyers, study websites, and brochures, and personal letters and emails.  
Less commonly reported methods (though more common recently) included use of social media ads 
and posts using platforms such as Facebook and Twitter.  Importantly, some methods were described 
as serving both consultative and disclosure functions.  For example, social media posts often allow 
for feedback, but interaction with ads or pages is often quite brief and primarily “one-way.”17-19             
Defining Populations  
Intended populations for public disclosure efforts were typically 
geographically-defined; efforts were most commonly directed toward 
the general public in the geographic area where the proposed study 
would take place.  There were reported attempts at notifying more 
focused populations.  For example, some teams utilized in-hospital 
notification methods (such as posters or flyers) to reach a population 
of patients or notifications directed to disease-related support groups 
whose members were familiar with the condition being studied.20-23  
Similar to strategies employed for consultation, there are also reports 
of focusing on high-incidence zip codes or other approaches that try 
to notify individuals more likely to be enrolled in a study.16-18,24,25 
Estimates of Effort and Inconsistent Metrics  
Across the studies, there were not uniform methods for reporting or 
assessing effectiveness of public disclosure activities.  Commonly 
reported metrics included process measures such as number of 
activities or venues and the diversity of audiences sought.  Other 
reports described the content of the disclosures.  Other measures 
included the number of people exposed to, or aware of, a public 
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disclosure message.  Actual “penetration” of such messaging is 
difficult to estimate and were not often reported.  Metrics of this kind 
that were sometimes reported include number of website views, time 
spent on websites, numbers of surveyed individuals and 
patients/families who were aware of the study, and estimates of 
readership or listenership of common media outlets.  Web-based or 
social media disclosure do allow for more precise reporting of metrics 
such as hit rates, but time spent was often quite low, making real 
exposure difficult to assess.  Furthermore, estimates of viewership or 
readership may not reflect awareness.  Published estimates of 
awareness, both within communities in which research was 
conducted and among individuals ultimately enrolled in a particular 
study after a public disclosure effort, were very low (with the 
exception of very focused notifications within a particular hospital 
unit, for example)22, rates of opt-out requests received were also invariably low.2,22,24,26,27  
Conceptual or Policy-Focused Literature on Community Consultation and Public Disclosure 
There were 30 articles that focused on conceptual ethical or policy issues related to community 
consultation and/or public disclosure.  These pieces focused more often on community consultation 
than on public disclosure. Some empirical reports also contained substantive discussion about these 
issues. 
Value and Purpose of Community Consultation   
One major focus of some articles was the value of community 
consultation.  Two forms of value were identified relatively frequently.  
One form of value (more intrinsic in nature) highlighted the ability of 
community consultation to clarify the impact of trial enrollment on 
potential enrollees and potential ways to refine the study.  A second 
form of value (more extrinsic) was the potential for community 
consultation to promote trust within relevant communities, to provide 
transparency and education, and to demonstrate respect.  There 
were questions raised about the extent to which community 
consultation, as commonly conducted, accomplishes these goals, 
especially the more intrinsic form.  Another key theme regarding the 
value of community consultation was the reiteration that community 
consultation is not intended to be a “consent” process or vote.  The 
EFIC regulations, for example, emphasize that it is meant to be 
primarily a public comment and feedback process rather than a 
deliberative process.  There was less robust endorsement of the 
value of public disclosure.  Some authors did highlight the potential 
of public disclosure to facilitate transparency (and avoid secrecy) to 
increase trust and education about research.  Others highlighted its 
potential to facilitate opt-out for individuals who may wish not to be 
included in a study. 
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Views on Consultation and Disclosure Methods 
There were a variety of views expressed regarding specific 
consultation and disclosure methods, and several sub-themes 
emerged.  First, there was an emphasis that community consultation 
activities should be context-specific and tailored to the audience.  
One specific way in which context-sensitivity was emphasized was 
an argument that the extent and nature of required community 
consultation may be related to the risk level of the study.28,29  
Second, many commentators emphasized the “two-way” nature of 
community consultation.30  These commentators frequently argued 
against the use of more quantitatively-oriented, less interactive forms 
of consultation on multiple grounds.  They emphasized the ability of 
more interactive methods to facilitate more substantive input, for 
example, and the fact that views often change over the course of 
discussion.29,31  Third, in contrast to the emphasis on interaction and 
dialogue, some commentators did ground support for more 
quantitatively-oriented methods on the extent to which they involved 
“representative” samples.11,15  Finally, some commentators 
emphasized the importance of attempting to focus consultation 
efforts on persons at risk for or with connections to the disease under 
study.32   
 
Challenges Related to Community Consultation  
Two clear challenges emerged in the literature on community 
consultation specifically.  First, many commentators reiterated 
difficulties that teams often face defining the relevant community for 
consultation.33,34  Second, there is an acknowledgement of the 
challenge of interpreting data related to acceptance or objection to 
the proposed study.6,29,31  Though a rate of acceptance around 70% 
seems to be the norm and is high relative to typical rates of consent 
to clinical trials, others have emphasized that this still indicates that 
an important portion of the population has concerns about the use of 
EFIC for the proposed study.35  Moreover, in most contexts, 
individuals who do not want to participate can simply decline; in EFIC 
trials, they often do not have that opportunity. 
 
Views on public disclosure  
Public disclosure was a less common focus.  One key theme that 
runs through the published literature was an emphasis on the need 
to ensure that it be recognized that public disclosure and community 
consultation serve different functions.19,32  This is clear in the 
regulations and guidance document.36  A second theme was 
uncertainty regarding the value or “return on investment” from public 
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disclosure activities.  Finally, related to both of the prior challenges, it 
was clear in review of this literature that there is an absence of any 
established metric regarding how to assess whether public 




The requirement for community consultation and public disclosure is 
one of the more novel elements of the EFIC regulations.  Because 
they are not required in any other context by federal regulation, 
emergency researchers and IRBs have had to develop approaches 
to their implementation and evaluation.  More than 20 years after the 
passage of these regulations, there has now been substantial 
experience accumulated, and there is a valuable body of literature 
that helps to demonstrate areas of some consensus that may help to 
clarify best practices; there are also remaining questions on which 
there may be an opportunity to develop greater clarity. 
 
One area on which there appears to be consensus is that community 
consultation efforts such as town hall meetings and other open public 
forums have fallen out of favor.  These types of efforts were used in 
many early EFIC studies and appear to have been characterized by 
low attendance and viewed by research teams as inefficient.37  
Related, though the frequency with which descriptive reports of how 
community consultation is executed has decreased within the 
literature, there appears to be some consensus that effective 
community consultation often involves multiple methods for a 
particular project.33  This matches our impression as active 
researchers engaged in EFIC research over many years.  Different 
methods clearly serve different goals and require different types of 
resources.  
 
Another area of broad agreement within the emergency research 
community is the general recognition that that community 
consultation should be a two-way exchange and does not represent 
a referendum or vote on a study.  This view is validated by the fact 
that very few cases appear to exist in which community consultation 
has led to a proposed EFIC trial not being conducted.30  As 
articulated previously, there have been important questions raised 
regarding what, if any threshold of acceptance, ought to be met 
before a study is allowed to go forward, and there is an important 
sense in which asking for input from the community should imply a 
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willingness to listen and heed to strong objections.38  However, there 
is a general emphasis on substance of input over frequency of 
particular responses.39 
 
Much has been written within the literature on two central, and 
connected, issues.  First, is there a need to focus community 
consultation efforts on individuals with connections to the condition 
under study, as a function of having had the condition, being at risk 
for the condition, or being involved in treatment of that condition?  
And is there a need specifically to involve members of the general 
public in the geographic area in which the study will be performed?  
The second question relates to whether community consultation 
should be a quantitatively-driven, survey-based process design to 
ensure numeric representation of key demographic categories or stakeholder types, or whether it is 
should principally be a qualitative, interpersonal and interactive  
process between a research team and relevant community 
members.4,29,31-33,39 
             
Regarding the priority population or community for community 
consultation, the published literature reflects heterogeneity in focus. 
The empirical literature frequently reports geographically-focused 
consultation efforts, often involving the general public.  However, 
there is a theme in the conceptual and policy-focused literature that 
the feedback obtained from individuals with various connections to 
the conditions under study may be more meaningful and higher yield.  
There is also some evidence to suggest that patients enrolled in trials 
find the fact that investigators talked to “people like them” more 
meaningful than investigators’ talking with members of the general 
public.40  Regarding the “type” of community to be consulted, it is 
important to recognize that there is a false dichotomy that can easily 
be reified in discussions about geographic versus condition-related 
communities.  The EFIC regulations and associated guidance 
documents do not require that these two be considered separate 
communities, and the geographic requirement seems primarily 
intended to ensure that community consultation is conducted in the 
area where the study will be conducted and not to require 
involvement of the general public.36  The real question, then, relates 
to the value of consulting the general public.  
 
The literature also clearly demonstrates heterogeneity in approaches 
to community consultation.  Stand-alone surveys are common 
among published empirical reports, but they may be over-
represented due to the extent to which they may be viewed as more 
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publishable. This is particular important because there is also a 
theme in the conceptual and policy literature that the primary goal of 
community consultation is to achieve a two-way process involving 
feedback.  The ability of less interactive, more quantitatively-focused 
methods to achieve this goal has been questioned.4,31,32,39  
Moreover, there appears to be relative consistency in acceptance 
across geographic areas and across different types of studies.4,11  In 
this respect, there have been questions raised regarding the 
incremental value, particularly given the associated expense, of 
further quantitative efforts at community consultation.  It may be that 
these large-scale, population-based efforts served a very important 
role earlier in the EFIC experience.  At that time, background 
attitudes toward EFIC research were not well understood.  Now over 
20 years after the EFIC regulations were created, and particularly in 
institutions where a substantial number of EFIC trials have been 
conducted, the role of these efforts may be reduced. 
 
A relatively focused finding within this review is that there are 
multiple ways that attitudes toward EFIC trials have been assessed.  
One of the most common methods is the use of a survey.  It has 
been previously documented that different ways of asking questions 
about acceptance of EFIC studies may have very different results, a 
finding that is not surprising given the importance of survey 
design.5,6,9  While there may be good reasons for wanting to get 
feedback from community consultation participants on domains other 
than their personal acceptance of EFIC enrollment in the proposed 
trial, we do think there are important reasons to prioritize this type of 
question over others. It is the question that most naturally lends itself 
to comparison with other studies, is relatively straightforward for 
participants to understand, and is a question we believe most 
participants feel more confident and comfortable answering. 
 
Ultimately, there may be a role for further guidance to clarify the 
value of various forms of community consultation and engagement of 
different types of people.  Defining what is meaningful in different 
contexts may help investigators and IRBs to make determinations of 
when community consultation efforts are sufficient and how to most 
effectively elicit feedback.   
 
 
Public disclosure has been much less a focus of both the empirical 
and conceptual literature.  The clearest themes within the literature 
are that there are multiple ways to conduct public disclosure and that 
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awareness of EFIC studies tends to be low in cases where 
penetration of disclosure efforts have been assessed.2,24,26  It is also 
clear that many teams have undertaken extensive, resource-
intensive public disclosure campaigns.  However, the literature also 
does not reflect a particularly well-developed sense of the key goals 
of public disclosure.  As a result, there are no clear standards or 
benchmarks by which investigators or IRBs can assess the 
adequacy of disclosure efforts.   
Given what we consider to be unavoidably low rates of penetration or 
awareness, it seems unreasonable to expect public disclosure efforts 
to have a substantial role in helping people who do not want to 
participate in an EFIC trial to identify that they would want to opt out 
of participation, for example.  In this sense, it seems unlikely to play 
any meaningful justificatory role in terms of assessing or indicating 
acceptance on the part of a community.  Rather, it seems more 
appropriate to treat the requirement as requiring a “good faith effort” 
on the part of a research team to be transparent with the community 
in which they are conducting a study.  It avoids secrecy and may 
help to facilitate trust and educate the community about research, both the specific study and the 
process more generally.  It also may serve as a sort of mirror for 
research teams by forcing them to think through how trials they are 
proposing may be received in the community. Because many 
disclosure efforts can be highly resource-intensive, however, we do 
believe greater clarification regarding what constitutes a “good faith 
effort” may be helpful for investigators and IRBs. 
 
The EFIC regulations were foundational in creating a structure within 
which to conduct clinical trials in emergency settings.  The 
accumulated experience with and reflection on the requirements for 
community consultation and public disclosure within the literature 
offer important lessons and provide a body of limited evidence to 
guide this field moving forward.  In particular, there is a recognition 
that neither public disclosure nor community consultation poses an 
insurmountable barrier to conduct of important EFIC trials.  Available 
literature and accumulated experience also clarify that there are 
multiple ways to accomplish both of these activities and that they 
serve multiple purposes.  Investigators and IRBs will, appropriately, 
need to continue to consider each protocol and setting in order to 
assess the most suitable approach to both forms of public 
engagement.  There are also notable areas where uncertainty 
remains. Given that further guidance at the federal level is unlikely, 
clarification of norms and consensus among experts in this space 
could be helpful.  Two areas specifically emerge where such 
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clarification could be helpful.  First, there are not settled norms regarding assessments of adequacy 
and extensiveness of public disclosure efforts.  Second, there has been a lingering debate about the 
needed “reach” and the role of more targeted community consultation efforts given the fact that 
background attitudes among the general public, in particular, are relatively well understood. Clarity on 
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Tables for Scoping Review 
  
Table 1- CC Methods (can talk about how to order, etc.) 
  
Method Type of 
Interaction 









-Face-to-face interaction -opportunities 
for feedback and discussion -increased 
attendance relative to town hall-style 
meetings 
-ability for IRB to observe 
-Can be tailored to most relevant 
groups 
-can pair with survey. 
-Variable attendance 
-Possible selection bias/reduced 
generalizability based on groups 
- May be difficult to schedule 














-Face-to-face interaction -Opportunities 
for open feedback and discussion 
-Ability for IRB to observe 
-Can pair with survey 
-Opportunity for interested people not 
in targeted groups to be included 
-Lower attendance than at existing group 
meetings 
-Possible response bias from those 
choosing to attend meetings -Significant 
effort for few participants 















over the phone 
or internet 
-Large numbers are achievable 
-Can capture more representative 
population (geographically) 
-Time-efficient  
-Lack of interactivity and discussion 
-Heavily dependent on framing (both the 
study and the questions) -Response bias 
based on method (landline, internet access) 
-Expensive, requires expertise 
-Tends to represent general public rather 















-Potential for capturing large numbers 
in a geographic area 
-Avoids expense of RDD 
-Avoids landline/internet selection bias 
-Time-efficient; some opportunity for 
interaction and discussion with staff 
present  
-Potential responder bias 
-Selection bias based on type of event 
-Relatively minimal or brief interaction 














ED or inpatient 
-More focused population 
-Potential for significant number of 
respondents -Level of interaction and 
discussion depends on method and 
personnel 
-Labor-intensive 
-May afford little interaction and discussion 



















-Opportunity for open discussion and 
dialogue 
-Ability to ensure greater 
understanding of the study among 
respondents than some other methods 
-Can focus on target population (often 
with condition-relevant experience) 
-Higher level of recall of study 
information among respondents 
-Can pair with survey 
-Small sample size 
-Labor-intensive and potentially expensive -
Concerns about generalizability of 
feedback/selection bias 












Table 2- Assessment questions in community consultation 
Content Examples Potential 
Advantages/Disadvantages 
Personal 
acceptance of EFIC 
enrollment in 
proposed trial 
- “My own EFIC enrollment in this study would 
be acceptable.”6 
- “If you were having a heart attack and were 
to be treated by paramedics, would you object 
to participating in this study?”3 
-Face validity 
-Epistemically more valid (people 
can know the answer for 
themselves) 
Willingness to enroll 
in proposed trial 
- “If today your child had been in a coma as a 
result of a serious head injury, would you 
agree to enroll him/her in this study?”1 
- “Would you agree to participate in this 
study?”27 
-Face validity 
-Does not specifically address 
EFIC (attitude toward study and 
not EFIC enrollment) 
General 
acceptance of EFIC 
for proposed trial 
- “Do you object to the enrollment of someone 
in this research study without their individual 
consent before the study begins?”43 
- “Sometimes no family member can be found 
to make medical decisions for patients with 
traumatic brain injury. It is okay to include 
those patients in the ProTECT study without 
consent.”71 
-May avoid idiosyncratic 
preferences 
-Difficult to answer for others 
-Potential bias toward more 
negative response 
Acceptance of EFIC 
in community 
- “EFIC is acceptable for emergency research 
in our community.”6 
- “Would you be willing to allow us to do this 
study in your community?”3 
-Lacks face and content 
validity/hard to know what is being 
asked 
-Heavily dependent on phrasing 
Importance of 
proposed trial 
- “Do you feel there is potential benefit from 
receiving the experimental blood substitute, 
PolyHeme?”43 
- “The COMBAT study is an important study to 
do.”10 
-Straightforward 
-Ceiling effect and lack of 
understanding on respondents’ 
part 






proposed trial with 
surrogate consent 
- “If you are confused or drowsy, you might not 
be able to make such a decision for yourself. 
Would you be happy for your next of 
kin/relative (or other representative) to take 
this decision for you?”72 
- “If I had a traumatic injury and a family 
member agreed to include me in the COMBAT 
study, I would be okay with being included.”10 
  
-Face validity is a strength 




Table 3- Acceptance rates of Personal EFIC enrollment 
  









RDD survey 500 76% -Even though they used zip code targeting, the 
population had lower representation of 






105 85% -Used audience-response technology (ARS)   
-Increased engagement through the use of 
ARS during CC may lead to more 





In-person surveys 215 74% -A previous history of CSDH and age greater 
than or equal to 66 years showed a non-






309 77% -One of the only studies to show higher 
acceptance of general EFIC (84% than 
personal (77%).  
-Community members were more accepting of 
general and person al EFIC compared to 






Multi-site: Town Hall 
meetings; Meetings 




2612 71% -Increased acceptance with interactive 














RDD survey 2418 64-79% -inverse relationship between age and desire to 
enroll in study  
-limitation: survey questions and order of 
questions varied among sites – 
-willingness to enroll decreased from 77% to 
64% between 2 survey administrations in 
Portland due to negative press coverage of an 




In-person surveys 171  91% -UK study 
-Exact questions were not published 
-84% said they would be willing to participate 
- 91% Acceptability of surrogate consent by a 
doctor independent to the trial 
TBI/manage





137 93% -100% of participants were okay with the study 
being done in community 






Town Hall meetings 150 64% -pre-survey projection of 68% trial enrollment; 










Survey; Town Hall 
meetings; Meetings 




-community meeting respondents more willing 
to receive experimental treatment themselves 
or for family member than phone or web 
respondents 











In-person surveys 6,936 74% -29 were subjects in the intubation study; 22 
had been notified of the study prior to the 
intubation/enrollment; the other 7 were notified 
of the study weeks or months after being 
enrolled,  
-of the 22 who had been notified prior to 
enrollment, 13 had agreed to participate; of the 




In-person surveys 497 51% -Attitudes in community where CC was done 
rather than with true CC participants 
*Assent, not consent  





Table 4- Public Disclosure Methods 
  
Method Described Advantages (include 
reach and cost) 
Described Limitations 





-Can reach large audiences 
-Can approximate reach 
-Expensive 
-Passive approach  
–People don’t always read 
them 







(Radio, TV, PSA 
Press 
Conferences,) 
-Can reach large audiences 
-Can approximate reach 
-Expensive 







Social Media ads  -Geographic targeting 
(Facebook ads) -Cheaper than 
traditional advertising, can 
increase website traffic 
-May only reach certain 
demographics (younger) 
-Very little engagement 








phone calls)  
-Can target specific communities 
and/or community leaders 
-Better opportunities to opt out 








-Can target specific communities 
(parents for peds studies) 
-Better opportunities to opt out 






-Can target specific communities 
(i.e. patients with a specific 
disease) 
-Reaches people in the 
healthcare system 
-Passive method 
-People often don’t notice 






Websites -Can measure hit rates 
-Can facilitate opt-outs 
-Can provide more detail, multi-
media options 
 -Often short interactions 
with people who land on 
sites 
-Have to drive traffic to sites 








focus groups with 
hospital staff) 
-Inform staff members likely to 
be involved 
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5. Save this document on your local computer with your last name at the end of the file 
name.   
6. Read through each section of the document and consider whether the findings or 
interpretations reflect your expertise and experience with EFIC and your existing 
familiarity with the literature.  Particularly, please provide input on sections you feel 
require revisions, more detailed explanations, or where you see gaps. 
7. Enter your comments in the closest text box to the right of the corresponding section.  
Make observations and comments only where you feel you have something of value to 
add.  You do not need to comment if you think the relevant concept has been well 
captured. 
8. Save the document with your comments and email it to LizJansky@westat by January 
31, 2020.  





Model Operational Procedures for the Implementation and Review of 
NIH Sponsored Multicenter Clinical Trials with Exception from 
Informed Consent (EFIC) for Emergency Research 
 
A. Introduction 
B. Investigator’s EFIC Implementation Plan 
C. Application for Single Institutional Review Board Review   





A.  Introduction 
 
The purpose of this document is to provide a model process and procedures that can be 
used as starting point for implementation of clinical trials using Exception from Informed 
Consent for Emergency Research (EFIC) in NIH funded multicenter clinical trials.  The 
process and procedures described can and must be adapted to the specific needs and 
details of any future trials.  The materials provided were developed and informed by 
both thorough review of the accumulated scholarship related to EFIC, and other lessons 
learned through practical shared experiences of prior NIH funded emergency care 
researchers.   
This document is intended to be a useful, practical, and tested tool for future 
investigators in this field.  It is not intended to be a definitive guideline for application of 
the EFIC regulations, and should not be interpreted as any form of regulatory guidance.  
This document does not represent the only way to implement Exception from Informed 
Consent, and may not be applicable or optimal for EFIC studies that differ from those for 
which this document was created.  
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This document is intended to be open access, and shared through a Creative Commons 
Attribution-NonCommercial (CC BY-NC) license that lets others adapt, and build upon 
the work non-commercially.  New works must acknowledge the source materials and 






B. Investigator’s EFIC Implementation Plan 
 
This “Investigator’s EFIC Implementation Plan” is a sample procedure based upon a trial 
enrolling participants with acute severe traumatic brain injury (TBI).  This is intended to be used 
as a model or template for trials involving patients with any qualifying emergency condition.  
For trials involving patients with other conditions, the elements in this example that refer to TBI 
must be modified as appropriate to the clinical trial for which this is being adapted.  The plan 
also sometimes refers to specific elements of the sample trial’s protocol, which should also be 
disregarded when adapting this procedure for a future trial. 
This model plan has the following components.  An introduction and overview lay out the 
anticipated use of EFIC and informed consent in the trial.  The following section explains how 
the trial qualifies for EFIC by explicitly addressing all criteria of the regulations point-by-point.  
Subsequent sections describe the underlying goals and principles upon which the proposed 
plans for community consultation and public disclosure are based, followed by specific menus 
and descriptions of the types, numbers, and mix of events in which sites are required to 
engage, and how the results of these should be reported. 
 
INTRODUCTION 
The goal of this document is to describe the 
implementation of the protections associated with 21 
CFR 50.24, Exception from Informed Consent (EFIC) 
Requirements for Emergency Research in a specific 
clinical trial.  Implementation of this plan is the first 
phase of conducting the proposed trial.  The findings 
acquired from planned activities will be presented to the 
Central IRB (CIRB) to help the IRB assess community 
attitudes related to the study.  
Research involving the acute care of patients with 
emergencies such as severe Traumatic Brain Injury 
(TBI) presents ethical challenges. Respecting 
participants and their autonomy through the informed 
consent process is a cornerstone of ethical research, 
but patients with severe TBI are comatose and unable 
to participate in an informed consent process. When 
available a legally authorized representative (LAR) may 
act as a surrogate decision maker for a comatose 






patient. The LAR can decide if the patient will participate in the research study, even 
though the wishes of the patient may not be known. 
However, for many patients with severe TBI, no LAR is 
readily available during the patient’s resuscitation and 
emergency care.  Excluding patients without capacity or 
an available LAR from TBI research does not 
necessarily defend patient autonomy since the patient’s 
actual wishes are unknown.  In fact, when they can be 
asked, patients and their representatives choose to 
participate more often than not. Excluding patients 
without capacity, however, limits the ability to ever 
scientifically improve care, and makes enrollment in the 
emergency setting impracticable. Therefore, this study 
will enroll participants for whom an LAR is unavailable 
with EFIC.       
 
OVERVIEW 
All patients meeting eligibility criteria for this trial will be 
obtunded or comatose and unable to give informed 
consent to participate.  Participants will be enrolled in 
this trial either with the informed consent of a LAR or 
with exception from informed consent (EFIC) for 
emergency research under the conditions established at 
21CFR50.24 and pursuant to 45CFR46.101(i) and the 
HHS Secretarial Waiver at FR Doc. 96–24968 .   
Upon hospital arrival of a potentially eligible subject, 
study teams will diligently attempt to determine the 
patient's identity and the availability of an LAR.  If an 
LAR is available at any time prior to the routine 
emergent placement of intracranial probes for standard 
clinical management of severe TBI, the patient may only 
be enrolled with prospective informed consent from the 
LAR, as documented by a signed informed consent 
document.  If an LAR is not available prior to the routine 
emergent placement of intracranial probes, eligible 
patients will be enrolled with EFIC.  When enrolling with 
EFIC, enrollment and randomization take place 
immediately after probe placement.  Subsequent to an 
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EFIC enrollment, attempts will be made to notify an LAR at the earliest opportunity, and 
consent to continue in the study will be sought.   
Enrollment with Consent 
If an LAR is available prior to the routine emergent placement of intracranial probes, the 
patient will only be enrolled with the prospective informed consent of the LAR.  Informed 
consent is a process involving a meaningful and compassionate exchange of 
information, questions, and answers between an LAR and a study team member 
delegated to obtain informed consent.  The study team member will discuss the 
opportunity to participate in a balanced and noncoercive manner and will review the 
informed consent document with the LAR. The informed consent document provides a 
record of the informed consent process. The LAR signature on the consent document 
indicates permission for the patient’s participation and acknowledges this consent.   
Enrollment with EFIC 
Upon hospital arrival of a potentially eligible subject, study teams will diligently try to 
determine the patient's identity and the availability of an LAR.  Both routine hospital and 
study team resources and processes should contribute to these efforts. The steps 
undertaken to identify the patient and find the LAR should be documented on the 
informed consent log case report form.  If an LAR is not available prior to the routine 
emergent placement of intracranial probes, eligible subjects will be enrolled with EFIC.  
After EFIC enrollment, efforts to contact an LAR will continue.  Once the LAR is 
available and as soon as it is feasible, the LAR will be informed of the subject’s 
enrollment in the study.  Details of the study, the potential risks and potential benefits of 
participating in the study will be explained to the LAR.  After discussing the study with 
the LAR, the LAR will be given the option of allowing the subject to continue study 
participation, or to withdraw from the study.  The LAR will be informed that the decision 
to continue participation in the study may be withdrawn at anytime throughout the 
course of the study. If the LAR wants to continue the subject’s participation, the LAR will 
sign the informed consent form.   
The informed consent log case report form is used to document the continuing efforts to 
locate an LAR, the notification of the LAR, the consent process, and the decision of the 
LAR.  This log will include the types of attempts made, the number and times of those 
attempts, and the outcome of each attempt.  If the subject regains decision-making 
capacity, the patient will be notified of the study and will be asked if he or she wants to 
continue the study.  If no LAR is found and the subject never regains decision-making 
capacity, the subject will remain enrolled under EFIC.  For subjects who expire prior to 
identification of an LAR, consent is not obtained. If an LAR is eventually located, they 
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should be notified of the subject’s participation.  In the rare case where an LAR cannot 
be found and the subject remains incapable of consent at 6 months, attempts to find an 
LAR will be discontinued, but documentation of the LAR search process until that time, 
and the subject’s decisional capacity, will be documented. 
Withdrawal from Participation 
Regardless of whether a subject was initially enrolled with informed consent or EFIC, an 
LAR may withdraw the subject from further participation at any time and for any reason.  
If the subject regains consciousness and decision making capacity, subjects may also 
withdraw from further participation.  Whenever possible, the reason for wishing to 
withdraw should be determined.  Those wishing to withdraw the study intervention 
should be aware that the intervention can be discontinued (i.e. request that the PbtO2 
probe be removed, or that ICU staff be unblinded to PbtO2 values) without withdrawing 
from the trial and further data collection.  Discontinuation of the study intervention itself 
does not constitute withdrawal from further participation in the study.  After withdrawing 
from either the intervention or any further participation in the study, the participant’s care 
should revert to usual care based upon patient characteristics, treating physician 
preference, and institutional practice.  Consistent with OHRP and FDA guidance, 
participant data collected prior to withdrawal from the study is maintained in the study 
database, but no additional participant data will be collected from the participant or their 





REGULATORY CRITERIA FOR USE OF EFIC 
FDA regulations identify the specific circumstances in which 
EFIC is appropriate even when performed under the 
secretarial waiver rather than an IND or IDE.  This trial fulfills 
these requirements for emergency research.  In the following 
section.  The components of the regulation are reproduced 
(in italics), along with an explanation of how this trial will 
comply with each requirement.  
TBI is life-threatening and available treatments are 
unsatisfactory or unproven. 
21 CFR 50.24(a)(1) The human subjects are in a life-
threatening situation, available treatments are unproven or 
unsatisfactory, and the collection of valid scientific 
evidence, which may include evidence obtained through 
randomized placebo-controlled investigations, is necessary 
to determine the safety and effectiveness of particular 
interventions. 
TBI is a major cause of death and disability in modern 
industrialized societies, the scope of which is described in 
section 2.1 of the study protocol.  Despite 52,000 deaths from 
TBI annually in the US, and years of clinical investigation, 
there are still no proven specific treatments available.  
Although both ICP guided and PbtO2 guided goal-directed 
therapy are used in the care of patients with severe TBI, 
neither is proven to be effective. The Cochrane Library 
(http://www.cochranelibrary.com/) contains numerous 
systematic reviews of various unsuccessful or persistently 
unproven interventions.  Further clinical trials are needed.  
TBI has been recognized as a condition qualifying for EFIC in 
several prior studies.  
Obtaining prospective informed consent is often not feasible.  
21 CFR 50.24(a)(2) Obtaining informed consent is not 
feasible because: (i) the subjects will not be able to give 
their informed consent as a result of their medical 
condition; (ii) the intervention under investigation must be 
administered before consent from the subjects' legally 
authorized representatives is feasible; and (iii) There is no 
reasonable way to identify prospectively the individuals 
likely to become eligible for participation in the clinical 
investigation. 
Potential subjects with severe TBI are unconscious and 
unable to provide informed consent due to their medical 
condition. Critical care of patients with TBI, however, must be 
initiated rapidly after hospital arrival. The hypothesized 
benefit of reducing tissue hypoxia in this trial relies upon early 
detection and correction.  The BOOST 2 trial demonstrated 
that brain tissue hypoxia is already present in many patients 






at the time that their monitoring was initiated.   
In ProTECT 3, a trial which treated 882 participants with moderate to severe TBI within 4 hours 
of injury, an LAR was available to provide consent within 6 hours for 427 participants (48%).  An 
LAR was not available to provide consent within 6 hours for 52% of participants.  When an LAR 
did not arrive within 6 hours, the time lag until an LAR did become available rapidly increased, 
with a median value of about 30 hours.  In this previous TBI trial, the consent for continued 
participation after EFIC enrollment and retention rates were very high.  Without EFIC, half of the 
TBI patients potentially desiring participation may be denied access to the trial, making the trial 
impracticable.  Since TBI is accidental and unpredictable, there is no reasonable way to 
prospectively identify the individuals who will become eligible for participation in the research.  
Participation holds prospect of direct benefit to subjects 
21 CFR 50.24(a)(3) Participation in the research holds out the prospect of direct benefit 
to the subjects because: (i) subjects are facing a life-threatening situation that 
necessitates intervention; (ii) appropriate animal and other preclinical studies have been 
conducted, and the information derived from those studies and related evidence support 
the potential for the intervention to provide a direct benefit to the individual subjects; and 
(iii) risks associated with the investigation are reasonable in relation to what is known 
about the medical condition of the potential class of subjects, the risks and benefits of 
standard therapy, if any, and what is known about the risks and benefits of the proposed 
intervention or activity. 
Participation in sample TBI trial offers the prospect of direct benefit to subjects. Subjects may 
directly benefit from participation because TBI is a life-threatening condition and the PbtO2 goal 
directed interventions used in this study may be more effective than the ICP goal directed 
therapies alone.  In particular, risks associated with the intervention, comparison of two goal-
oriented strategies of care, are reasonable in relation to what is known about severe TBI and its 
treatment.  The risks of intervention align with the range of risks of standard care as both 
strategies themselves are variations of standard care.  Some participants report comfort and 
appreciation from the attention and follow up from the study team that is inherent to their 
participation.  
The trial can not be practicably carried out without exception from informed consent 
21 CFR 50.24(a)(4) The clinical investigation could not practicably be carried out without 
the waiver. 
This research could not be carried out without EFIC because treatment for TBI (including 
placement of probes and care driven by these measurements) needs to begin rapidly after 
hospital arrival.  Since TBI patients are unable to consent for themselves and there often is no 
LAR available within the therapeutic window of the proposed intervention,  we expect that 
approximately half of the participants in this trial will be enrolled under EFIC.  In TBI, time to 
treatment is critical.  Inability to obtain informed consent in the absence of EFIC can limit the 
ability to discover better treatments for this critical and life-threatening condition.  
Need for rapid treatment of TBI often precludes consent from an LAR 
21 CFR 50.24 (a)(5) The proposed investigational plan defines the length of the potential 
therapeutic window based on scientific evidence, and the investigator has committed to 
attempting to contact a legally authorized representative for each subject within that 
window of time and, if feasible, to asking the legally authorized representative contacted 
for consent within that window rather than proceeding without consent. The investigator 
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will summarize efforts made to contact legally authorized representatives and make this 
information available to the IRB at the time of continuing review. 
The narrow therapeutic window described above, the inability of patients with TBI to 
communicate, and the lack of an LAR available to provide surrogate consent in more than half 
of potential subjects precludes the possibility of obtaining informed consent for many eligible 
patients in sample TBI trial.  Attempts to contact LAR for notification and consent to continue 





REGULATORY PROTECTIONS FOR IMPLEMENTING EFIC 
The regulations for EFIC research mandate additional 
requirements for the implementation of this kind of clinical 
trial.  Each of these additional protections and components of 
the regulation are reproduced (in italics) here, followed by an 
explanation of how the sample TBI trial will comply with the 
requirement.  Further details about implementation will follow 
in a subsequent section.     
Provision of an informed consent document 
21 CFR 50.24(a)(6) The IRB has reviewed and approved 
informed consent procedures and an informed consent 
document consistent with Sec. 50.25. These procedures 
and the informed consent document are to be used with 
subjects or their legally authorized representatives in 
situations where use of such procedures and documents is 
feasible. The IRB has reviewed and approved procedures 
and information to be used when providing an opportunity 
for a family member to object to a subject's participation in 
the clinical investigation consistent with paragraph (a)(7)(v) 
of this section. 
A written informed consent document for this study will be 
reviewed and approved by the study CIRB.  Subjects enrolled 
in sample TBI trial, or their LAR, are approached for consent 
prior to enrollment or informed of the subject’s inclusion in the 
clinical investigation at the earliest possible opportunity. The 
study team is immediately notified of the arrival of all potential 
subjects. An on-call study team member quickly responds to 
the hospital to enroll subjects or to complete the subject 
enrollment under EFIC.  For the latter, the subject (or LAR or 
family) is approached, and an informed consent process 
initiated as soon as feasible. The study team notifies the 
subject or LAR/family about the subject’s enrollment, 
provides information about the study, the subject’s rights, and 
the responsibilities of the investigators.  The study team 
answers any questions about the study and further 
participation. A written informed consent document is used to 
reinforce the information provided in the consent discussion, 
and to document the decision to continue in the study or to 
not participate any further. A copy of this form is provided to 
the subject and another copy is placed in the research 
record.  
Community Consultation 
21 CFR 50.24(a)(7) Additional protections of the rights and 
welfare of subjects will be provided, including, at least: (i) 
consultation (including, where appropriate, consultation 
carried out by the IRB) with representatives of the 
communities in which the clinical investigation will be 
conducted and from which the subjects will be drawn 
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The community will be consulted prior to the initiation of research.  The community will be asked 
to give their opinions about the research and the need for EFIC in order to complete this trial.   A 
detailed menu of acceptable options for community consultation is included later in this plan.   
The site will choose from this menu and perform sufficient consultations to ensure the CIRB that 
community consultation has been satisfactorily completed at each site.  Reporting of community 
consultation results will be standardized across the sample TBI trial sites. 
Public Disclosure 
21 CFR 50.24(a)(7) Additional protections of the rights and welfare of subjects will be 
provided, including, at least: ….(ii) Public disclosure to the communities in which the 
clinical investigation will be conducted and from which the subjects will be drawn, prior to 
initiation of the clinical investigation, of plans for the investigation and its risks and 
expected benefits; (iii) Public disclosure of sufficient information following completion of 
the clinical investigation to apprise the community and researchers of the study, including 
the demographic characteristics of the research population, and its results 
Public disclosure is the primary element in making certain that sample TBI trial is conducted in 
an entirely transparent manner. Methods of announcing information about the trial, and the 
development of advertising and other materials about the trial, will take place both locally and 
nationally. Public disclosure will be initiated prior to approval of the trial, may continue during 
enrollment, and will conclude with dissemination of study results after the trial is completed. A 
menu and discussion of many public disclosure methods and procedures is included later in this 
plan. The CIRB will approve the types and forms of public disclosure.  Reporting of public 
disclosure efforts will be standardized. Summaries of public disclosure will be reported to the 
CIRB, and made publically available. 
Data Monitoring Committee 
21 CFR 50.24(a)(7) Additional protections of the rights and welfare of subjects will be 
provided, including, at least: ….(iv) Establishment of an independent data monitoring 
committee to exercise oversight of the clinical investigation; 
A Data and Safety Monitoring Board (DSMB) is appointed by the NINDS to provide ongoing 
evaluation of safety data as well as the overall conduct of the trial, per institute guidelines. The 
members will meet with the study team prior to study commencement to discuss the protocol as 
well as content and format of the DSMB reports. The DCC will prepare requested reports at 
specified time intervals. Data and safety monitoring will be performed consistent with the 
guidance provided by the NIH notices 98-084 “Policy for data and safety monitoring” and OD-
00-038 “Further guidance on data and safety monitoring for phase I and phase II trials”, and by 
the NINDS document based on these notices “NINDS Guidelines for Data and Safety 
Monitoring in Clinical Trials”. 
Contacting Other Family 
21 CFR 50.24(a)(7) Additional protections of the rights and welfare of subjects will be 
provided, including, at least: …. (v) If obtaining informed consent is not feasible and a 
legally authorized representative is not reasonably available, the investigator has 
committed, if feasible, to attempting to contact within the therapeutic window the subject's 
family member who is not a legally authorized representative, and asking whether he or 
she objects to the subject's participation in the clinical investigation. The investigator will 
summarize efforts made to contact family members and make this information available 
to the IRB at the time of continuing review. 
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Whenever possible, informed consent will be used in lieu of EFIC enrollment.  EFIC enrollment 
will also not proceed if an LAR or any other surrogate present either at the bedside or remotely 
declines participation on behalf of the potential subject. A provision of the protocol has been 
made to allow subjects who learn of the trial through public disclosure efforts or other means, 
and who, if treated in the hospital for TBI, would not want to participate, to communicate that 
decision to the ED without causing any delay in treatment. As part of the primary assessment of 
any TBI patient, ED providers already check for medical alert jewelry to ascertain emergent 
medical information about the patient. If the words “sample TBI trial declined,” or similar 
alternative designation, are listed on the medical alert tag, the patient will not be enrolled in the 
clinical investigation. A hypoallergenic silicone bracelet may also be provided by the study team 
to members of the public if requested  to indicate their wishes to decline study participation.  
Use of this enrollment exclusion will be tracked and this information will be provided to the CIRB 
at the time of continuing review. 
Post Enrollment Notification and Consent to Continue 
21 CFR 50.24(b) The IRB is responsible for ensuring that procedures are in place to 
inform, at the earliest feasible opportunity, each subject, or if the subject remains 
incapacitated, a legally authorized representative of the subject, or if such a 
representative is not reasonably available, a family member, of the subject's inclusion in 
the clinical investigation, the details of the investigation and other information contained 
in the informed consent document. The IRB shall also ensure that there is a procedure to 
inform the subject, or if the subject remains incapacitated, a legally authorized 
representative of the subject, or if such a representative is not reasonably available, a 
family member, that he or she may discontinue the subject's participation at any time 
without penalty or loss of benefits to which the subject is otherwise entitled. If a legally 
authorized representative or family member is told about the clinical investigation and the 
subject's condition improves, the subject is also to be informed as soon as feasible. If a 
subject is entered into a clinical investigation with waived consent and the subject dies 
before a legally authorized representative or family member can be contacted, 
information about the clinical investigation is to be provided to the subject's legally 
authorized representative or family member, if feasible. 
Subjects enrolled in sample TBI trial, or their LAR, are informed of the subject’s inclusion in the 
clinical investigation at the earliest possible opportunity as detailed above.  It is anticipated that 
the notification of subjects, or their families or LAR, will most commonly take place in the ED 
within hours of subject enrollment. Attempts to notify the subject or an LAR are repeated until 
successful. All notification attempts are logged and recorded in the subjects’ online case report 
form in CTMS. Reports of these attempts will be available for inclusion in annual reports to the 
CIRB. 
Record Keeping 
21 CFR 50.24(c) Like other IRB records, records of the determinations above must be 
kept for a minimum of three years after the completion of the clinical investigation. Again, 
like other IRB records, these are subject to inspection and copying by FDA. 
Records documenting the enrollment of participants using EFIC, procedures for notification of 
enrollment, and informed consent forms will be kept for a minimum of three years after 
completion of the clinical investigation. 
IND Requirement 
21 CFR 50.24(d) Protocols involving an exception to the informed consent requirement 
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under this section must be performed under a separate investigational new drug 
application (IND) or investigational device exemption (IDE) that clearly identifies such 
protocols as protocols that may include subjects who are unable to consent. The 
submission of those protocols in a separate IND/IDE is required even if an IND for the 
same drug product or an IDE for the same device already exists. Applications for 
investigations under this section may not be submitted as amendments under Secs. 
312.30 or 812.35 of this chapter. 
This trial has been reviewed by FDA, including intent to enroll with EFIC, and the Agency has 
determined that an IDE is not required for this trial.  The Agency has pointed out that this finding 
is consistent with their latest guidance on EFIC specifically for device trials.   
Communication of IRB Determination 
21 CFR 50.24(e) If an IRB determines that it cannot approve a clinical investigation 
because the investigation does not meet the criteria in the exception provided under 
paragraph (a) of this section or because of other relevant ethical concerns, the IRB must 
document its findings and provide these findings promptly in writing to the clinical 
investigator and to the sponsor of the clinical investigation. The sponsor of the clinical 
investigation must promptly disclose this information to FDA and to the sponsor's clinical 
investigators who are participating or are asked to participate in this or a substantially 
equivalent clinical investigation of the sponsor, and to other IRBs that have been, or are, 
asked to review this or a substantially equivalent investigation by that sponsor. 
Pursuant to the NIH single IRB policy for multicenter clinical trials, sample TBI trial will be 
reviewed and approved by a single CIRB.  If the CIRB does not approve the trial, no subjects 
will be enrolled at any site, and all stakeholders will be informed.  Because of a single IRB of 
record, there will be no opportunity for discordant IRB findings, and no other reporting of 






COMMUNITY CONSULTATION PRINCIPLES 
Implementation of community consultation in this trial is based on the applicable 
regulatory language, applicable FDA guidance documents (from March 2011, updated 
April 2013), and the investigators own empirical ethics research and experience in 
developing best network practices.   
 
Goals 
The regulatory intent and specific goals of community 
consultation are not explicit in the regulations, and have 
been the subject of academic disagreement.  As 
described in the FDA guidance, the goals of community 
consultation include: 
● To show respect for persons by informing the 
community about the study in advance; 
● To inform community members about the trial in 
advance and provide a means for affected 
communities to provide meaningful input to 
the IRB before its decision to approve, require 
modifications to, or disapprove the study; 
● To show respect for the community by allowing 
representatives of the community to identify 
potential community-level concerns and effects of 
the research; and   
● To show respect for subjects’ autonomy. Respect 
may be shown by including in community 
consultation activities individuals who may 
have, or be at risk for, the condition under 
study (and thereby obtain input from a group that 
is expected to be similar to the eventual study 
subjects).  
 
This EFIC plan incorporates and interprets these goals 
into the following specific actionable elements.   
To show respect for persons, we require CC events 
that include going out into the community to talk to 
people where they already gather, rather than simply 
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asking them to come to us at events that we originate.  Showing respect also involves 
CC events that specifically engage the investigators responsible for the research with 
the members of the community, rather than only allowing consultations that can be 
outsourced or delegated.   
To create effective opportunities for the affected communities to provide meaningful 
input to the IRB, we train for and promote event formats that ensure that study teams 
listen as much as they talk.  Simply giving a presentation about the trial and then asking 
if there are any questions is not effective CC.  Deliberately brief descriptions of the trial, 
preferably with few or no slides, are followed by probing the community members for 
what additional information is important to them, and by soliciting the values and 
experiences of the community members that are most relevant to the research and to 
TBI.  Community members are experts about themselves.  How their own narratives 
intersect with the proposed research and the way in which it will be carried out (under 
EFIC) is the most useful input the community can provide to the IRB. 
To show respect for the community, CC activities explicitly reach out both to individuals 
in the community without specific roles, and to representatives of the community.  
Representative of the community may be religious leaders, community organizers, 
patient or disease advocates, local political leaders, or others best equipped to identify 
group-level concerns.   
Demonstrating respect for the autonomy of a group of individuals who may have, or 
be at risk for, the condition under study is particularly challenging in TBI research 
because traumatic injuries can happen to anyone.  We meet this goal by asking sites to 
describe the breadth and depth of the communities they serve, and then asking that 
they complete CC activities that reflect a sufficient portion of that spectrum.  In past TBI 
trials we have specifically sought out communities that are high risk of TBI, but that may 
be hard to engage in CC, such as Motorcycle or ATV Clubs and young adult males 
playing basketball or football.   Sites have historically accessed TBI support groups to 
speak to TBI victims and their caretakers as well.  These groups are keenly aware of 
possible treatments and the cost a traumatic TBI can have on one's quality of life.     
It is also important to explicitly reinforce the FDA guidance by stating the goal of CC is 
not intended to represent community consent.  Consent to participate in research is 
meaningful only as an individual decision; community support of the research does not 
reflect consent for all members of the entire community.    Community consultation is 
therefore not intended to be a form of unbiased voting, deliberative democracy, or other 
purely quantitative activity, but rather an opportunity for open discussion and 
commentary.  The IRB makes the final determination on study approval based on 
information obtained from the community consultation.  
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Definition of Community 
For the purposes of EFIC, the definition of community 
includes “the community in which research will take 
place” and the “community from which subjects will be 
drawn.”  In other words, the community includes the 
geographical area from which patients will be drawn and 
the group of patients with, or at risk for, the disease of 
interest.  Communities have many subgroups that can 
be defined by innumerable characteristics such as race, 
ethnicity, religion, age, gender, wealth, education, 
employment, neighborhood and other factors.  
Community consultation should consider the 
heterogeneity of the community and seek diverse input.  
It is understood, however, that it is impracticable to 
reach every possible subgroup, but each site will 
complete activities that reflect a sufficient portion of the 
spectrum of their relevant communities.    
Content 
The content of community consultation will inform the 
community participants that informed consent will be obtained for any research subjects 
prior to enrollment whenever possible, and will not be obtained when no LAR is 
available.  Informational materials developed for sample TBI trial CC activities are 
included in the appendix of this plan and are subject to IRB approval.  Additional 
materials developed later will be submitted to the IRB for approval before being used in 
any CC/PD activities.  Specifically, the content of all CC activities will: 
● Tell the community about the most relevant aspects of the trial including its 
potential risks and potential benefits, and the 
therapeutic window (based on timing of probe 
placement, but generally within about 2-10 hours 
of injury). 
● Hear the perspective of the community on the 
proposed research, elicit values and experiences 
● Explain how individuals wishing to be excluded 
may indicate this preference 
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Types of Events 
Based on our interpretation of the regulations and their proposed ethical basis, we have 
prepared a menu of the types of events and activities that sample TBI trial sites may 
use to meet their requirements for CC.  Sites will prepare a site plan that lists all the 
events and activities that they will use to engage the community.  Each site plan will:  
● Provide opportunities for broad community discussion 
● Ensure that representatives from relevant communities participate in the 
consultation process 
● Include more than one type of event or activity to provide for effective community 
consultation 
● Consider multiple factors including, but not limited to, the size of the 
communities, the languages spoken within those communities, the heterogeneity 
of the population 
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COMMUNITY CONSULTATION MENU 
 
A ( Interactive - Direct ) B ( Asynchronous - Delegated) 
A presentation and discussion by an investigator 
visiting a meeting of an existing group (visits to 
existing meetings)  
Telephone survey (random digit dialing) 
Focus group (moderated small group session) Web-based survey 
In-person individual interviews or meetings  Social media messaging 
A booth or table at community events involving  
interactive discussions (not just surveys) 
In person solicited survey e.g., waiting room 
survey, booth survey without other interaction 
Meetings convened by the investigators inviting 
the targeted audience (preferably with RSVP) 
 
 
Required mix is at least 6 total CC events or activities.  
Among these 6 events or activities, at least 2 events or 
activities must be of a type in column A, and at least 1 
event or activity must be of a type in column B.  The 2 
events of a type in column A may be of the same type, 
for example, they could both be focus groups or visits to 
existing groups.  Events should include participants 
representing a sufficient breadth of the diversity of both 
the geographic community primarily served by the 
enrolling sites’ institution, and the community either at-
risk for, or familiar with, TBI.  There is no expectation 
that all of the subgroups of either community can be 
engaged.   
Visits to existing meetings or existing groups 
In this method of community consultation, members of 
the study team, sometimes accompanied by 
representatives of their participating institutional 
research leadership, ask to present the study and lead a 
discussion about the study at a regularly scheduled 
meeting of a relevant community group.  Sometimes, 
the existing group may hold a special meeting for this 
purpose, but the study team still goes to the group 
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(rather than asking members of the group to come to 
the study team).   
Existing groups that might be consulted using this 
method may include, but are not limited to: disease-
related support or interest groups, civic groups, 
neighborhood groups, service organizations, athletic 
groups (inclusive of athletes, coaches, and trainers at 
any level of competition from high school to 
professional), parent-teacher associations, faith-based 
organizations, political or governmental bodies, 
business groups, social clubs, retiree groups, and 
college fraternities or others.  Examples of disease-
related support groups include TBI support networks of 
parents of children and young adults with TBI.  
Examples of governmental bodies include law 
enforcement and fire department groups, city councils, 
and community boards.  This approach may also 
include study team visits to senior centers or 
rehabilitation facilities.  Participation in an existing 
meeting shows respect for community by bringing the 
information to the community, reduces inconvenience to 
the community and exposes the study to a diverse 
audience.  Community members may be more 
comfortable expressing their opinions in a known 
setting.  Investigators may have to travel, attend multiple 
meetings and conform to the community group’s 
schedule.  Using this method can encourage more 
involvement by co-investigators and other members of 
the study team, which can be advantageous. 
Prior to and during the visit, the study team must clearly 
communicate that being allowed to attend the meeting 
does not imply any implicit approval or endorsement by 
the group being visited. 
Best Practices: 
● An investigator should be present to take and 
answer questions from the community. 
● Presentation should be brief (i.e., 10 to 15 
minutes). 
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● If a presentation is longer than 15 minutes, it 
should be interactive throughout the presentation. 
● The presenter should be knowledgeable about 
the study and comfortable with the group.  
● Allow ample time for community discussion (at 
least 15-30 minutes). 
● Often best to ask for 30 minutes on an existing 
meeting agenda to allow 10 minutes to present, 
15 minutes for discussion, and 5 minutes to 
hand-out and get back evaluation surveys.  
Insufficient time for solicitation of feedback 
greatly reduces the utility of this method. 
● Probe for discussion using open-end questions.  
Ask participants about their experiences and 
what they care about. 
● Ensure that the discussion includes feedback 
from the participants on EFIC. 
● Light refreshments may be sponsored; direct 
monetary incentives are uncommon. 
● An anonymous survey for group participants to 
indicate their thoughts, feelings, and opinions about the EFIC regulations and the 
study is typically collected at the end of the event.  The survey template is 
available on the sample TBI trial website in the toolbox under EFIC. 
 
Focus groups 
In this approach, a trained facilitator interviews and moderates a discussion in several 
small groups (generally about 8 to 12 participants).  This method can be conducted with 
or without an investigator present, but the former is favored.  Unlike focus groups 
designed for other research purposes, these focus groups are performed as community 
consultations.  They are an opportunity for investigators to directly listen to community 
members, and to show their respect by listening humbly.  An investigator may often 
start the session by briefly presenting information about the trial or may elect to allow 
the facilitator to proceed, and listen and be available to clarify issues and answer 
questions.  The facilitator runs the discussion using an explicit guide prepared by or 
reviewed beforehand by the investigative team. The facilitator elicits the group’s views, 
questions, concerns and comments about the study.  The interaction is generally audio-
taped (and possibly videotaped) for review by the investigative team and the facilitator 
to allow subsequent analysis and reporting of the session.  Focus groups could solicit 
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feedback from any relevant focus of the community, 
including: the general public, individuals affiliated with 
particular organizations or subgroups, or specific patient 
populations.   
Recruitment methods for focus group participants will 
depend on the targeted population.  Participants may be 
recruited by mail or telephone, at random from volunteer 
banks or public data sets or from special populations 
(such as patients with prior brain injury or their families, 
advocacy group representatives or other vested interest 
groups).   
Compared to other methods of community consultation, 
focus groups may allow for more in-depth discussion of 
the study because of their small size.  They also allow 
for interaction not only between the facilitator and 
participant but between participants.  For these reasons, 
focus groups offer a rich set of information and have 
often been found by investigators and IRB members to 
be a high-quality source of information.   
Best Practices: 
● The meeting should be at an accessible location and time for the population 
included. 
● The session should generally be run by a trained facilitator; sometimes it is 
helpful if it is someone who is also demographically concordant with the focus 
group participants (experience, race, ethnicity, or gender). 
● Sessions should be small, generally including 8 -12 participants. 
● Focus groups generally run 1 to 2 hours in length. 
● Refreshments should be provided. 
● Participants are generally paid for participation in focus group sessions in an 
amount and form appropriate to the participant population. 
● An anonymous written survey for group participants to indicate their thoughts, 
feelings, and opinions about the study and the focus group session should be 
conducted at the end of the event.  
Convened (invited) meeting 
Sometimes called a “Town Hall Meeting”, this type of CC uses the same structure and 
best practices as visits to regularly scheduled meeting, but invites a target audience to a 
meeting convened by the study team.  The potential advantage of this method is that 
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multiple groups of attendees can be invited to the meeting, and have a chance to 
interact with each other and the investigator.  Because the meetings are typically open 
to the public, there is the potential to involve everyone.  The disadvantage with this 
method is that organizing such a meeting and attaining adequate attendance can be 
burdensome and difficult.  To be successful, however, an intensive effort to diligently 
invite several potential attendees and secure their commitment to participate is needed.  
Merely advertising a public meeting and seeing who shows up leads to events with very 
few community members.  Such low attendance events have been commonly held in 
prior EFIC trials, but are not acceptable for sample TBI trial.  The use of invited 
meetings, therefore, is discouraged unless the site has a track record of successfully 
using this method in the past. 
 
Community events - interactive or survey 
In this type of event, the study team and investigator typically set up a booth or table at 
an existing community event and interact with individuals one at a time as they browse 
or stop by the booth.  Events of this kind have occurred at State Fairs, Fire and 
Emergency Services Open Houses, Farmers Markets, Art Festivals, Music Concerts, 
Health Fairs, Ice Cream Socials, Disease-related Fundraising Events, Tailgates and 
other Sporting Events.  This kind of event often allows exposure to a large number of 
community members.  Depending on the kind of event it may allow investigators to 
reach a focused or very diverse group and a large 
number of participants.  Because conversations are 
typically one on one, this method often allows more 
intimate and revealing opportunities for the investigator 
and members of the public to interact.  Disadvantages 
of this approach is that most of the contacts are very 
brief, usually limiting the opportunity to exchange 
information.  Also, the time commitment from the study 
team to staff the booth for the duration of the event may 
be significant, making this potentially inefficient.  This 
type of event can be conducted in a way that is more 
interactive (a column A event), in which an investigator 
or other study team member primarily engages 
participants in conversations, often concluding with 
having the participant fill out a survey either through an 
interview or by completing a written tool.  The event can 
also be conducted in a way that is primarily driven by 
just giving out written information about the study and 
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asking participants to fill out a written survey (a column B event).  In this case, the booth 
can be staffed without an investigator present, which can be more efficient for the study 
team.   
Best Practices: 
● Booths should have good signage that attracts passers-by.   
● Have small treats or “swag” to attract participants and thank them for taking time 
to talk to you. 
● Have enough staff at the booth to engage with anyone who wants to talk. 
● Have enough clipboards and pens to make certain no one has to wait to 
complete written feedback. 
● It is often effective to make this kind of event a fun social team-building exercise 
for the study team.   
 
Telephone (random digit dialing) survey  
Large telephone surveys can provide the most 
statistically representative description of community 
responses to questions about the study and EFIC.  This 
approach also has the potential to access the views of 
members of the community that are unlikely to attend 
other types of community consultation activities.  This 
kind of survey is often outsourced to a vendor.  Vendors 
are often costly, but because they can deliver rapid, 
predictable data, and consume relatively little study 
team time, this approach can still be efficient.  
Interviewers should be trained by the study team about 
sample TBI trial.  Telephone surveyors are trained to 
read information verbatim provided to them by the study 
team about the study and EFIC.  They then ask close-ended questions and solicit open-
ended comments and questions.  This information is then summarized and reported 
back to the investigators and the CIRB.  It is important that the survey and 
accompanying guide used by the interviewers should be carefully written and tested by 
the study team.  Vendors can potentially perform large online surveys that are akin to 
these large random digit dialing surveys. 
There are several limitations to this method.  Telephone surveys can be intrusive and 
unwelcomed.  Also, because they are delegated rather than conducted directly by the 
investigators, they do not allow investigators to demonstrate the same level of 
interpersonal respect for persons or communities as other methods.  Questions are 
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typically narrow and closed ended in this approach.  
Professional surveyors are also not generally equipped 
to answer clarifying questions about the trial or EFIC.  
To achieve a reasonable sample size, telephone 
surveys have to be short.  The presentation of EFIC and 
BOOST3 is therefore necessarily very limited, so 
responses may not be as well informed or may be less 
reflective than responses solicited in more interactive 
methods.  The extent to which this method produces 
systematically different responses is unknown.   
 
Simple solicited surveys like those performed online, in 
waiting rooms, or at booths 
Simple individual surveys, whether performed on-line or in person, can also be used to 
solicit community questions and views.  This method can be used to reach large 
numbers and a wide variety of respondents.  Online surveys can be linked to social 
media platforms or can be easily solicited by email.  Respondents can also be recruited 
to complete surveys distributed in-person in relevant clinical settings like emergency 
department or clinic waiting rooms.  These simple survey methods may not be as 
statistically representative as telephone surveys, but can be potentially provide more 
background information and are much less expensive.  Internet and paper surveys also 
allow respondents to see visual aids and diagrams not possible with telephone surveys.  
Waiting room surveys may allow focus on populations with particular health care or TBI 
experience.  Online and waiting room surveys otherwise have the same limitations as 
telephone surveys.  Careful writing and testing of surveys remains critically important. If 
surveys are distributed in person, surveyors need to be well trained in the study protocol 
and in the EFIC regulations. 
Best Practices: 
Whenever possible, these surveys should be conducted by members of the study team, 
and or delegated surveyors with medical knowledge and training in the protocol and 
EFIC. Medical students and residents can sometimes be recruited as surrogates for the 
investigative team. 
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Other social media 
Social media offers a low cost, potentially far reaching, 
and potentially interactive method to exchange 
information with members of a community.  Recent data 
suggest that the penetrance of social media is very high 
with 80% of adults in the US accessing Facebook, 
Youtube, Instagram, Pinterest, Snapchat, LInkedin, 
Twitter, or WhatsApp daily (while only 29% read print 
newspapers daily).  Social media may also allow 
messages to be directed to selected subgroups and 
demographics.  However, investigators should still be 
aware that despite the high prevalence of social media 
overall, that use is still somewhat weighted toward 
younger adults, those living in suburbs, those with 
higher incomes, and those with more education.  Also 
different platforms are favored by different 
demographics. Social media is a medium that blurs the 
line between one way communication (as used in public 
disclosure) and dialog (as used in community 
consultation).  The former type of use is probably more 
common, but truly interactive social media 
communications are also possible.  If chosen as a CC 
activity, the content of the presentation, the methods to allow interaction, and gaps in 
the available population should be clearly described. 
REPORTING COMMUNITY CONSULTATION 
RESULTS 
All community consultation activities must be reported to 
the CCC via the Community Consultation (CC) Form in 
CTMS.  Here, study site personnel will data enter the 
aggregate data of their community consultation 
activities, by event.  Data captured includes:  
information about the participants, the presentation, 
participant questions and comments, and responses to 
closed- and open-ended survey questions.  A complete 
list of CC Form data fields is available on the sample 
TBI trial website in the toolbox under CTMS.  The 
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PUBLIC DISCLOSURE PRINCIPLES 
Public disclosure is defined in guidance as the “dissemination of information about the 
research sufficient to allow a reasonable assumption that communities are aware of the 
plans for the investigation, its risks and expected benefits and the fact that the study will 
be conducted”. It also includes “dissemination of information after the investigation is 
completed so that communities and scientific researchers are aware of the study’s 
results”.   
Goals 
The regulatory intent and specific goals of public 
disclosure are not explicit in the regulations, and have 
been the subject of academic disagreement.  This plan 
is based on the presumption that the primary goal of 
public disclosure is transparency.   
Transparency is achieved when information about the 
study is broadly and publicly disseminated through 
multiple channels.  We note that transparency has a 
protective effect because investigators will not propose 
anything that they would not be willing to announce and 
defend openly.  
Adequacy of public disclosure and transparency is best 
measured like advertising, by the size of the potential 
audience of the disclosure, rather than by knowledge or 
recollection of the audience.  In fact, the more benign 
and acceptable the content of a public disclosure is, the 
less likely it will be internalized and recalled.   
Content 
The content of public disclosure materials will vary with 
the media used.  Advertisements (whether signs, print 
media, broadcast, or electronic) may have limited 
space.  These disclosures may convey short messages 
and how the audience can obtain more detail.  Follow 
up examples may include ways to talk to the study 
team, or a link to the study website.  Short messages 
should at a minimum emphasize: 
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● That a research study of patients with traumatic brain injury is being conducted 
locally. 
● That the study will enroll patients with injuries that prevent them from 
participating in informed consent. 




Other forms of disclosure, such as press releases, 
websites, or brochures for example, allow for greater 
detail and should, depending on available space, also 
include: 
● Information about TBI and how it is treated 
● The purpose of the research 
● Who will be included in the study 
● A description of the two treatment strategies 
being compared 
● A balanced description of the potential clinical 
and research risks and benefits 
● Synopsis of the research protocol and study 
design 
● Participating sites/institutions 
● Description of the attempts to contact a LAR 
● Information about opting out of the study 
After the clinical trial is completed, further public 
disclosure should include: 
● The findings of the trial 
● Impact of what was learned on patient care 
● Where to find resources for further information 
● Gratitude and thanks to the study subjects, their 
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PUBLIC DISCLOSURE MENU - PRE-TRIAL 
 
A (networking) B (paid advertising) C (conventional outlets) 
National or local study website 
Newspaper advertisement 
(and similar print advertising) 
Press release 
Social media postings 
Television and radio ads 
(broadcast advertising) 
News stories, interviews (print, 
radio, or TV) 
Mailings (including email 
circulars/bursts and direct 
paper mailings) 
Outdoor advertising (placards, 
bus ads, billboards, etc.) 
Newsletters (articles or 
informational ads, print or 
electronic) 
Booth/Table Community event 
Paid online advertisements 
(banner, block, or video ads 
purchased from Google, 
Facebook, Youtube, etc.) 
Brochures, flyers, handouts, 
bulletin boards 
  
Radio or TV PSA (public 
service announcements) 
 
Many different channels of public disclosure should be used.  This will increase the 
depth and breadth of market penetration.  The required mix is at least 6 total PD 
activities including at least 2 of a type in column A, and at least 1 of a type in column B 
or column C.  Distribution of activities should be cognizant of the anticipated audiences, 
and should include audiences representing a sufficient breadth of the diversity of both 
the geographic community primarily served by the enrollment site, and the community 
either at-risk for, or familiar with, TBI.  There is no expectation that all potential 
audiences will be reached.  It is expected that PD efforts will represent a good faith 
effort to provide transparency across the relevant 
communities. 
Networking 
Electronic platforms can provide a passive or interactive 
approach to disseminating information that has benefits 
and challenges.  Measurement of the audience reached 
by these methods may be elusive.  Access may be 
limited to those segments of the population with regular 
computer access, although internet access through cell 
phones is rapidly becoming common in all parts of 
society.  Despite these minor concerns, electronic social 
media and other e-platforms are inexpensive to develop, 
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are wide-reaching and can be relatively democratic, and 
can even permit continuous and anonymous input from 
the public.  Hospitals and community based 
organizations often host and curate websites, social 
media accounts (Facebook, Twitter, etc) and listservs, 
that can be efficiently leveraged to disseminate a 
message broadly.  
 
Paid advertising 
Purchased advertising in broadcast and print media 
ensures dissemination of accurate materials to a wide 
audience. Advertisement of the study may occur on a 
major news radio station serving the area surrounding 
the study hospitals.  A 30 to 60 second sound bite 
should include a general description of the study, the 
website address, and contact information where more 
information can be provided if desired.  Printed 
materials, including advertisements for publication in 
newspapers and magazines, brochures, and flyer, are 
available electronically on the sample TBI website.  
Advertisements should be placed in both English 
language and foreign language newspapers as 
appropriate to the local community.  Printed 
advertisements should provide a general description of 
the study, the national and/or local website address, as 
well as site contact information. 
Conventional informational outlets 
Press releases leading to newspaper and periodical 
articles are an effective form of public dissemination.  
Investigator appearances on local news, radio or 
television call-in talk shows can accomplish both public disclosure and community 
consultation.  In addition to traditional news outlets, it is often possible to obtain 
coverage in local health focused newsletters, in direct mail advertisements and 
educational materials sent out by health care organizations and in newsletters of TBI 
advocacy and support groups.  A video on emergency medicine trials and EFIC 
research in general will be available for use in public service announcements and for 
dissemination to media outlets.  Local community access cable stations may be 
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accessible to investigators.  Cable access channels may offer appearances on shows 
presenting issues of local interest or may offer to broadcast prepared materials. 
Brochures and flyers may be disseminated in locations 
including: 
● Medical sites (e.g., emergency department 
waiting rooms, medical clinics, dentist offices, 
etc.) 
● Health fairs (community, employer, school, etc.) 
● Support groups and other existing community 
groups 
● Schools, universities,  
● Churches and other religious affiliates 
● Grocery & laundry-mat bulletin boards 
● Through large employers (i.e., hospitals, 
universities, etc.) 
Local flyers and brochures distributed should reference 
the trial website as an additional resource for patients, families, and healthcare 
providers to get information as well as ask questions about the trial.   
 
PUBLIC DISCLOSURE ACTIVITIES - POST-TRIAL  
Post-trial public disclosure activities may include any of the methods used pre-trial, 
especially press releases because results of trials can be especially newsworthy.  Post-
trial public disclosure also includes a number of more specific additional methods.  Post-
trial disclosure includes publication of the trial results in a major scientific journal and 
presentation of the results at scientific meetings.  Through these publications and 
presentations, it usually possible to leverage the existing public relations machinery of 
the journals and the meeting to amplify the message through broader media outlets as 
well.  Another specific post-trial public disclosure method is return-of-results to the study 
participants and their families.    
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REPORTING PUBLIC DISCLOSURE ACTIVITIES 
All public disclosure activities must be reported to the CCC via the sample TBI trial 
Public Disclosure (PD) Form in CTMS.  Study site personnel will data enter data on 
each activity including:  name and type of activity, size of anticipated audience, and 
characteristics of the intended audience, and timing and duration when relevant.  A 
complete list of PD Form data fields is available on the sample TBI trial website in the 
toolbox under CTMS.  Activity data will be further collated to produce individual site or 
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CONTACTING A LEGALLY AUTHORIZED 
REPRESENTATIVE (LAR) 
The definition and hierarchy of LAR is determined by 
local state regulations.  
When more than one LAR are present, the LAR highest 
in the local hierarchy should give consent. However, 
unless otherwise stated in local or state regulations, any 
LAR may consent if others are not promptly available.  
EFIC does not obviate the need to seek an LAR to 
provide consent prior to enrollment if possible, and to 
seek patient or LAR consent to continue participation 
after EFIC enrollment. Potential subjects are also not 
enrolled under EFIC if any family contacted prior to 
enrollment objects to enrollment, even if they are not an 
LAR or are only available by telephone.  Subjects 
enrolled in sample TBI trial, or their LAR or family, are 
informed of the subject’s inclusion in the clinical 
investigation at the earliest feasible opportunity. The 
study team is immediately notified of the arrival of 
potentially eligible patients in the emergency department 
(ED). An on call study team member quickly responds to 
the ED to determine eligibility, seek an LAR for consent, 
and enroll the subject if consent is obtained or enroll 
under EFIC when appropriate.  The subject (or LAR or 
family) is approached, and an informed consent process 
initiated as soon as possible. 
LAR identification and tracking will typically be a shared 
responsibility between the onsite social workers (or 
equivalent) and the study team. Each site PI and team 
will meet with their social workers (or equivalent) before 
the trial initiation to inform them of the trial protocol and 
need for intensive LAR search. The site team should 
review the local protocol for an LAR search and assure 
that it is sufficient (multiple methods for locating LAR 
and multiple attempts), and if not, recommend additional 
steps be put in place. 
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Once available after an EFIC enrollment, an LAR will be informed of the patient’s 
enrollment into the study and of the study details and potential risks and potential 
benefits of study participation.  At that time, the LAR will be given the option to continue 
participation in the study, or to cease participation then or at any time throughout the 
course of the study. If the LAR wants to continue participation, an informed consent 
process is performed and an informed consent form signed by the LAR will be obtained. 
If an established LAR has given consent for the participant to be enrolled, other family 
members' objections to inclusion will not result in the participant's removal from the 
study.  If the participant regains decision making capacity, the participant will be asked 
to consent to or decline continued participation in the study.  If the participant wishes to 
continue and an LAR has not already provided consent and signed a consent form, the 
participant will sign an informed consent form.  If the LAR has already signed a consent 
form, an additional form signed by the participant is not required. 
Using the Informed Consent CRF, the study team will document efforts to find the LAR.  
This will include contact person (Subject, LAR, Other), number of attempts, date and 
time and outcome of attempts. The tracking process should continue until consent or 
withdrawal is obtained. The tracking process is complete once the LAR or participant 
has provided consent or has withdrawn.  It is expected that LAR consent or withdrawal 
be obtained within the first 24 hours, except in rare circumstances (no LAR identified, 
LAR not available, participant identification is unknown, participant expires prior to 
consent being obtained, etc.). 
For participants who expire prior to identifying an LAR or before LAR consent is 
obtained, consent should not be pursued further. However, once an LAR is located, 
they should be informed of the subject’s participation.  The study team should document 
the notification conversation.  If it is not possible to have this notification conversation 
with the LAR or family of a deceased subject in the hospital, a “family notification letter 
for a deceased subject’’ should be used to notify the LAR or other family.  The template 
for this letter can be found in the “Toolbox” section of the sample TBI trial website.  A 
copy of the family notification letter (with return receipt) should be kept with the study 
documents. 
In the rare case where no LAR consent is obtained, the LAR is never available, and the 
participant remains incapable of consent at six months, documentation of the attempt 
process and condition of the participant will be recorded on the Informed Consent Log 










DESCRIPTION OF REFUSAL OF PARTICIPATION 
PROCEDURES (OPT-OUT) 
Individuals who learn about sample TBI trial and do not 
wish to participate may contact the trial investigators 
through the trial website,  or by otherwise contacting a 
site study team or the CCC.  At their request, their name 
will be put on a list of those declining to participate. Prior 
to the start of the study they will be provided an opt-out 
medical alert silicone bracelet that says “sample TBI trial 
declined” at no expense. Members of the public may 
also obtain and may wear this medical alert bracelet, or 
any other medical alert notification with the same 
message and be excluded from the trial without 
providing their name.  Wearing the provided bracelet or 
any other medical alert notification that says the name 
of the trial and the words “trial declined” is how the 
individual can communicate to the care team or study 
team, her/his wishes to opt out of the study in the event 
of a severe TBI.  The presence of a medical alert with 
the statement “sample TBI trial declined” is the metric for those with prior knowledge of 
the study to indicate their desire to opt out, which is an 
enrollment eligibility exclusion.    
 
DATA SAFETY MONITORING BOARD 
An independent Data Safety Monitoring Board (DSMB) 
has been established and has reviewed and approved 
the trial protocol.  The DSMB will oversee the course of 
the clinical trial.  The DSMB will provide ongoing 
evaluation of safety data as well as the overall conduct 
of the trial, as per institute guidelines.   
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This appendix lists the kinds of trial specific community consultation and public disclosure 
materials that are created and provided as central resources for all participating sites.  This 
would be pre-approved by the CIRB at the time of protocol review, and the unmodified content 
of these used by sites without further approval.  If sites develop additional new and valuable 
materials, the CCC would send these to the CIRB for review prior to their use by the site.  When 
approved, new materials are added to the list for subsequent use by any site. 
Because these materials can be dynamic, the links on this page have been disabled.  The list is 
included here only as an example of the kinds of materials that the study could provide. 
 
CC Material 
Suggestions for Community Consultation Opportunities 
  
Meeting recruitment flyer 
Focus group moderator guide 
CC slide set - Full  
CC slide set - Reduced 
 
Letter to community physicians 
Letter to community members 
 
Survey Instruments 
Self-Administered Survey  
Self-Administered Survey – Additional languages 
Group Evaluation Survey  
Telephone Survey  
 
PD Material 
Suggestions for Public Disclosure Opportunities  
 
Website and Video Content 
Trial-specific Video/Public Service Announcement (6 seconds) 
Trial-specific Video/Public Service Announcement (15 seconds)  
Emergency Research Video Scripts – Non-trial specific  




Brochure – Additional languages 
AD/Flyer/Poster 
AD/Flyer/Poster – Additional languages 
 
Opt-out Material 
Opt-out bracelet request form  





Additional EFIC Material  







C. Standard Operating Procedure for Trial Applications involving 
Exception from Informed Consent (EFIC) to a Single/Central 
Institutional Review Board 
 
Purpose  
Our goals for this procedure are to protect the interests 
of human research participants to be enrolled in 
emergency research trials with EFIC, to respect the 
communities from which participants will be enrolled, to 
comply with applicable regulations and their intent, and 
to create efficiencies for both the IRB and the applicants. 
 
Definitions   
The following are operational definitions for the purposes of this procedure  
CC/PD refers to Community Consultation and Public Disclosure activities as described 
at 21 CFR 50.24 
CCC refers to the investigators’ Clinical Coordinating Center for the trial 
IRB-IS  refers to the web based IRB information system 
DCC refers to the investigators’ Data Coordinating Center for the trial     
DSMB refers to the trial-specific Data Safety Monitoring Board 
EFIC  refers to emergency research conducted with exception from informed consent 
as regulated primarily under FDA regulations 21 CFR 50.24.  EFIC also refers 
to research conducted under 45 CFR 46.101(i) when consistent with the HHS 
Secretarial Waiver from October 2, 1996 -- Notice, HHS, Informed Consent 
Exemption for Emergency Research   
CIRB refers to the Central Institutional Review Board reviewing the application 
FDA the United States Food and Drug Administration 
IND Investigational New Drug application 
IDE Investigational Device Exemption application 
CTMS  refers to a comprehensive Clinical Trial 
Management System  
 
Procedures 
A. FDA approval of IND or IDE identifying the plan 
to conduct a trial using EFIC.   
For EFIC research regulated by FDA, the 
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sponsor will obtain approval for an IND or IDE 
prior to submitting an IRB application.  For EFIC 
research not regulated by FDA, the investigators 
should typically provide documentation of this, 
such as a letter from FDA concordant with this 
determination.  An application may proceed while 
the IND/IDE is on clinical hold if the reasons for 
the clinical hold do not contain concerns related 
to the protection of human research participants. 
B. DSMB approval.  
The applicants will present the study protocol and 
consent form to the study DSMB for comment, 
suggestions, and approval before submission to 
the ER-CIRB. 
C. Protocol (Parent) application submission to ER-
CIRB. 
The applicant will submit an IRB protocol 
application that also includes an EFIC plan into 
IRB-IS.  The EFIC plan will be submitted as 
“Additional Documentation”.  The EFIC plan will 
include the following; 
a. Itemized descriptions of how the trial meets each 
required qualification for EFIC described at 21 
CFR 50.24 
b. Menu of community consultation event types and 
a plan for a minimum required mix of events 
c. Menu of public disclosure activities and a plan for 
a minimum required mix of activities 
d. Check off list for disease-based and geographic-
based communities of special interest that will be 
engaged 
e. Templates for materials to be used for community 
consultation and public disclosure 
D. ER-CIRB review of protocol application. 
The ER-CIRB will review the study protocol, 
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consent form, and EFIC plan.  If the ER-CIRB identifies concerns or requires 
modifications, the investigators will revise the application as needed.  If the 
protocol, consent form, and EFIC plans are acceptable, the ER-CIRB will 
approve the protocol application.  No CC/PD will be conducted until approval of 
the protocol application and EFIC plan. 
E. Sites prepare individual CC/PD plans. 
Sites use the IRB approved menus and the IRB approved required mix of events 
(from the protocol application) to develop lists of proposed individual CC/PD 
events and activities. The CCC oversees and assists sites throughout this site 
development process.  
a. The site plan includes a log of proposed CC/PD events and activities, including 
planned dates and intended communities to be engaged.  These events and 
activities are entered into CTMS.  The ER-CIRB will also have access to these 
event logs in the CTMS. 
b. The site plan includes a supplemental EFIC local context form that will also be 
completed in the CTMS with additional information about communities served by 
the institution.   
c. If sites develop new materials for use in CC/PD these must be submitted to the 
sponsor, via the CCC.  The CCC will submit any additional sponsor approved 
material to the ER-CIRB through IRB-IS via an amendment to the protocol 
application for review and approval prior to their use.   
d. The ER-CIRB will have continuous access to the site plan (the CC/PD event logs 
and supplemental EFIC local context form) in CTMS throughout the conduct of 
CC/PD. 
F. Sites perform CC/PD activities and events. 
a. Sites commence the CC/PD activities and events they have listed in the log.  As 
activities and events are completed, event forms are completed in CTMS.  
b. If activities and events are rescheduled or replaced with new events, these 
changes are immediately logged in CTMS.  In this way, site progress may be 
checked by the CCC or the ER-CIRB at any time.   
c. Representatives of the CCC or the ER-CIRB may also use the log to plan their 
own visits to site CC/PD activities and events at their discretion.     
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G. Site application submission to the ER-CIRB. 
Sites submit all information for their site CIRB 
applications in CTMS, including any revisions to the 
EFIC local context form.  After a site has completed 
its CC/PD and submitted all findings and summaries 
to CTMS, these are reviewed by the CCC and a 
report of findings is prepared to include as additional 
documents with the site ER-CIRB application.  The 
CCC then submits the site application to the ER-
CIRB through IRB-IS.  Click for example of a site-
specific CCC activities report. 
 
H. ER-CIRB review of site applications. 
The ER-CIRB does an explicit review of each site 
application including discussion of each site-
specific CC/PD report.  The ER-CIRB may use a 
checklist to aid in the review of each site.  
Specifically, the IRB will check if the site’s 
completed activities complied with the menu and 
requirements in the IRB approved EFIC plan in 
the protocol application, if the completed 
activities reflect a sufficient portion of the 
spectrum of community described in the sites 
local context form, if the CC/PD performed 
represent sufficient engagement and notification 
of the communities, and if any of the findings 
reported indicate a need for additional follow up 
CC/PD.  If the site application and EFIC reports are 
acceptable, the site may be approved by the ER-CIRB and 
permitted to begin enrollment.  Site applications may be 
reviewed as rapidly as submitted or may be batched at the 
discretion of the ER-CIRB. 
I. Reporting to the public. 
Cumulative reports of CC/PD will be assembled by the CCC 
and reported to the FDA docket at least annually until all pre-
trial CC/PD are completed.  An additional report of post-trial 
public disclosure activities will be assembled by the CCC and 
to the FDA docket after the trial is completed.  If the trial is not 
FDA regulated, the same materials will be posted on another 
public facing web-page. 
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J. Reporting to relying institutions.   
Sites will be able to download their own CC/PD findings report from CTMS and 
may use these to report to their own relying institution if their institution requests 
to review these internally, but this is not required.  Similarly, the ER-CIRB will 
provide minutes of the review of the site application to the CCC to provide to the 
relying site if requested.   
K. Protocol application close out. 
At the end of the clinical trial, all sites will report all required post-trial public 
disclosure activities in CTMS.  The CCC will prepare a cumulative report of all 
post trial public disclosure activities at all sites, which will be submitted to the ER-












D. Process Guideline for Central IRB Review of Site Applications for 
EFIC Trials:  How to Review Local Community Consultation and 
Public Disclosure Findings 
  
This document is intended to provide advice to central IRB panels on potential 
processes they might use to guide and manage deliberations related to local context for 
site applications of clinical trials involving exception from informed consent (EFIC) for 
emergency research.  The document is informed by observations of IRB deliberations of 
EFIC-related community consultations and public disclosure and a related stakeholder 
workshop conducted as part of an empirical ethics grant from the NIH Office of the 
Director.  In addition to this qualitative research, this document is also informed by the 
cumulative experiences and views of the investigators.  The document is meant to 
suggest a framework to aid in efficiency and 
effectiveness of the review, but is not intended to 
constrain IRB consideration or discussion in any way. 
Review of the trial EFIC plan in the protocol application 
Prior to review of site applications for a trial involving 
EFIC, the IRB should briefly re-cap the trial-specific 
EFIC plan proposed with the previously approved 
protocol application.  This allows the panel members to 
re-familiarize themselves with the quantitative and 
qualitative expectations of sites.  These expectations 
describe the site self-assessments and reporting of 
important elements of their own local context, and the 
number and types of community consultation and public 
disclosure activities to be completed.  The plan also 
describes the underlying goals of community 
consultation and public disclosure as contextualized for 
the application. At the IRB meeting, the IRB chair or 
other designated reviewer or member should be 
assigned to present the key elements of the plan to the 
full board. 
Community consultation / public disclosure site report 
format 
Site applications for clinical trials involving EFIC will be 
accompanied by a consistently formatted report 
summarizing the community consultation and public 
disclosure activities performed by the site.  The report format presents a brief narrative 
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summary and aggregated data at the front, and then 
many more pages of granular listings of individual 
comments in the rest of the report.  At the time of the 
first site application to be reviewed by the panel, prior to 
deliberation of the reports content and the site 
application, the IRB chair or other designated reviewer 
or member should briefly orient the full board to the 
sections and structure of the report format. 
Deliberation - quantitative consideration 
During the discussion and deliberation of each site 
application, a systematic approach to the review of local 
context requirements may start with quantitative aspects 
of the site community consultation / public disclosure 
report.  The trial EFIC plan requires a specific number of 
activities in more than one category of activity types.  
The IRB should confirm that these requirements have been met.  Site applications 
failing to meet these criteria may be tabled and the site queried prior to further review, 
or the review may continue but the site application not approved until the deficiency is 
addressed. 
The panel may also want to consider quantitative aspects of the community consultation 
/ public disclosure report that do not have pre-defined requirements, but may be salient.  
The IRB may wish to consider the number of activities performed at each site, the 
number of participants in each event, and the number of open-ended comments or 
closed-ended responses collected and reported.  There are no required numerical 
criteria for these aspects because they are expected to differ from site to site based on 
the nature of the activities performed.  For example, sites performing in depth focus 
groups may have fewer participants but more feedback, while those hosting a booth at 
the state fair may have far more participants but briefer contact and fewer recorded 
responses from each.  In the absence of objective criteria, the panel members should 
evaluate these quantitative aspects subjectively.  Panel members may consider these 
metrics in the context of the numbers they might expect based on the type of activities 
reported, or in comparison to the numbers reported at other sites.  In comparing to other 
sites, the panel should keep in mind that there will always be a range and that all sites 
cannot be above average.  
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Deliberation – qualitative considerations 
The panel then should consider qualitative aspects of the community consultation / 
public disclosure report.  First, the panel should consider whether the activities 
performed by the site are appropriately aligned with, and sufficiently address, the 
principals and goals established for community consultation and public disclosure in the 
trial-specific EFIC plan.  For example, is there evidence 
for respect for community, for two-way communication 
in consultations, for transparency in public disclosures?  
The site report should be demonstrative of how 
principals and goals were considered. 
Consideration may be given to whether a variety of 
types of stakeholders participated in the site’s activities.  
Were both geographic and disease-related communities 
consulted?  While it is impracticable to reach all 
demographics in a representative manner, the panel 
should consider the diversity achieved in the events 
conducted.  The panel may consider whether any parts 
of the community with increased stakes or special 
interest in the research have been adequately 
consulted.  The diversity of community may be considered by the IRB in the context of 
the site’s self-reported local context report, or by 
comparison with other sites.  
Other qualitative assessments of the community 
consultation / public disclosure findings include 
consideration of the closed-ended and open-ended 
feedback from participants in the site’s activities.  While 
EFIC is explicitly not a community consent process, the 
degree of support or concern expressed in these 
responses can be considered in the context of similar 
findings from the literature and the FDA EFIC docket for 
previous EFIC trials, or comparing different 
communities.  The IRB may also consider the nature of 
specific concerns and any of these should preclude site 
participation or be otherwise addressed.  
Other elements of local context review 
Before completing the deliberation of community 
consultation and public disclosure the panel should 
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review and consider other elements of local context review.  Site self-reporting of local 
context issues related to the community served, past relevant experiences with EFIC or 
emergency research at the site, local regulations or laws impacting the research, local 
medical practice patterns intersecting with the trial should all be considered if they may 
affect the protection of human subjects.  Local IRB or other elements of the local 
institutional research administration also have the option of submitting information 
relating to local context as well.  If submitted, such optional information should be 
considered and discussed at this point in the site review. 
Board actions 
These considerations of site applications for clinical trials involving EFIC are 
supplemental to the standard elements of site application review by the IRB.  Approval 
based on deliberation of community consultation and public disclosure is incorporated 
into the IRB approval of the site application. 
Queries, contingencies, or non-approval based on review of community consultation / 
public disclosure activities should be reported back to the sites as specifically as 
possible.  Clear and explicit descriptions of any additional activities desired, or 
modifications of the application required, are necessary to rapidly providing the panel 
with any necessary corrective actions. 
Process refinement 
Centralized review of clinical trials involving EFIC is 
new.  It is expected that the IRB and the investigators at 
both the Clinical Coordinating Center and the sites will 
identify ways to improve the content and the process 
over time.  Mechanisms for incorporating these lessons 
back into systematic improvements will be pursed and 
supported by all parties.  
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Network EFIC project - Accumulated ROC/NETT experiences and findings related to EFIC:  
SIREN Subproject #2 
 
Discussion Guide Preamble [OPENING SLIDE] 
Thank you for taking part in this expert panel discussion. We are delighted that you have agreed to join 
us.  My name is [FACILITATOR NAME].  I am from Westat, a research organization headquartered in 
Rockville Maryland, and will be facilitating the discussion on behalf of the team of researchers led by 
Dr. Robert Silbergleit at the University of Michigan and others involved in the SIREN Network.  I am 
joined by my colleague, Carl Riley, who is Westat’s technical expert and will be running the WebEx for 
us today. 
As you know, the purpose of this project is to collect, share, and consolidate the experiences and 
scholarship of emergency care clinical trials researchers relative to implementation of exception from 
informed consent (EFIC). You have been invited to participate because of your experience and 
expertise.  We are not here to discuss the basics of EFIC, but want to take advantage of your 
familiarity with the fundamentals of EFIC and to build on them so we can discuss the heart of the 
controversies and tough challenges.  We will not have time to solve any of the challenges today, but 
we want to make sure that we hear a range of your opinions on this topic. 
Prior to this web conference, some of you were able to review and provide written comments on two 
documents: a draft of a scoping review of the literature on EFIC implementation, and a draft of a 
model operational process manual for EFIC implementation. Now we are conducting this expert panel 
discussion to explore and better understand areas in which experts expressed differing views or 
interpretations.  Everyone, even those who did not provide written feedback, is invited to equally 
participate in today’s discussion. 
Before we continue, I want to stop and see if you have any questions about what I have said so far. 
Answer any questions. 
Housekeeping/Ground Rules [SLIDE] 
Okay, now I’d like to go over a few guidelines for our conversation today.   I’m here to guide the 
discussion, but I encourage you to converse among yourselves. If you would like to add to an idea, or 
if you have an idea that is different from someone else, feel free to speak up or use the “hand icon” 
in the WebEx features so I know to call on you. I may also ask to hear from individuals who haven’t 
yet provided their perspectives. 
My role is also to ensure that we do not exceed our allotted time.  Since we have several concepts to 
discuss, I may suggest that we curtail comments if the conversation veers off course or if we need to 
move on to the next topic.  We will aim to spend about 15 minutes on each topic. 
As we are on a web conference, when you are NOT speaking please mute your line.  When you do 
speak, unmute your line and first state your name prior to making your comment.  This session will 
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be recorded and detailed notes taken so please speak clearly and one at a time so we can capture 
your input.  If you are experiencing any technical issues, please use the chat function to explain the 
problem, and Carl and I will resolve the issue.  
I wanted to note that there are others on the line from the SIREN project team, most of whom will be 
observers.  However, the primary authors of the two documents, Dr. Robert Silbergleit and Dr. Neal 
Dickert, may also be engaged in the discussion to keep us on topic or to ask clarifying questions.   
Are there any questions before we get started? Answer any questions. 
Roll Call [SLIDE WITH NAMES AND AFFILIATIONS OF PARTICIPANTS] 
Before we begin the discussion, I would like to confirm who is on the call.  Several of you may be 
colleagues or have worked together on past projects and trials. When I read your name, please 
confirm you are on the line. [FACILITATOR READS LIST] I know that some of you indicated you will 
not be available for the complete 90 minutes.  If you need to leave the call and/or rejoin, you do 
not need to say anything.  We should be able to track who is with us using the participant list on 
the WebEx dashboard. 
Set Up [SLIDE WITH NAMES OF DOCUMENTS AND LIST OF THEMES] 
As a general frame to the discussion, we will be focusing on three themes that arose from the synthesis 
of your feedback on the draft EFIC documents.  The two documents are shown on this slide: 
1. Scoping Review of Literature on Implementation of Community Consultation and Public 
Disclosure for Research Using Exception from Informed Consent (EFIC) for Emergency Research 
2. Model Operational Procedures for the Implementation and Review of NIH Sponsored 
Multicenter Clinical Trials with Exception from Informed Consent (EFIC) for Emergency 
Research.   
Reviewers were instructed to provide feedback in targeted sections, specifically reflecting topics that 
need revision or clarification, and where there may be gaps.  This information across both documents 
has been reviewed by the project team, and the following themes have been distilled for further 
discussion: 
1. Theme 1: Engaging Diverse Communities 
2. Theme 2: Exploring Potential Goals, Methods and Metrics of Community Consultation (CC) 
3. Theme 3: Exploring Potential Goals, Methods and Metrics of Public Disclosure (PD) 
We’ll review each theme individually, and I will have some general and specific questions to obtain 
further clarification on these themes. We are not looking to gain consensus from the group, but your 
feedback will help ensure that these documents are useful and applicable to EFIC researchers.  
Discussion  
THEME 1: ENGAGING DIVERSE COMMUNITIES 
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1. The first theme we’d like to discuss is engaging minority communities or other communities 
affected by discrimination or vulnerability.  From your experience and knowledge of the 
literature, how do you recommend we provide guidance for researchers to ensure they 




 Do you recommend researchers conduct community consultation and public disclosure 
events that target the general population?  Or reach out to minority communities on 
their own as separate special interest groups?  Or should they allow the diversity of 
experiences in the community to be heard without attempts at proportionality?  
 How do plans for CC and PD interact with the burden of the disease, or the burden or 
benefit of the research among different minority groups?  
 Should representation in CC and PD resemble that in the geographic community, or the 
demographics of the disease of interest, or of patients enrolled in a particular hospital? 
 What are the best ways to build trust through community consultation and public 
disclosure activities that target specific ethnic, racial, socio-economic, or other groups?   
 
THEME 2: EXPLORING POTENTIAL GOALS, METHODS AND METRICS OF COMMUNITY CONSULTATION 
2. The next theme we’d like to discuss is related to community consultation.  From your 
perspective, what does the literature tell us about the kind of goals researchers should aim to 
achieve from their community consultation activities (e.g., to get meaningful input on the 
protocol, to demonstrate respect for persons)? 
 
Probes: 
 Describe examples of how the CC strategies or methods might differ depending on the CC 
goal the researcher is aiming to achieve. How feasible are these strategies/methods?  How 
effective are these strategies/methods? 
 Should researchers prioritize the breadth of community discussions so as to increase 
“representation,” or prioritize the quality of community discussions and other interactions 
(i.e., the depth of message dissemination)? 
 Should researchers target their community discussions to a geographic area, to specific 
underrepresented groups, or to patients with trial-specific conditions?   
 How, if at all, does the adequacy of CC activities depend on the risk of the intervention? 
What recommendations can you make to help researchers determine whether their CC 
activities will be adequate in relation to their intervention?  
 
2b. As the next step after researchers design and implement their CC activities, what 





 How do you recommend researchers provide evidence that their CC goals have been 
achieved? 
 In what format should researchers report the output of their CC activities (e.g., 
description of CC events and attendees, protocol revisions made based on CC input)? 
 
THEME 3: EXPLORING POTENTIAL GOALS, METHODS AND METRICS OF PUBLIC DISCLOSURE 
3. Now I’d like to discuss the same set of questions but in thinking about the goals of public 
disclosure.  From your perspective, what does the literature tell us about the kind of goals 
researchers should aim to achieve from their public disclosure activities (e.g., creating 
transparency, creating awareness, ensuring an understanding of the trial)? 
 
Probes: 
 Describe examples of how the PD strategies or methods might differ depending on the 
PD goal the researcher is aiming to achieve.  How feasible are these 
strategies/methods?  How effective are these strategies/methods? 
Probe for recommended methods to achieve specific goals: 
o Create transparency 
o Create awareness 
o Ensure knowledge, recall or understanding of the trial 
 Does the literature and you past experience support a recommendation that 
researchers aim for large numbers of respondents like what one can achieve using 
random-digit dialing or certain types of social media, OR do we emphasize smaller 
numbers of more human face-to-face interactions directly with investigators? 
 How, if at all, does the adequacy of PD activities depend on the risk of the intervention? 
What recommendations can you make to help researchers determine whether their PD 
activities will be adequate in relation to their intervention? 
 
3b. As the next step after researchers design and implement their PD strategies, what 
recommendations do you have for demonstrating that they have achieved their goals? 
 
Probes: 
 How do you recommend researchers provide evidence that their PD goals have been 
achieved? 
 In what format should researchers report the output of their PD activities (e.g., in 
metrics, in qualitative summary, some other demonstration of success)? 
 
Closing Statement 
Thinking back to our discussion, does anything else come to mind that you think might be important?   
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 Drs. Silbergleit and Dickert, do you have any follow-up questions you would like to ask or 
clarifications you’d like to make at this time? 
Thank you for participating.  You have all worked hard and we have learned a great deal from you.  We 
























Scoping Review of Literature on Implementation of Community Consultation and Public Disclosure for Research Using Exception 
from Informed Consent for Emergency Research  
 
Summary of Phase I – Feedback from Reviewers4  
 





Restructure or relabel this section Revision e.g., section can be called “Forms of Assessment” and 
include Surveys, Qualitative Reports, etc. under this 
section; change “Inconsistent Metrics” to strategies 
Detail results from each method as sub-sections Revision  
Add more description of surveys Clarification Include type of format (in-person, anonymous, 
electronic, paper), type of question (Likert scales, 
open-ended questions), strength of random digit 
dialing and electronic surveys, and reference FDA 
Docket 955-1058 re: survey sample size and 
community consultation 
Add more description of community consultation  Clarification e.g., includes two-way communication, focused on 
community impact and not individual acceptance 
Include information on how to interpret the meaning 
of each type of result 
Clarification  
Provide more definition of “community” in the 
studies reviewed  
Clarification e.g., US only; did studies make individual-level or 
group-level comparisons; definition of ‘relationships;’ 
describe community where research will be performed 
and community where participants will be drawn 
Add more description about focus groups and 
meetings  
Clarification e.g., presence of a trained facilitator; open to the 
public; town hall 
                                                 
4 Feedback is not verbatim but summarized for presentation.  Excluded:  Duplicative feedback re: content, general positive comments, and indications of 
agreement 
5 Feedback type classification:  Revision (refers to comments about edits, wording, terms used, or reorganization of sections of the document; Clarification 
(specific suggestion for elaboration or different information about a topic introduced in the document); Gap (refers to the absence of a relevant, substantive topic 




Describe whether results vary by trial/topic (e.g., 







Add detail about opt-out rate frequency Clarification  
Specify that public disclosure occurs before, during 
and after the study 
Clarification  
Specify that “pre-consenting” an entire community 
may not be possible 
Gap Text expresses well the criticism that distribution 
metrics do not translate to public awareness 
Specify that ethnic distribution of the expected 
patient population should be targeted 











Move this section up to the Community Consultation 
and Public Disclosure sections  
Revision they describe the analysis of CC/PD and the value of 
different methods 
Add data on how often CC concerns are raised, if 
protocols have been modified based as a result,  and 
how often IRBs participate in CC activities 
Gap  
Differentiate between the purpose/intent of CC 
versus its value  
Gap terms like “intrinsic” and “extrinsic” are not helpful 
Address the idea that PD and CC should occur while 
the protocol is being developed and at a national 
level, but still have local sites do PD to allow for 
output 
Gap  
Add detail about reported acceptance rates by CC 
method and rates of opt-out use 
Gap  
Describe problem of poor community comprehension 
of research-related concepts 
Gap consider adding that PD communications are reviewed 





Suggest revising the description of regulations from 
“novel” to “challenging and subject to vast 
interpretation” 
Revision  
Insert a grid of method by goals and resources Revision Agree with value of multiple methods 
Clarify whether there is evidence besides select 
publications to support that CC efforts have fallen out 




Clarify why there are questions about whether CC 
should be qualitatively or quantitatively focused 
when the regulations require both 
Clarification suggest adding that it might depend on the 
generalizability of the condition under study 
Clarify that the regulations require both the 
geographic and targeted communities be involved in 
CC (and that targeted community members can be 
part of the geographic community);  
Clarification suggest reviewing Kahn, Mastroianni, and Sugarman, 
Beyond Consent Seeking Justice in Researc 
Clarify that the reduction in value of large-scale 
population-based efforts is a matter of opinion 
Clarification there could be confounding factors (e.g., benefit of 
random digit dialing, challenge of community 
comprehension) 
Clarify that individual acceptance is not the goal of CC  Clarification but to ensure that the respondents understand the 
reasons why IC cannot be obtained and if the study 
should be conducted in their community, and to 
ensure the respondents understand the difference 
between research and treatment 
Emphasize that the regulations allow for variation in 
methods 
Clarification suggest surveying patients/families part of EFIC 
studies 
Clarify that penetration/awareness is the issue with 
PD coverage versus the amount of coverage 
Clarification  
Emphasize that two-way CC exchange reflects the 
importance researchers place on establishing 
trust/respect with the community 
Gap  
Emphasize that surveys are easier to complete but 
there is an issue with community comprehension; 
consult FDA docket for other forms of CC and PD 
Gap  
Add discussion of post-study public disclosure Gap including a report of who was enrolled in the EFIC 
study 
Add use of marketing professionals (vs research staff) 
to improve CC/P 
Gap  
Specify that CIRBs and PIs should ensure mutual 
agreement on expectations 
Gap an emerging model is for the CIRB to decide if the 







Suggest restructuring paper to start with conceptual 
material/normative basis for EFIC regulations and for 
judging whether activities reflect reason for the 
regulations 
Revision  
Reference #s34 and 59 are the same Revision  
Add to the conceptual literature list: Smirnoff M, 
Wilets I, Ragin DF, Adams R, Holohan J, Rhodes R, 
Winkel G, Ricci EM, Clesca C, Richardson LD. A 
Paradigm for Understanding Trust and Mistrust in 
Medical Research: The Community VOICES Study 
(PMID: 29368998) 
Gap  
Add text re transparency in CC and PD, given that 
regulations require evidence of PD in FDA docket 
Gap  
Add text re non-mandatory but strongly 









Model Operational Procedures for the Implementation and Review of NIH Sponsored Multicenter Clinical Trials with Exception 
from Informed Consent (EFIC) for Emergency Research  
 
Summary of Phase I - Feedback from Reviewers6 
 
SECTION FEEDBACK TYPE7 
Introduction  
(box 1) 
Use language consistent with FDA guidance Revision 
Reframe the document so that it serves as a general EFIC guidance document that 
can be used for various types of conditions 
Revision 
Clarify the enrollment process and the LAR’s role Clarification 
Include language on the importance of protecting patients’ rights, informed 
consent, situations when informed consent cannot be obtained 
Gap 
 
Overview       
(box 2) 
Clarify the purpose of the document, include background of the TBI study, EFIC and 
decision points 
Clarification 
Clarify language about participant data collection following withdrawal of the study Clarification 
Revise language to explain that enrollment in EFIC studies does not preclude the 
LAR consent  
Clarification 
Revise language re: procedures to provide information about the emergency 
research per 21 CFR 50.24 
Clarification 
Include language about therapeutic window, key decision points for searching for 




criteria for use of 
EFIC                  
(box 3) 
Include a transition to describe the focus on EFIC Revision 
Streamline specific discussion on TBI Revision 
Describe if patients in this study meet the HHS/FDA guidance definition of life-
threatening?  
Clarification 
                                                 
6 Feedback is not verbatim but summarized for presentation.  Excluded:  Duplicative feedback re: content, general positive comments, and indications of 
agreement 
7 Feedback type classification:  Revision (refers to comments about edits, wording, terms used, or reorganization of sections of the document; Clarification 
(specific suggestion for elaboration or different information about a topic introduced in the document); Gap (refers to the absence of a relevant, substantive topic 




Clarify what is meant by “sample” trial and if this refers to a proposed or actual trial Clarification 
Provide justification on why it would be impractical to conduct the trial as a non-
EFIC study 
Gap 





EFIC                 
(box 4) 
Rename section title Revision 
Clarify acronyms (e.g., CIRB) Revision 
Clarify how this study is conducted without an IDE, which contradicts 21 CFR 
50.24(d) which indicates these studies must be conducted under a separated 
IND/IDE 
Clarification 
Clarify mention of NINDS in document, how this relates to all EFIC studies Clarification 
Clarify that EFIC enrollment is not an alternative to LAR/Family consent, as stated in 
the document 
Clarification 
Describe the process if e-consent is used rather than paper consent Gap 
Explain how a non-LAR relative can refuse consent to participate Gap 
Describe under what circumstances public disclosure would occur during 
enrollment 
Gap 




principles    
(boxes 5-8) 
Clearly distinguish between public disclosure/informing vs. community consultation 
informing 
Clarification 
Describe that there is a significant degree of agreement re: CC forms through 
network research structures 
Gap 
Include historical context of racism and patient enrollment without consent, need 
for CC to include members of minority groups 
Gap 
Address the detailed discussion on geographic community. Discussion of racial, 
ethnic, and age community of patient population should be emphasized instead.  
Gap 
Include sentence that encourages exploration of the definition of the community 
between the investigator and the IRB of record 
Gap 
Increase emphasis that certain communities (the poor, people of color, or ethnic 
minorities) should especially be included if appropriate for condition and location of 
study 
Gap 
Consider including recommendation on who is appropriate to conduct CC activities Gap 
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menu           
(boxes 9-16) 
Ensure that this section is cohesive with rest of document, as this section is more 
general and not trial specific 
Revision 
Consider including the following in the survey described (in “Visits to existing 
meetings or existing groups” section): age, race/ethnicity, gender, education, and 
experience with the condition being studied; and brief knowledge check questions 
Revision 
Reference the source for the 80% statistic (adults accessing social media) Revision 
Replace BOOST3 with “sample TBI study”? Revision 
Clarify why there should be a mix of at least 6 required activities and how this 
number was derived, evidence of this number of activities  
Clarification 
Consider providing basis for the recommended presentation length of 10-15 
minutes (in “Visits to existing meetings or existing groups” section) 
Clarification 
Note the role of observer/note-taker at the meetings, i.e., to observe and create 
record of the interactions and document questions/concerns raised by attendee 
Clarification 
Partnering with community leaders who can encourage community participation 
has been a valuable approach 
Clarification 
Consider providing the basis for why an investigator should be present for a 
meeting but may or may not be present at focus groups 
Clarification 
Comment on any anecdotal reports of meetings that were highly attended Clarification 
Reviewers agreed there are limitations to RDD; one reviewer commented that their 
IRB determined that RDD is not an appropriate CC activity 
Clarification 
Mention that the strength of RDD is that responses can be weighted to match the 
age, gender, race, and ethnic distribution expected in the study 
Clarification 
One reviewer disagreed with the statement “Large telephone surveys can provide 
the most statistically representative description of community responses to 
questions about the study and EFIC” 
Clarification 
Note that, to make valid comparisons, the same survey should be used across sites Clarification 
Provide specifics on monitoring reach of CC activities Gap 
Consider mentioning the need to have 2-way communication if using a survey Gap 
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Consider describing ways to measure the impact of community events (e.g., the 
number of conversations) 
Gap 
Consider adding recommendations to leverage institutional social media accounts 
and PR interfaces, and engaging professional organizations in social media efforts 
Gap 





results            
(box 17) 
Demographics of the study area should also be included in the report 
 
Clarification 
Discuss how the results of CC shape the conduct of trials Gap 
 
Public disclosure 
principles    
(boxes 18-20) 
Delete “In fact, the more benign and acceptable the content of a public disclosure 
is, the less likely it will be internalized and recalled” because it is unclear how it can 
be operationalized 
Revision 
Consider including that the messages need to be consistent and IRB approved Clarification 
Gratitude may not be appropriate in all cases and could be misinterpreted Clarification 
Gratitude to subjects and their families should be done on a personal level, in 
addition to other broader approaches 
Clarification 
Press releases, alone, might not be considered a public disclosure method Clarification 
State whether “at least 6 total PD activities” is an NIH policy Clarification 
One reviewer thinks the best measure would be the number of people aware that a 




menu – Pre-trial         
(boxes 21-23) 
Engaging professional organizations might boost reach Clarification 
Number of website hits can help determine impact Clarification 





menu – Post-trial            
(box 24) 
Note that post-trial PD must include the demographics of the participants in the 
trial 
Clarification 








(LAR)               
(box 26) 
Provide references to the federal regulations re: how a non-LAR relative can refuse 
consent  
Revision 
Recommend changing “… the LAR highest in the local hierarchy should give 
consent” to “…the LAR highest in the local hierarchy should be asked to provide 
consent” 
Revision 
Revisit the sentence stating “informed consent process is performed”—revise to 
“discuss risks and benefits”? 
Revision 
Clarify the intent of “the LAR highest in the local hierarchy” (e.g., the LAR highest in 
the jurisdiction’s legal hierarchy? 
Clarification 
Clarify whether or not NIH requires obtaining informed consent for continued 
participation in the study 
Clarification 





out)  (box 27) 
Consider commenting on the response if subject carries a DNR/DNI card/bracelet or 
has DNR/DNI documentation at the institution 
Gap 
 
C. SOP for trial 
applications 
involving EFIC to 




Clarify what is meant by “an application may proceed” in the context of the IND/IDE 
being on clinical hold; or delete if inaccurate 
Clarification 
Clarify what is meant by “approval of the protocol application” (e.g., by whom?) 
 
Clarification 





review of site 
applications for 
EFIC trials    
(boxes 35-41) 
Sites should provide local demographics and any special considerations- similar to 
local context issues provided for CIRB submissions for non-EFIC studies 
Clarification 
CC/PD plans should be fully reviewed before implementation, and IRB expectations 
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Network EFIC project - Accumulated ROC/NETT experiences and findings related to EFIC:  
SIREN Subproject #2 
Expert Panel: FINAL WEB CONFERENCE NOTES – 2020_02_13 




Discussion Guide Preamble [OPENING SLIDE] 
Housekeeping/Ground Rules [SLIDE] 
Are there any questions before we get started? Answer any questions. 
NONE. 
Roll Call [SLIDE WITH NAMES AND AFFILIATIONS OF PARTICIPANTS] 
Set Up [SLIDE WITH NAMES OF DOCUMENTS AND LIST OF THEMES] 
Discussion  
THEME 1: ENGAGING DIVERSE COMMUNITIES 
4. The first theme we’d like to discuss is engaging minority communities or other communities 
affected by discrimination or vulnerability.  From your experience and knowledge of the 
literature, how do you recommend we provide guidance for researchers to ensure they 




 Do you recommend researchers conduct community consultation and public disclosure 
events that target the general population?  Or reach out to minority communities on their 
own as separate special interest groups?  Or should they allow the diversity of experiences 
in the community to be heard without attempts at proportionality?  
 
Ben Abella:   It’s important not to reach out to minorities blindly, but rather try to match your local 
environment. Equal representation of various minority groups sounds good, but it is more important to 
mirror the community in which you are doing consent.  E.g. if primarily enrolling a Hispanic community, 
then reflect that.  Some people do a blanket approach to include all minorities, but if it doesn’t mirror 
the local community—and one can put it a lot of effort—it doesn’t really make sense.    
 
Sara Goldkind:  I agree with that. Depends on what the study is and who might be the most affected 
minority population based on the study itself. It’s important to go into the community—and not expect 
minorities or individuals to come to CC activities but to go into their communities in a way that reflects 
the importance of certain sites or community events for them, e.g., barbershops in Black communities 
and maybe churches, and so forth. I think it depends on the scientific goals of the research and what the 
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disease or condition is of study, which minority groups will be most affected. CC materials and activities 
need to be tailored to the important centers within those communities. 
 
Gail Povar:  I’m in vigorous agreement with what has been said. Challenge with articulating what we 
ought to be doing with no regulatory guidance on this.  At IRB level, the challenge is to figure out how 
directive to be and what is acceptable.  We have seen really engaging and creative ways to reach out to 
communities, from meeting with chaplains and going out to religious groups. One site talked to Spanish 
interpreters at hospitals to figure out how to reach community, they said here is a community leader- go 
for a walk with him. PI went for a walk in the community and met with leaders.  There are a lot of ways 
of doing this that are important and reflect what’s been recommended—i.e., tying it to metrics of 
specific institution and its community, and making sure it’s not institutional based, but community 
based. It would be very helpful for IRB for there to be some sort of guidance, because the FDA regs are 
understandably extremely vague.   It’s possible for IRBs to differ dramatically based on their 
interpretation. 
 
Tom Aufderheide:   I think it’s the wrong question.  You need to start with the study you are doing and 
understand what your expected ethnic distribution of the population that will participate in study and 
address those communities within your own community accordingly. Re: lack of guidance… I think it’s a 
double-edged award.  In 1995, FDA specifically didn’t mandate certain approaches because every 
community is different, and there are different approaches that are most appropriate for that local 
population.  So, they were intentionally vague. I raise consciousness of group to be careful re: what is 
mandated or said about what people have to do—it’s a wide world and every community is different.  
What is optimal for one community might not be optimal for another community.  
 
Opeolu Adeoye:  I agree with what a lot of what has been said.  Principle that research community 
expecting each EFIC study to be different is essential because it depends on the study, and depends on 
the community, so we should expect every single study to be different.   Back to the original question – 
it is essential that minority communities in fact be sought out. Investigators do not know their own blind 
spots. I can’t think of a justification for an EFIC study that says “this particular participant population is 
not likely to be involved.” From BOOST study experience with Advarra, we found that we targeted 
people accessible to us, we reached a largely educated African-American community. When we gave 
education levels to Advarra, the IRB asked us to target an uneducated African American cohort because 
that is actually a huge portion of the population that was likely to be enrolled in study. We were not 
aware of that blind spot. I differ with Tom on the use of targeted efforts. 
 
Tom Aufderheide: I completely agree. We need to reach out to everybody, but base your focus on what 
your expected ethnic distribution is. 
 
Harry Selker:  First thing to do is, start with the right sites to engage the diverse communities.  SIREN has 




Will Feldman:  It seems most agree there needs to be some matching between people engaged and 
enrolled. One concrete thing we found in our research is the % of AA enrolled in these trials tend to be 
in high 20% range, whereas % of AAs surveyed is closer to 15%.  In as much as surveys are part of CC, 
that is one concrete way to get more minority voices.  
 
Mike Linke:  Once we’ve identified the community we need to engage, then it’s important to identify 
leaders of those communities and start there.  This seems to work best in EFIC in Cincinnati. It’s 
important to identify the leaders of those communities. 
 
Sara Goldkind: FDA guidance identifies reaching out to community leaders might be a good idea when 
doing CC. I’ll echo what others have said-- the challenge in writing guidance on broad regulations is to 
allow a broad array of different options that are suitable for particular studies. FDA regulations and 
guidance are largely permissible for a large array of CC and PD activities, which I think is advantageous.   
They’ve identified certain principles that are important to guiding those activities, but they are not 
proscriptive.  That is one of the advantage of docs such as the MOP, and including a wide array of 
activities. It’s a real strength of the document.  It can be a resource for IRBs and investigators. 
 
Gail Povar:  Each site should have a lot of flexibility in how they reach out to their communities.  
Floor/ceiling issue with regs.  I’m hearing people say FDA is being permissive.  If IRB is central and 
doesn’t know the local community, its important to have some self-awareness on how to let community 
know it appears to have blind spot without being too prescriptive. It’s challenge for IRBs to walk the line 
between telling community they may not be doing optimal job and respecting local knowledge. 
 
[LIZ – posed question about historical origins of distrust….] 
 
James Paxton:  it should be part of game plan to make efforts of engaging minority communities well 
known and visible.   Part of building trust that may have been violated in the past.  In Detroit, the mostly 
African American patients are distrustful of research and would be of this technique. Drawing attention 
through media or otherwise is an important aspect. 
 
[LIZ – posed question about other pathways…] 
 
Art Derse: When research is being done, it’s typically done through an academic institution. It’s 
important to have good relationships with patients in clinical and therapeutic settings, before 
researchers wants to “enroll patients in study in this way…” Some of the way has to be paved with the 
institution’s relationship already with the community. 
 
[LIZ – posed question about pre-engagement…] 
 
Art Derse:  Yes, I think that’s right. 
 




Mike Linke:   In Cincinnati, through our CTSA/CTSP, there are research advisory panels.  One is based in 
African-American neighborhood. Couple EFIC studies used that group as part of CC. 
 
 How do plans for CC and PD interact with the burden of the disease, or the burden or 
benefit of the research among different minority groups?  
 Should representation in CC and PD resemble that in the geographic community, or the 
demographics of the disease of interest, or of patients enrolled in a particular hospital? 
 What are the best ways to build trust through community consultation and public disclosure 
activities that target specific ethnic, racial, socio-economic, or other groups?   
 
THEME 2: EXPLORING POTENTIAL GOALS, METHODS AND METRICS OF COMMUNITY CONSULTATION 
5. The next theme we’d like to discuss is related to community consultation.  From your 
perspective, what does the literature tell us about the kind of goals researchers should aim to 
achieve from their community consultation activities (e.g., to get meaningful input on the 
protocol, to demonstrate respect for persons)? 
Ben Abella:  In literature… the ability to potentially modify materials based on community feedback.  
The community may offer suggestions re: what is clear or it’s important to understand this or that 
aspect. Which is valuable. We are into our science, communication piece to the public sometimes needs 
adjustment. 
 
[LIZ – ….goal for researchers?] 
 
Ben Abella:  Think it is an actionable goal [modifying materials based on community feedback]. 
 
Alex Limkakeng:  In the era of CIRBs (e.g., BOOST 3 trial), it feels disingenuous to do CC when protocol is 
IRB approved and essentially fixed in local context. Conducting CC when there is no means to radically 
change the protocol or impact the CIRB’s broad assessment of the protocol. There should be some 
element of CC done centrally before going to local communities, or it could be done in a number of 
representative local communities as part of IRB deliberations. 
 
[LIZ – examples?] 
 
Harry Selker:  This is not well addressed; CIRB does not abrogate needs of local communities. There are 
people who are trying to lay this out. But, this would be a great document to do that [reference to 
MOP?]. The local sites’ responsibilities isn’t well articulated in many places.  Good point. 
 
Tom Aufderheide:   Thought what Adavrra did for BOSOT3 was phenomenal.  It gave every site a 
selection of approaches from a table to adapt an optimal approach locally. From an IRB standpoint, I 




Mike Linke:  Strokenet CIRB, we reviewed an EFIC study. For grant reasons, they needed protocol 
approved before CC. They indicated in letters that it may need to be revised based on results of CC…we 
were aware of that when we approved the protocol.   
 
Gail Povar:  Two issues: How to figure out how to do CC? We talked with Mike Linke and other IRB 
members-- focus groups might be a good place to start before CC fully articulated. FGs can let 
investigators pilot test materials and plan, and get feedback from community members. I imagine IRB 
would be happy to see that sort of process. The 2nd issue is the IRB’s protocol approval before 
communities seeing it. FDA says that IRB has authority to change protocol based on CC feedback data, 
but not sure how that is handled.   It will depend on quality of data we get from community. Changing 
protocols assumes you are getting high quality community data—and I’m not sure we know how to 
judge that yet. 
 
James Paxton:  My concern is when we have a protocol through IRB, the community decides don’t like 
something and we change it.  Do we go back to community and let them know it’s been changed. They 
may have more opinions about that [change]. Do you go back to them a second time? 
 
Opeolu Adeoye (uncertain): I’m thinking of the administrative burden and scale of administrative 
burden.  E.g., LA requires a certain protocol change, then NY versus Tallahassee… I scale that quickly in 
my head, and it becomes untenable and may compromise the quality of the study questions. E.g., if each 
site wants different protocol modifications. 
 
Probes: 
 Describe examples of how the CC strategies or methods might differ depending on the CC 
goal the researcher is aiming to achieve. How feasible are these strategies/methods?  How 
effective are these strategies/methods? 
 [LIZ – rephrased this question - Should researchers prioritize the breadth of community 
discussions so as to increase “representation,” or prioritize the quality of community 
discussions and other interactions (i.e., the depth of message dissemination)? 
Michele Russell-Einhorn:  Go back to last conversation – we have to expect any protocol will be 
modified down the road-- it’s the nature of research.  CC is different from the ongoing responsibility for 
PD, you need to look at it with common sense perspective.  If initially you describe protocol in certain 
way, and modifications don’t change fundamental nature of the research, then I don’t think you need to 
go do another CC or look to re-consent people, depending on how the whole thing is framed.  But may 
play into a need for PD about how the research initially described to the community has changed.  I 
worry about getting too caught up in, if we change protocol we’ll have to do this or that.  [Want to] 
thank everybody.  But have to agree that we don’t want guidance from government because it becomes 
too proscriptive.  I think that local contexts vary, and who knows how that will change down the road. 
We really need guidance for IRBs and investigators in particular.  Is this group putting together guidance 
to go out to investigators that would help them understand at least general concepts about PD and CC? 
[no comments from group] 
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[LIZ – back to question I asked before, does the panel have any feeling whether researchers should focus 
on broad representation or more targeted in-depth methods for the community—or might it depend on 
the research?].    
Unknown:  Think there should be both [pathways]. 
Sara Goldkind:  I agree as well. 
[LIZ – what if both strategies conflict or there’s not enough time in the day?] 
Opeolu Adeoye (uncertain): Back to Cincinnati example, research advisory panels…we have defacto 
focus groups.  Have overall research expertise but not expertise about each exact study.  Sets them 
apart.  Have blind spots just like investigators do. They counsel us in the outreach, and then in the 
outreach we capture broader opinion.  I don’t think it doesn’t overtly conflict. We have scenarios where 
we learn from advisory panels and advisory panels learn from community.  Suggest that we as 
investigators and advisory panels or FGs have to be open to learning from community at large. 
James Paxton: I would recommend diversity over depth. I’d like to have as many opinions as possible—
even if its gut reaction-- if it represents more of the community. It’s nice to have in-depth conversations, 
but I would rather have a broad range of opinion rather than a really deep opinion from one person.  
Alex Limkakeng:   The way I envision both-- one question we are asking folks in CC, we have patient 
advisory councils – ask them how can we do PD better?  Having the first step of in-depth panel on how 
you can do the broad outreach. Have a panel guide you on your broad outreach.  Can guide you on how 
to do it better.  E.g., one member is on the board of previous TBI survivors and she will connect us to 
that group to publicize about the study.  CC can set up your PD. 
 Should researchers target their community discussions to a geographic area, to specific 
underrepresented groups, or to patients with trial-specific conditions?   
 LIZ - How, if at all, does the adequacy of CC activities depend on the risk of the intervention? 
What recommendations can you make to help researchers determine whether their CC 
activities will be adequate in relation to their intervention?  
[Liz rephrased. Do you have any recommendations we can make?] 
Gail Povar:  Assume [this is] tied to metrics, and interested in benchmarking and I’m mindful of the 
comment about surveys…Can we hear from people re:  whether they think there is such a thing as 
proportional representation from the community, in terms of number of participants and if should that 
be correlated to size of the institution in some rough way? And how specifically written surveys 
collected might be used as a metric in terms of numbers and adequacy for specific responses, in terms 
of the ns for each response.  Don’t know the answer, can group address? 
Alex Limkakeng:  Like Tom from Wisconsin mentioned layout of activities and options from BOOST 3 
trial incorporated into the model EFIC procedures document. For BOOST 3, they set out a defined 
quantitative amount of activities in various categories and recognizing it might not be be-all and end all, 
but measurable and seems reasonable and feasible. So that’s a pretty good source of good guidance for 
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future IRBs. We could argue about specifics but is reasonable and feasible, and seems to match the goals 
of CC and PD. 
Will Feldman:  Comment on surveys.   I don’t conduct EFIC trials but sifted through surveys done. 
Surveys are helpful.  I noticed a lot of heterogeneity in how questions are worded even within same 
trial, sites will word things differently. If someone is trying to compare, it becomes difficult to compare 
across sites or across trials.  If surveys continue to be a part of CC, ideally more standardization in terms 
of the questions and how it all gets reported.  There is a tremendous amount of info that’s been 
collected. But can be challenging to access… as we think about metrics, the questions about what is the 
right threshold for saying people agree is hard, because even looking at questions that can be grouped 
together e.g., re; willingness to be enrolled, there is lot of variability in wording, so hard to talk about 
threshold with the heterogeneity. 
Robert Silbergleit:  There are some real tensions.  Is good survey methodology good CC, and vice versa? 
This comes up with controversial topics like RDD, which is arguably the best surveying method for CC, 
but a lot of people don’t like for CC because not personal, it doesn’t give investigators the opportunity to 
sit across the table and talk to somebody. Tension between depth and quality of survey tends to be 
there.  What IRBs and and sponsors demand will drive what we do.  Whether we want to drive toward 
more face-to-face things or better survey methodology. Survey methods done so far are very limited 
from survey standpoint. I struggle with this tension. Others? 
Tom Aufderheide:  Crucially important issue.  Personal opinion, each approach has strengths and 
weaknesses. One on one interactions with community are terrific, but Personal [approaches] only reach 
so many people. RDD has a strength.  Black community 26% but only 20% responded in RDD, you can 
weight to assure 100% ethnic coverage, and weighed samples that directly reflect the ethnic distribution 
you are targeting, and no other approaches can do that, but there are downsides – e.g., no one on one 
interactions. I’d advocate for multiple approaches to maximize the strengths of all the different kinds of 
the approaches.  
Gail Povar:  I agree with all of that. These menus [reference to MOP document] should push not just 2—
but maybe 3 or 4 from each “column” – so there is wide spread of activity even though it may challenge 
the sites and address complementarity people are mentioning.  Also the menu - credit to Rob et al., 
good effort – is a superb shortcut but needs to be fleshed out [more] re: what the options mean.  Even 
within each section, here is what we think the best way to do it… Maybe language that says, this just 
isn’t aspirational, describe floor and ceiling.   Increasing the variety of activities that sites use can 
address the comments about each method having strengths and weakness. 
[LIZ – advantages and disadvantages of one over other?   And other comments re: methods?] 
Mike Linke:  Random digit dialing.  In our last EFIC study, we were asked not to do RDD because of 
coverage. [muddled] institute for policy research…there are real problems with random digit dialing, 
especially using auto-dialers… in our consultation with experts, we decided that RDD was NOT a good 
approach.  Other issue, lot of people use cell phones now.  Cell phones does not suggest community 
localization. Discouraged use of RDD for CC. 
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[LIZ – any other thoughts? - there were NONE] 
2b. As the next step after researchers design and implement their CC activities, what 
recommendations do you have for demonstrating that they have achieved their goals? 
 
Probes: 
 How do you recommend researchers provide evidence that their CC goals have been 
achieved? 
 In what format should researchers report the output of their CC activities (e.g., 
description of CC events and attendees, protocol revisions made based on CC input)? 
 
THEME 3: EXPLORING POTENTIAL GOALS, METHODS AND METRICS OF PUBLIC DISCLOSURE 
6. [LIZ - Now I’d like to discuss the same set of questions but in thinking about the goals of public 
disclosure.  From your perspective, what does the literature tell us about the kind of goals 
researchers should aim to achieve from their public disclosure activities (e.g., creating 
transparency, creating awareness, ensuring an understanding of the trial)?] 
 
Ben Abella:  “CYA” – there is no feeback loop, maybe a radio or nerwspaper ad. Like a checkbox. There is 
a need for delineated mechanism for feedback -- phone number, email, probably several different 
mechanisms.   Gotta be multiple mechanisms for feedback, may not have access to email.   
 
Alex Limkakeng:  Two thoughts re: metrics.  Modern age with social media, it is much easier now, e.g., 
Twitter account can see how many people viewed tweet. Through other social media platforms, it’s 
much more feasible to get a sense of how many eyes have seen your PD announcement.   Opportunity 
to start collecting data on what is common or the norm for PD activities.  Compared to CC, which should 
be done locally, it seems there is opportunity to emphasize central PD a bit more.  The NIH sponsors 
EFIC studies – they are excellent at disseminating info about health, seems good way to have central 
resources in general for EFIC that could be leveraged for all EFIC studies.  Surgeon General disseminates 
information on health.  A resource that could be there but is not for local investigators. 
 
[LIZ – 2 prongs.  Centralized PD to reach broader audience?  But also researches should conduct localized 
face-to-face?] 
 
Alex Limkakeng:  Yeah, but even on the central side. Most have a central coordinating center with 
website for local sites…Seems like our national organization could have EFIC general info that is patient 
and media friendly so not such a foreign concept…normalize it, so people see that it has been tried 
nationally for 30 years and is not a foreign concept.  
 





Tom Aufderheide: This is a very important question; I don’t have an answer.  Over the years, we’ve had 
people with loved ones enrolled who say I never heard about this, [that] you were inadequate in your 
PD.  So we double up our PD when someone says that. One message is: you can’t get into everyone’s 
head no matter how much PD you accomplish.  That needs to be said.   I look to group re: goal. 
 
Gail Povar:  We had a wonderful image one of our IRB members said, our goal should be that 
institutions don’t shoot themselves in the foot in the public square.  Don’t demonstrate absence of good 
faith effort.  Trying to figure out outcomes on PD is almost impossible.  The process is what is important 
rather than trying to measure an outcome.  I think it’s about a good faith effort. I think it’s more about 
the process than trying to measure the outcome.  A good faith effort would include some of the same 
things as CC.  Make sure you have reached out to your catchment area.  Reach out to your digitial/aural 
media in that area, use of social media can’t be too heavily depended on – it won’t reach people over 65 
very much. I think the emphasis should be on process not outcomes.  Process should represents good 
faith effort, just like CC, to reach the population that uses the institution and likely to be in involved. 
 
Alex Limkakeng:  Agree.  Easier to say what it is NOT the goal, than what is NOT the goal.  State the goal 
is not community informed consent. It’s not a (reprimand?) on the study. Explicitly state that – it was in 
document.  Be transparent.  Not possible to disclose every possible risk and have everyone see it or 
understand it, given what everyone is paying attention to in the media. It wouldn’t be feasible. Can’t 
reach everyone or document that you have reached them. 
 
[LIZ – other thoughts?  Goals of PD? - NONE.  Additional thought definition of adequacy in relation to risk 
of the intervention?  NONE.  Turn over to Rob and Neal….] 
 
Probes: 
 Describe examples of how the PD strategies or methods might differ depending on the PD 
goal the researcher is aiming to achieve.  How feasible are these strategies/methods?  How 
effective are these strategies/methods? 
Probe for recommended methods to achieve specific goals: 
o Create transparency 
o Create awareness 
o Ensure knowledge, recall or understanding of the trial 
 Does the literature and you past experience support a recommendation that researchers 
aim for large numbers of respondents like what one can achieve using random-digit dialing 
or certain types of social media, OR do we emphasize smaller numbers of more human face-
to-face interactions directly with investigators? 
 How, if at all, does the adequacy of PD activities depend on the risk of the intervention? 
What recommendations can you make to help researchers determine whether their PD 




3b. As the next step after researchers design and implement their PD strategies, what 
recommendations do you have for demonstrating that they have achieved their goals? 
 
Probes: 
 How do you recommend researchers provide evidence that their PD goals have been 
achieved? 
 In what format should researchers report the output of their PD activities (e.g., in 
metrics, in qualitative summary, some other demonstration of success)? 
 
Closing Statement 
Thinking back to our discussion, does anything else come to mind that you think might be important?   
 Drs. Silbergleit and Dickert, do you have any follow-up questions you would like to ask or 
clarifications you’d like to make at this time? 
Robert Silbergleit:  Neal you go first since I already asked one question.  
Neal Dickert:  Thanks everyone for being here and for comments on documents and thoughts today.  
Will mentioned challenge with survey methodology is the different formulations of question, which 
matters – content and phrasing.  Difficult to compare but at same time relative frequency of agreement 
is often quite uniform within narrow range of studies and across contexts.  Wondering what the likely 
reactions are…are there ways in which repeating this is helping us or is it doing same thing over and 
checking the box?  How are we adding value and how can we be most helpful in thinking about tips for 
doing this better? 
Opeolu Adeoye: Checking box comment.  Every time we do it, it’s very different.  People we are 
reaching are very different.  It just needs to be done again and again. It gets at earlier point about 
accepting that each study is different. Have to check the box for this study, and have to check the box 
for the next study, which is different.  
Neal Dickert:  Interactions with people are different, but seems like survey responses are in a narrow 
range.  I was thinking specifically about the assessment tools and methods. 
Alex Limkakeng:  Having a broad openly available survey as form of PD allows anyone who can find 
survey link….democratization of the process. Anyone who accesses the link can comment.   Focus groups 
are invited and perhaps targeted, not open to anybody to provide comment.  It’s not so much about the 
process but about the transparency. 
Robert Silbergleit:  New topic.  Goals re: diversity. There is tension we come up against…went to a 
general community event, make sure it approached the community with diversity that reflects the 
community we are talking about.  If % of racial/ethnic minority, we want the general population group 
to reflect that as well.  Other way to reach diversity have specific events with these specific groups in 
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isolation….seems like there is a difference between these two.  Assume you have a general population 
group that is balanced, would you still want to go out to do the individual groups? 
Tom Aufderheide:  I think you do.  Can be cultural differences in attitudes toward approach that are 
import to solicit. 
Sara Goldkind:  One of the goals of both CC and PD is promotion of transparency.  Another is promotion 
of trust between research institution and research community/catchment area - those potentially part 
of research, where subjects will be drawn.   Have to ask the question raised by Rob with that in mind.  
One reason to drill down further into diverse/minority communities is the promotion of trust and the 
promotion of transparency.  These two are potentially linked. 
Gail Povar:  100 percent agree with Sara.  Add – Liz asked about historical abuses.  Making the decision 
to reach out to communities that don’t have a voice typically in our public square, and who are less 
likely to be the ones to go look at a website about health care issues or fill out survey on a website, is a 
way to build trust for future by meeting with those communities-- maybe even disproportionately to 
their overall presence in the community-- is a good way of addressing past oversights.  Jeremy Sugarman 
calls it research justice.  How to make up for past behavior? Respectfully make this effort to drill down 
into communities that have been abused. 
Will Feldman:  Another advantage to think about with targeting African-American groups or other 
ethnic minorities, it gives people safe space to think through their opinions, deep ethical questions, 
what type of trials should we do without consent…[he was] trained in philosophy; it’s hard to think 
through all of the nuances. A lot of people don’t have well formed views.  Think through in your mind 
with others that look like you and share some of your values from the same community. 
Robert Silbergleit:  That is what I was fishing for. There is a tendency to think of this as scientists …. That 
this is all about info collecting – it’s probably only half or less about that.   A lot of it is about 
demonstrating respect, asking permission, showing people you care enough to sit and talk with them 
even if they don’t give you any new information.  The other half is information collecting…  Jeremy… 
telling about what he said…. The information you do collect from people is information about them.  
They tell you something about them, low likelihood they will tell you something you didn’t know about 
your protocol.  Likely they will tell you something about themselves that you didn’t know. Rarely learn 
something that means you will change protocol.   Learn more about how to approach people.  A driving 
method for choosing methods (e.g., surveys vs face to face) could be this idea about demonstrating 
respect, different level of that in different type activities. 














Strategies to Innovate EmeRgENcy Care 










An Employee-Owned Research 
Corporation® 
1600 Research Boulevard 
Rockville, Maryland 20850-3129 
(301) 251-1500 
 Understanding Paramedic, Trial Network, and 
Patient’s Family Experiences in Emergency 
Research Clinical Trials 
PROJECT 3: Experience of Family Members of Victims of Cardiac Arrest 
and Severe Neurotrauma 




December 24, 2020  




Table of Contents 
Executive Summary ....................................................................................................................................... 4 
Introduction .................................................................................................................................................. 6 
Research Questions and Study Design ....................................................................................................... 6 
Research Team .............................................................................................................................................. 7 
Methods ........................................................................................................................................................ 7 
Stage 1: Case Study ................................................................................................................................... 7 
Recruitment .......................................................................................................................................... 8 
Guide Development .............................................................................................................................. 8 
Data Collection ...................................................................................................................................... 9 
Data Management and Analysis ........................................................................................................... 9 
Stage 2: Workshop .................................................................................................................................. 10 
Recruitment ........................................................................................................................................ 10 
Pre-Workshop Survey ......................................................................................................................... 10 
Format and Agenda ............................................................................................................................. 11 
Data Management & Analysis ............................................................................................................. 12 
Integration of Findings ............................................................................................................................ 13 
Results ......................................................................................................................................................... 14 
Participant Characteristics ...................................................................................................................... 14 
Interview Participants ......................................................................................................................... 14 
Workshop Participants ........................................................................................................................ 16 
Findings: Case Study Interviews and Workshop ..................................................................................... 18 
Information Needs .............................................................................................................................. 18 
Communication Needs ........................................................................................................................ 25 
Emotional Needs ................................................................................................................................. 30 
Sociocultural Needs ............................................................................................................................ 36 
Physical Needs .................................................................................................................................... 38 
Limitations & Recommendations ................................................................................................................ 40 
Study Constraints and Limitations .......................................................................................................... 40 
Recommendations .................................................................................................................................. 42 
References .................................................................................................................................................. 43 
Appendices .................................................................................................................................................. 44 
3 
Appendix A: Family Member and Professional Interview Guides .......................................................... 45 
Appendix B: Interview Distress Protocol ................................................................................................ 56 
Appendix C: Interview Codebook ........................................................................................................... 58 
Appendix D: Pre-Workshop Family Member Survey .............................................................................. 63 
Appendix E: Workshop Informational Booklet ....................................................................................... 69 
Appendix F: Workshop Distress Protocol ............................................................................................... 84 
Appendix G: Reflection Session Discussion Guides................................................................................. 86 
Appendix H: Breakout Sessions 1 & 2 Discussion Guides ....................................................................... 97 
 
List of Figures & Tables 
Figure 1. Research Questions Guiding Data Collection................................................................................. 6 
Figure 2. Overview of Study Design .............................................................................................................. 7 
Figure 3. Questions Guiding the Workshop Design .................................................................................... 11 
 
Table 1. Descriptions of Data Sources ........................................................................................................ 14 
Table 2. Characteristics of Health Care Professional Interview Participants (Stage 1: Case Study) ........... 15 
Table 3. Characteristics of Family Member Interview Participants (Stage 1: Case Study) ......................... 15 
Table 4. Characteristics of Workshop Participants (Stage 2: Workshop) ................................................... 17 
Table 5. Family Members’ Information Needs by Level of Influence ......................................................... 22 
Table 6. Family Members’ Communication Needs by Level of Influence ................................................... 28 
Table 7. Family Members’ Emotional Needs by Level of Influence ............................................................ 34 
Table 8. Family Members’ Sociocultural Needs by Level of Influence ....................................................... 37 
Table 9. Family Members’ Physical Needs by Level of Influence ................................................................ 39 







Family members’ experiences in the emergency department (ED) and intensive care unit (ICU) following 
a loved one’s critical illness or injury and the impact of these experiences on family member and patient 
outcomes are not well understood. Under the leadership of the Strategies to Innovate EmeRgENcy Care 
Clinical Trials Network (SIREN), this project aimed to design and implement a robust exploration of 
existing knowledge and knowledge gaps related to the experiences of family members of victims of 
cardiac arrest and severe neurotrauma, focusing on the first 48 hours following the patient’s 




A sequential, qualitative mixed methods approach with data collection occurring in two stages was used 
to capture information related to the following key research questions: 
• What are family members’ needs in the first 48 hours after the patient’s hospitalization? 
• How are these needs addressed by hospital staff and institutions (i.e., EDs and ICUs)? 
• How can hospital staff and the institution better address family members’ needs? 
The first stage was a single-site case study to generate formative research findings from interviews with 
both family members and health care professionals, and the second stage was a virtual workshop on 
November 19, 2020 that relied on facilitated discussions among a diverse sample of family members and 
health care professionals. Information collected from all data sources was analyzed and themes were 
organized according to an analytic framework based on an ecological model, which grouped family 




In the first stage of the project, seven family members and twelve health care professionals were 
interviewed. Seventeen family members and 12 health care professionals participated in the virtual 
workshop. Family members discussed a variety of needs, including information needs (e.g., information 
about their loved one’s care and status, what to expect in the immediate timeframe and post-
discharge); communication needs (e.g., consistent and coordinated information from the care team, 
assistance with processing information); emotional needs (e.g., sensitivity and compassion from care 
team, support from family and friends); sociocultural needs (e.g., religious support services, equitable 
treatment); and physical needs (e.g., comfortable spaces while waiting, private meeting rooms for 
sensitive conversations). 
 
Limitations & Recommendations 
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The project operated under several constraints that impacted the execution of the research stages, 
including recruitment challenges and the transition to conducting the workshop virtually due to the 
COVID-19 pandemic. A key limitation of the study was the small, nonrandom sample of participants. 
Although an aim of this project was to recruit a demographically diverse sample of family members, 
there was little representation of marginalized communities who often experience health care 
inequities. Cross-cutting recommendations are provided based on the knowledge gained from this 
project, which may be useful to health care professionals and institutions seeking to improve the 






Through experience with patient engagement in planning emergency care research, and empirical ethics 
research interviewing past emergency trial participants, it has become clear to emergency research 
networks and trialists how little is known about the experience of family members of patients with 
critical emergency illness and injury. The impact of that experience on both patient and family member 
outcomes, and on emergency research participation and retention, is potentially important but 
remains poorly understood.  This project was designed to assess the experiences and needs of 
family members of victims of cardiac arrest and severe neurotrauma, with particular emphasis on 
the first 48 hours following the patient’s hospitalization.   
 
The purpose of this project, undertaken under the leadership of the Strategies to Innovate 
EmeRgENcy Care Clinical Trials Network (SIREN), was to design and implement a robust 
exploration of existing knowledge and knowledge gaps regarding the experiences of family 
members following a loved one’s cardiac arrest or severe neurotrauma as related to the provision of 
clinical care in emergency departments (EDs) and intensive care units (ICUs).  This included the 
collection of primary data from family members and health care professionals to inform domains 
for further exploration, and the identification of leading investigators to collaborate on the 
planning of a workshop to further explore these topics with family members and other 
stakeholders as a culmination of these efforts.   
 
Research Questions and Study Design 
The project followed an exploratory research approach that included several methods of data 
collection to capture information related to the research questions outlined in Figure 1, below. 
 
Figure 1. Research Questions Guiding Data Collection 
 
Qualitative data collection occurred via two sequential stages (Figure 2). During the initial stage, a 
single-site case study methodology was employed to generate formative research findings from 
interviews conducted with family and health care professionals to better understand their 
experiences after a patient’s cardiac arrest or traumatic brain injury (TBI). Concepts generated 
from the interviews were used to inform discussion topics during the second stage of the project, 
the virtual workshop.   
 
 
• What are family members’ needs? 
• How are these needs addressed by hospital staff and hospital institutions (i.e., EDs 
and ICUs)? 




neurotrauma. Data were collected via interviews with family member and hospital stakeholders. The 
qualitative case study methodology is described in more detail below. 
 
Recruitment   
Recruitment for interviews occurred via two distinct sequential nonprobability approaches.  First, health 
care professionals affiliated with the case study site, who communicate with family members during the 
first 48 hours following a loved one’s severe neurotrauma or cardiac arrest, were identified and 
recruited. To obtain a breadth of perspectives, the research team intentionally sought a cohort of health 
care professionals with diverse roles to reflect the range of care team members who interact with family 
members. A workshop co-chair whose primary affiliation is with the case study site conducted outreach 
to the identified health care professionals in July 2020 to request their participation in an interview. 
Health care professionals who expressed interest in participating received follow-up contact from 
Westat via email to identify a time for the interview.  
 
To identify family members whose loved ones received care at the case study site following severe 
neurotrauma or cardiac arrest, the research team engaged participating health care professionals in 
recruiting family members with whom they had existing relationships in a snowball sampling approach.  
Health care professionals1 were asked to contact 2-3 candidate family members to assess their interest 
in being interviewed. The research team aimed to speak with family members of diverse backgrounds 
with loved ones having a range of outcomes. 2  If the family member expressed interest in sharing their 
experiences, they were informed that Westat would be in contact with more details. Westat contacted 
the referred family members by email in August-September 2020 to provide more information and to 
schedule the interviews. 
 
Guide Development 
The research team used an iterative process to develop the final, semi-structured interview guides for 
the interviews with family members and health care professionals (Appendix A). The interview guide 
was based upon four major study constructs that were pre-identified via expert opinion. Questions 
assessed the types of information needed and received during the first 48 hours, the delivery of 
information, families’ emotional needs, and experiences with emergency research enrollment. Although 
the domains of the guide were the same for both the family member and health care professional 
interview guides, questions were tailored to the participant group. Because of the sensitive nature of 
topics, a distress protocol was developed to minimize risk of participants’ emotional distress during the 
interviews (Appendix B).  
 
                                                          
1 Health care professional participants who interact with patients only briefly or in a non-medical capacity were not 
asked to provide family member referrals since they often do not keep record of family member interactions. 
2 The coronavirus disease 2019 (COVID-19) pandemic struck the United States in early 2020, and as a result, 
hospitals across the nation took precautions to reduce the spread of the disease, such as limiting the number of 
family members in the emergency department and intensive care unit. The experiences of family members whose 
loved one had a cardiac arrest or traumatic brain injury during the COVID-19 pandemic likely differ from those 
whose loved one’s event took place before COVID-19. Therefore, the research team prioritized speaking to family 
members whose experiences were before the COVID-19 pandemic, but not more than a few years prior to COVID-
19.  
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Data Collection  
Hour-long interviews were conducted with health care professional participants in July-August 2020 and 
with family member participants in August-October 2020.  All interviews were conducted telephonically 
and were led by a Westat qualitative researcher. A second Westat staff member took notes and served 
as an observer during each interview.  
 
Data Management and Analysis 
Interviews were recorded with participants’ consent and were professionally transcribed verbatim. All 
transcripts were anonymous and any names of individuals or other descriptors that could compromise 
confidentiality were removed from the transcripts. Once validated, transcripts were posted on a secured 
drive where members of the research team could access the data for analysis. Transcripts were then 
formatted and imported into NVivo®11 Pro (NVivo, 2017) for analysis. Sensitive information about 
referred family members (e.g., contact information) was saved securely in an Excel spreadsheet, only 
accessible by the research team.   
 
A codebook, based on the interview domains, was developed for coding the interviews (Appendix C). 
Research team members trained in qualitative data analysis methods utilized NVivo®11 Pro to code the 
transcripts and retrieve coded segments for analysis. Prior to the start of analysis, all coders met to 
discuss and agree on specific coding rules to standardize the coding process. An inductive content 
analysis approach was used to code the transcripts, while also looking for emergent codes.  After the 
team of coders reached consensus on the codebook and coding process, coders continued to meet 
regularly to discuss the status of coding and resolve any issues.  
Analytic Framework 
Interview transcripts were analyzed and emergent themes were organized according to an analytic 
framework that focused on family members’ experiences grouped into five domains: 
• Information – verbal or written information about the loved one’s status or care and navigating 
the hospital and how to ensure the usefulness of this information  
• Communication – how this information is conveyed to the family member and strategies to 
present this information 
• Emotional – range of emotional needs and strategies to address these needs 
• Physical – how the hospital physical environment can be better suited for family members and 
how to address these needs 
• Sociocultural – how cultural, religious and social beliefs affect family members’ experiences and 
support services to address these needs 
These domains are affected by various levels of influence, including the individual family member’s 
needs and expectations, the individual hospital staff’s ability to address these needs, and the hospital 
institution’s (i.e., ED’s and ICU’s) organizational processes and systems to accommodate these needs. 
This framework was based on an ecological model where there are multiple and bidirectional 
interactions among the domains and levels of influence (adapted from National Institute on Minority 
Health and Health Disparities, 2017). Thus, these intersecting domains and levels of influence must be 
10 
viewed holistically when considering family members’ experiences. The framework addressed the 
research questions outlined in Figure 1, above. 
 
Stage 2: Workshop 
The second stage of the project was a workshop, conducted virtually on November 19, 2020. The goal of 
the workshop was to assess the transferability of findings from Stage 1, capture any missing themes 
related to family members’ needs, and dive deeper into a subset of topics.  
 
Recruitment 
To understand if findings from Stage 1 were transferable, the research team aimed to recruit 
approximately 30 participants from across the United States3, including family members with diverse 
racial-ethnic and socioeconomic backgrounds and health care professionals in a variety of roles that 
intersect with family members during the first 48 hours. The workshop co-chairs leveraged their 
networks to identify workshop invitees from across the United States who could bring valuable 
perspective or expertise to the workshop, including a subset of the case study interview participants. In 
total, 18 family members and 12 health care professionals were invited to the workshop.4  
 
A research team member contacted the family member invitees to provide background on the 
workshop and assess their experience with online conferencing platforms, access to a video-camera 
enabled computer, and reliability of their internet connection. The research team was committed to 
providing assistance to family members who expressed technological need so as not to exclude any 
interested family member from participation. A “save the date” Outlook meeting invitation was emailed 
to participants, and was later replaced with an Outlook meeting invitation that provided details for 
joining the virtual workshop.  Family member participants received an honorarium for their 
participation, arranged by the University of Michigan at the conclusion of the workshop. 
 
Pre-Workshop Survey 
A pre-workshop survey of family member participants was conducted as a means of collecting brief 
biographies about each family member participant for the workshop booklet (described below in Format 
and Agenda), and gathering preliminary information about their experiences to ensure discussion topics 
at the workshop were relevant and meaningful to participants. The brief survey included eleven 
questions, six of which captured family members’ demographic characteristics. The remaining items 
asked about their experience, including what they believed was most important for the research team 
to know (see Appendix D). 
 
                                                          
3 The team aimed to recruit a greater proportion of family members relative to health care professionals as the 
focus of the workshop was to further explore family members’ needs. Similar to the recruitment efforts in Stage 1, 
the team sought to recruit a sample of family member participants with balanced representation of family 
members having a loved one who had a cardiac arrest and having a loved one who had severe neurotrauma, with 
equal proportions of survivors and non-survivors. 
4 Stakeholders from the National Institutes of Health (NIH), American Heart Association (AHA), and the Sudden 
Cardiac Arrest Foundation, as well as members of the SIREN research team were also invited to attend as 
workshop observers.  
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The survey was programmed in JotForm, an online survey tool, and administered by email to the 18 
family members invited to the workshop. Along with the request for survey completion, the email 
included a request for a photo of each family member participant (with or without their loved one) to 
include with their short biography in the workshop booklet. The initial email was sent from 
SIREN@westat.com on October 28, 2020, and reminder emails were sent thereafter to non-responders. 
Survey data collection closed on November 13, 2020. Survey data were exported to Excel and securely 
shared with members of the research team. The team of facilitators met to discuss key themes that 
emerged from the survey data and used this source of data to refine a list of recommended discussion 
topics for the workshop.  
 
Email requests for a brief biography and headshot were sent to each of the 12 health care professional 
participants in advance of the workshop. The biographies and photos collected were used to populate 
the workshop booklet. 
 
Format and Agenda 
The workshop, Family Experience after Cardiac Arrest and Severe Neurotrauma, was held on November 
19, 2020 from 10:00am – 4:00pm Eastern Time. Out of concern for attendees’ health and safety during 
the COVID-19 pandemic, the workshop was conducted virtually using Zoom for Government. Zoom for 
Government is an online conferencing platform that meets federal security standards. Participants were 
asked to join the workshop from a computer or laptop, and use their device’s video camera so all 
participants could see one another, similar to an in-person gathering. Westat hosted the virtual 
workshop and provided four trained qualitative researchers to moderate discussion sessions throughout 
the workshop.  
 
The design of the workshop and selection of discussion topics was guided by the core questions outlined 
in Figure 3. 
 
Westat supported the workshop co-chairs to develop an agenda for the workshop, taking into 
consideration the aims for the workshop, findings from the case study interviews, and the pre-workshop 
family member survey responses. The agenda included a morning session comprised of two 
presentations led by workshop co-chairs followed by small group discussions to elicit participant 
reflections on the case study interview findings, and an afternoon session of breakout groups focusing 
on select topics of interest. Attendees were provided with the workshop agenda and information about 
the participants in advance of the workshop in a digital booklet (Appendix E).  Due to the sensitive 
nature of discussion topics, a distress protocol to manage and minimize participant distress during the 
workshop was prepared (Appendix F).  
• Are findings from the case study interviews transferable beyond the case study site? 
(validation) 
• What needs of family members were not sufficiently captured in the case study 
interviews? (elaboration) 
Figure 3. Questions Guiding the Workshop Design 
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Key segments of the agenda are described in detail, below. 
 
Presentations and Reflection Session. After reviewing the objectives and outlining “ground rules” for 
participation, two co-chairs delivered presentations. The first presentation provided an overview of the 
field, and the second presentation focused on findings from the case study interviews. After a brief 
“question and answers” session, attendees broke into four homogeneous groups (two groups consisted 
of family members, the other two groups consisted of health care professionals). Each reflection session 
was led by a trained Westat facilitator with backup support from a workshop co-chair. A few workshop 
observers joined each group, but did not participate in the discussion.  
 
The purpose of the reflection session was to determine the transferability of findings from the case 
study interviews. A discussion guide was developed to standardize and guide participant reflections in 
each group (Appendix G). Discussion questions sought to understand whether or not the case study 
interview findings resonated with participants and learn about any needs that were not captured in the 
case study interviews. During the reflection session, Padlet, a web-based collaborative discussion board, 
was used as a tool to collect input from participants.  
 
Breakout Sessions. To probe further into selected interview findings, two rounds of breakout sessions 
were conducted. The first breakout session included four homogeneous groups, similar to the reflection 
session (i.e., two groups of family members and two groups of health care professionals), and focused 
on family member logistical needs in the first 24 hours (for the family member groups) and provider 
training and care team approach (for the health care professional groups). The second round of 
breakout groups included four groups of mixed composition, and discussion topics focused on 
communicating and handling uncertainty in the first 48 hours.  
Discussion topics were selected as they emerged during the case study interviews as meaningful gaps 
that necessitated further elaboration and aligned with key research questions. It is important to note, 
however, that if a theme was generated during the interviews but not discussed during the workshop, 
this is not an indication of lower importance to the participants, but due to the limitations in scope to 
the workshop’s agenda.  
Similar to the reflection session, each breakout session was facilitated by a Westat researcher with 
backup support from a workshop co-chair, and observers in attendance refrained from participating in 
the discussion. Discussion guides were developed for both breakout sessions (Appendix H).  
 
Post-Workshop Communications. Following the workshop, an email was sent from SIREN@westat.com 
to all workshop attendees to thank them for their participation and follow-up with key items. The email 
included a link to the slides form the workshop presentations, information about the crisis text line, and 
an invitation for additional comments or reflections.  
 
Data Management & Analysis 
The workshop, including all reflection and breakout sessions, was recorded and professionally 
transcribed. Once validated, transcripts were posted on a secured drive where members of the research 
team could access the data for analysis. A rapid turnaround analysis plan was executed, whereby 
themes from the interview analysis were used to code the workshop transcripts. A team of coders 
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reviewed transcripts from all workshop discussion groups and the main discussion room, and coded text 
segments according to the analytic framework. Transcripts were also reviewed for practical 
recommendations to address gaps in addressing families’ needs. 
 
Additional data sources from the workshop included Padlet responses, chat messages, notes and 
observations from research team members and workshop co-chairs, and additional written comments 
via email from two workshop participants after the workshop. Secondary data sources were triangulated 
for validation and to provide a more complete representation of workshop proceedings. All data from 
secondary sources were saved on a secured drive.  
 
Integration of Findings 
Data collected from all sources were integrated to produce a summative assessment of themes 
related to family members’ needs and the strategies used by hospital staff and institutions to 
address these needs (see Table 1 for complete list of data sources). Analysts assessed the 
concordance or discordance of workshop participants’ experiences relative to the experiences of 
interview participants. For themes generated in both interviews and workshop discussion, analysts 
considered the theme transferable beyond the case study. New themes or subthemes that emerged 
from analysis of the workshop data were added to the overarching analytic framework, indicating an 
elaboration of a finding that was preliminarily explored in the interviews or a topic uniquely discussed at 







Overall, 29 individuals participated in the virtual workshop.6 Of these participants, 17 represented the 
family member perspective and 12 represented the health care professional perspective (Table 4). 
Unlike the case study interviews, participants’ loved ones received care at various hospitals across the 
United States, and the health care professionals serve diverse regions outside of the case study site. To 
have a continuous thread with the case study, two health care professionals and one family member 
interviewed in Stage 1 of the project participated in the workshop. Although there were roughly equal 
proportions of family members whose loved one had a cardiac arrest and family members whose loved 
one had a TBI, the vast majority of participants’ loved ones were survivors. 
All family member workshop participants completed the pre-workshop survey. According to family 
members’ responses to the pre-workshop survey, the large majority of family members (n=15) identify 
as non-Hispanic white and two identify as black or African American.  The sample was highly educated—
most family member participants (n=9) reported having more than a four-year college degree, five 
family members reported having a four-year college degree, and three reported less than a four-year 
college degree. Moreover, most family member participants (n=9) reported being “extremely” 
comfortable filling out medical forms alone, seven family members reported being “quite a bit” 
comfortable, and one family member reported being “somewhat” comfortable.7 Family member 
participants reported that their loved ones’ cardiac arrest or TBI occurred sometime 2008-2019.  
  
                                                          
6 This number does not include workshop co-chairs, SIREN research team members, Westat facilitators, or 
observers from the National Institutes of Health, American Heart Association, or Sudden Cardiac Arrest 
Foundation. 
7 The question assessing comfort with completing medical forms alone was included as a measure of health 
literacy. See Wallace, L. S., et al. (2006). BRIEF REPORT: Screening Items to Identify Patients with Limited Health 
Literacy Skills. J Gen Intern Med, 21(8):874-877.  
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Findings: Case Study Interviews and Workshop 
The following section represents key themes related to the family member experience that emerged 
from the interviews and workshop.  These themes are categorized by the five domains that are 
addressed in the analytical framework:  information, communication, emotional, sociocultural, and 
physical. Each table in this section represents themes that relate to these domains. To develop a holistic 
understanding of this experience, the analytical framework also considers the levels of influence that 
affect these needs.  Thus, in addition to identifying family members’ needs, strategies that hospital staff 
and institutions (i.e., EDs and ICUs) can or do implement to address these needs are also described.  
Main themes from interviews and the workshop are presented in the results tables below by level of 
influence and are in bold text.  Subthemes are indicated with bullet points under the main theme.  
Themes that were endorsed from interviews and/or the workshop are indicated with a checkmark in the 
designated column in the tables. On occasion, a theme that was discussed during the interview was 
further discussed in the workshop. Gray highlights indicate additional nuances to these themes which 
emerged from the workshop.   
Illustrative quotes in italics are included in the narrative text that introduces each results table to add 
context and richness to the findings and are attributed to the participant role (family member [FM] or 
health care professional [professional]) and data collection activity (interview, workshop discussion 
[WS], workshop chat [WS – Chat]], workshop Padlet [WS – Padlet], or pre-workshop survey [WS – 
Survey]).   
Given the complex nature of family members’ needs during this emotional period, each theme or 
domain cannot be viewed as mutually exclusive.  As often is the case in qualitative research, these 
concepts may be interrelated.  Additionally, as this framework was based on an ecological model, there 
are multiple and bidirectional interactions among the domains and levels of influence, all of which 
contribute to family member experiences.  For example, there is overlap in the presentation of 
communication and emotional needs as these concepts are difficult to disentangle and highlights the 
necessity for viewing family members’ experiences in a holistic manner.  Thus, in order for hospital staff 
and institutional strategies to improve the family member experience, they must intervene on multiple 
domains.  
It should also be noted that although the scope of the research questions focused on the first 48 hours 
after the loved one arrived to the hospital following severe neurotrauma or cardiac arrest, a number of 
family member participants discussed needs beyond this time period.  These participants explained that 
they are unable to fully describe their experiences within this arbitrary timeframe. This was more 
apparent in the workshop compared to the interview findings. As a result, several themes and 
subthemes address the time period beyond the 48-hour period, such as transitioning from the ICU to 
the hospital ward and transitioning from the hospital to home.  
Information Needs 
Table 5 presents findings related to families’ information needs and strategies implemented by hospital 
staff or institutions to address family members’ information needs.  Facilitated discussion during the 
virtual workshop focused specifically on two areas of information needs: the information needed to 
navigate the hospital environment and the information communicated when prognoses are uncertain.  
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In both the interviews and workshop discussion sessions, family members reported needing information 
about their loved one’s disease progression and expected outcomes. This theme was further elaborated 
upon during the workshop as family members discussed a desire to learn about the possible outcomes 
for their loved one, especially if the injury or condition may be fatal or seriously impact quality of life.  
I do remember feeling like frustrated or a little just – like the fear of the unknown. Like first they 
were talking about like on day one they were talking about like being in a coma, and like nobody 
ever said to me like your [loved one is] in a coma or – I mean, I could see that she wasn’t awake, 
but I don’t know, just to hear those words was hard, and then the next day they’re talking about 
a TBI. …  but like nobody ever said to me she has a traumatic brain injury. And I’ll tell you, that 
hit me the hardest. (family member [FM], interview) 
Another salient theme raised in both interviews and workshop discussions was family members’ need 
for information about their loved one’s care and status, including receiving results of all tests and 
updates about care plans. Families discussed wanting to stay updated at all times and expressed 
frustration when updates were not received in a timely manner. For example, one family member 
commented,  
I think things should be forthright and the person like me who is waiting for this stuff, especially 
if they have a major test like that, a CT scan, MRI, when you have those kind of things, you 
should be informed on what’s going on with them. (FM, interview) 
 
Not only did families discuss needing information and updates about their loved one’s status, they 
expressed a need to know whom to go to with questions and how to get in contact with the care team if 
they have questions. Additionally, both interview and workshop participants discussed a need to receive 
information to help them navigate the hospital (e.g., where to park upon arrival, lodging options), 
though this was typically viewed as lower priority relative to information about their loved one’s care or 
status. Although both workshop and interview participants agreed that information to help orient them 
to the hospital and care team were important, there were differences in family members’ experiences.  
As one family member noted, information was provided upfront in a brochure: 
My recollection is I got a brochure, or a packet, or something. I got something from this spiritual 
advisor who told me, you know, where the restrooms were, where the cafeteria was. Lots of 
information. A lot of which I didn’t pay attention to because I didn’t know what I didn’t know, and I 
didn’t know that I even needed that. But later on, you know, a day later or two days later it was very 
helpful to go back and check that resource. So that printed material was very helpful. (FM, workshop 
[WS]) 
In contrast, another family member reported having to figure out himself how to navigate the hospital 
environment and receive answers to his questions: 
I needed help managing logistics: if my wife was going to be hospitalized for a while, where would I 
sleep? Where can I get food? Where can I get a change of clothes, toothbrush, etc.? What the 
appropriate/effective ways to get medical updates on my wife? For questions that arose in the 
middle of the night, what are the best ways to get these answered the next day? I felt like I figured 
20 
this out on my own--I asked a lot of questions. But, a social worker MAIN contact would have been 
great. (FM, WS – Survey) 
To support informed decision-making, families commented on the importance of receiving clear 
information about options, including therapies and treatments; and discussed the significance of 
receiving second opinions from trusted medical sources. In both interviews and workshop discussions, 
family member participants discussed their appreciation of and reliance on family members in the 
medical field to help them make decisions. Others commented on using the internet to find additional 
information, though its utility may be limited unless the site is a vetted source of medical information.  
Searching the internet may be overwhelming for families during this traumatic time. As one family 
member suggested: “So much scary info online, so need to direct us to trustworthy sites/sources vs. 
looking up info on our own...” (FM, WS – Padlet). 
Despite the project’s focus on the first 48 hours of the loved one’s hospitalization, comments from 
family members highlighted information gaps at the point in which families prepare to transition to a 
different care setting or home. Both interview and workshop participants discussed families’ need for 
hospital staff to share information about what to expect and plan for as the loved one transitions from 
the ED or ICU. Families of non-survivors spoke about needing information to help them with making 
decisions about organ donation, arrangements for their loved one, including funeral planning and 
information about autopsying procedures. Families of survivors discussed needing information on how 
to apply for disability benefits, information about expected rehabilitation, and information about 
resources and support options after discharge. 
Health care professionals and families discussed a number of strategies used by hospital staff to address 
the information needs of family members during the first 48 hours. Strategies included honestly and 
clearly communicating expectations or uncertainty for cardiac arrest/TBI progression, explaining why 
there is uncertainty, keeping the family member informed of the loved one’s care and status, sharing 
information about different options, and framing end-of-life questions to focus on the patient’s wishes. 
Many strategies discussed during the case study interviews were also raised during the workshop 
discussion. Strategies uniquely discussed at the workshop included communicating ways family can 
interact with their loved one and providing ongoing updates to the family—even if nothing has changed.  
In particular, workshop participants emphasized the importance of avoiding false hope in 
communicating with families, and if uncertainty exists, clearly discussing the uncertainty with families. 
Some families appreciated learning about both best- and worst-case scenarios in these situations. 
Health care professionals in both interviews and the workshop discussed the responsibility of the 
physician to communicate uncertainty honestly to families. They noted variation across physicians in 
communicating uncertainty with patients, and discussed how jumping to conclusions can have 
deleterious effects on patient outcomes (i.e., a self-fulfilling prophecy) or result in false hope. As one 
health care professional stated:   
I don’t think everyone does it well, but I can tell you what we try to teach and preach, which is 
just – In a way embracing uncertainty… So it can be uncomfortable. But I think we do a disservice 
to our patients when we don’t acknowledge uncertainty.  (Professional, WS) 
Workshop participants also discussed a role of providers to manage expectations of family members 
regarding the communications from the health care team. Health care professionals discussed sharing 
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approximate timelines with family members so they are aware of when they will receive another update 
about their loved one, or if the next update may be from a different provider.  
Also, I would add an expectation of how quickly information will change is – you know, 
sometimes folks are expecting changes hour to hour, and so I try to emphasize, you know, this 
will probably you’ll get chunks of information over 12 hour, 24 hour intervals, not – you know, 
it’s not reasonable to say does he look better at 4:00 compared to 3:00. But tomorrow morning 
it’s reasonable to say, you know, what kind of changes happened. (Professional, WS) 
To support family members’ decision-making, health care professionals in both the interviews and the 
workshop mentioned clearly articulating options for the loved one with the family, providing results of 
confirmatory tests to the family (e.g., neurologic assessments), and asking family members what the 
patient would want. Physicians recognized that family members may seek second opinions, including 
internet searches, and may consult with others outside the care team. One health care professional 
commented, 
I encourage people to seek information. I try to be helpful and guide, you know, what 
information you should seek. So you know, if a person has a particular, you know, issue, I say, 
you know, you’re going to go Google this. Here are the words and terms that you should go read 
about. Be careful what you read about, but you know, rather than just unstructured looking for 
cardiac arrest and trying to digest the world’s literature for the past 30 years on an internet 
search, you know, I can help steer that. (Professional, WS) 
Institutional strategies to address family members’ information needs in the first 48 hours were 
discussed in both interviews and workshop discussions, with many themes elaborated upon further or 
new subthemes identified via the workshop. One institutional strategy raised in both interviews and at 
the workshop was orienting families upon arrival to the hospital. In general, family members 
appreciated when they were contacted (even if there were no updates) as they were travelling to the 
hospital. Families discussed receiving information upfront on where to go when arriving to the hospital 
and were pleased when they were personally greeted by someone from the care team upon arrival. One 
family member, however, wished she had received information about the loved one’s medical condition 
prior to arrival: 
But certain at an institution as large and comprehensive as [name of institution] there should be 
something in place to be able to at least provide the most basic of medical information to a 
family on route to connect with their loved one. That was – That made a harrowing nightmare 
experience even more so. Not knowing. (FM, WS) 
Although not emphasized in the interviews, workshop participants offered many ideas on how the 
institution could better inform and educate families in those initial few days. Participants discussed the 
value of the hospital sharing informational materials with families, including “questions to ask your 
physician,” care team information, and fact sheets about cardiac arrest or TBI; and how these materials 
should be available in multiple formats (e.g., printed, mobile application). Family members’ experiences 
receiving information from the institution to help them navigate the hospital environment varied across 
participants. Although these logistical needs were not top-of-mind for families as they arrived, the 






Throughout interviews and the workshop, participants emphasized the importance of communication 
between family members and health care professionals.  Table 6 presents themes from interviews and 
the workshop that relate to family members’ communication needs; strategies used by health care 
professionals and the hospital institution to address these needs are also included.  
When reflecting on the emotional 48-hour time period when their loved one was admitted to the 
hospital, family members emphasized the need for health care professionals to be clear, consistent and 
compassionate in their communication.  In particular, family members expressed that they were often 
overcome with emotion and distracted, and appreciated when health care professionals communicated 
in ways to assist with information processing. These strategies included repeating information, pausing 
for family members to ask questions, and avoiding using medical jargon.  As one family member 
explained:  
They’d answer and explain things in you know, terminology that we could all understand, and 
never made us feel rushed. We could ask whatever questions we wanted. They gave us their 
business cards. So I think they were source of comfort and you know, just trying to answer our 
questions and reassure us about things. (FM, interview) 
Family members in both interviews and the workshop also expressed the importance of being able to 
communicate with health care professionals to receive updated information about their loved one.  
Recommendations included receiving contact information from health care professionals so that they 
can be easily reached.  This was particularly important when shift changes among health care team 
members occurred.  This theme was also discussed in the workshop, and family members suggested 
that they should be made aware of the schedule for rounds so that they can participate and ask 
questions when needed.  Family members also suggested that health care professionals utilize 
messaging platforms to quickly and easily receive updates. 
Family members in both interviews and the workshop explained that often the roles and responsibilities 
of health care team members were not clearly explained, leaving them unsure of what type of 
information to request or whom to communicate with for certain questions.  Knowing the health care 
team members’ roles and responsibilities would reduce this stressor and allow family members to 
receive information needed about their loved one. This was echoed by one family member: 
I took it upon myself to ask the question – what are you going to do for my son and why. And 
that to me kind of helped simplify this huge structure that I felt like I had to keep track of when I 
looked at his care team. So I don’t know in terms of being proactive if clinicians are comfortable 
with, hi, I’m Dr. So-and-so, I’m going to do this for your loved one so that, you know, I’m going to 
do X so we can achieve Y. I don’t know if that introduction might be helpful, but it was really 
helpful for my family. And again, the people that we worked with were more than willing to 
answer that question and make sure that we were clear with what benefit they were bringing.  
(FM, WS) 
In interviews, family members stated the importance of being spoken to with compassion.  In particular, 
family members appreciated health care team members delivering unfortunate news about their loved 
one in an empathetic manner.   
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During the workshop, family members emphasized the importance of receiving consistent information 
from health care professionals, particularly when consultants and various team members are involved.  
These professionals should work as a holistic team, be in close communication with each other, and 
provide consistent information to family members.  
Health care professionals in both interviews and the workshop also spoke of various strategies used to 
appropriately and compassionately communicate with family.  These participants recognized the 
emotional state of family members during this time and employed various strategies to assist with 
information processing, such as encouraging questions, and use of appropriate terminology and active 
listening approaches.  As one health care professional explained: 
I try to do informal feedback after a family meeting to residents in particular about how they talk 
to families, and sometimes it’s simple things and not in a – in a super critical way, but maybe just 
word choice. Sometimes words are very complicated that residents will use, because it’s common 
language for them, but a family member may not understand that, and so encouraging them to 
be conscious of the word choices that they’re at the level of comprehension for families. And 
more informal.  (Professional, WS) 
The importance of timely outreach to the family was also discussed during the interviews and workshop. 
Health care professionals should speak with family members early and often, and preferably face-to-
face.  
Professionals also spoke of the importance of communicating with compassion to family members.  
These participants explained that they have used various techniques to achieve this, including allowing 
silent pauses when speaking in order to give family members time to react, and delivering updates in an 
empathetic manner.  Recognizing family members’ body language and preferred communication style 
and responding appropriately were also mentioned as important communication techniques throughout 
the interviews and workshop.  Participants also emphasized the importance of spending time with 
family members and building their trust. 
Participants spoke of various communication strategies implemented on the organizational level. Both 
interview and workshop participants spoke of the use of specific staff, such as a nurse “mediator” or 
“point person” to assist with communication between family members and heath care teams.  Thus, 
these dedicated staff are able to communicate with families as needed, allowing physicians to focus on 
the loved one’s care.  Health care professionals spoke of how this is extremely helpful, especially during 
the early, acute stages of care for the loved one: 
We frequently use chaplains or our charge nurses when we’re in the middle of a resuscitation, 
and they just sit with that family and talk with the family. And so I think that’s very useful. And I 
understand it’s hard to do elsewhere, but I think, you know, I hear a lot about care coordinators 
and navigators, and I think we underutilize those people assuming that only physicians or nurses 
can talk to families and keep their care coordinated. So one strategy might be to investigate the 
use of others who are more able to be with families for longer periods of time than very busy 
clinicians. (Professional, WS) 
Family members spoke of how care team members often vary, given shift changes and consultants. 
Thus, both family members and health care professionals spoke of the importance of care teams 
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providing consistent information and functioning as a collective unit, which facilitates communication 
and builds trust with members of the family.  This concept was discussed during interviews as well as 
the workshop.  As one family member expressed: 
We did not have a social worker greet us. We did not have a single point of contact…never met 
the neurologist, and I hope I don’t offend anybody by saying this, but I felt like they were on two 
different planets, the cardiologist and the neurologist.  (FM, WS) 
One health care professional had a similar view for consistent source of information and emphasized the 
need for coordinated communication:   
There may be a traumatic brain injury patient who has multiple injuries, and there are going to 
be emergency medicine physicians, intensivists, anesthesiologists, neurologists, neuro surgeons, 
trauma surgeons, and many other consultants that may be involved in the care. And I think it is 
very important that someone is identified as the point person who is the attending physician, the 
supervising physician of record to coordinate this.  (Professional, WS) 
A health care professional also explained the nature of shift work and implications on the consistency of 
the care team: 
One of the principle problems in all of this is that modern medicine is shift work, and so you don’t 
have the same provider from start to finish. And that’s true at the nursing level, just as much as 
that is true at the physician level with very rare exceptions. And that becomes a problem. 
(Professional, WS)  
In terms of communication training, health care professionals spoke of communication training and 
observation as a typically informal, one-time event, which is not evaluated.  For physicians to strengthen 
their communication skills, and for hospital institutions to reinforce the importance of this, professionals 
recommended physicians undergo formal training, such as completing a palliative care rotation.  This 
would provide professionals with the opportunity to learn how to conduct difficult conversations with 
family members.  This topic was further explored during the workshop; professionals also discussed the 
importance of providing tools and opportunities for professionals to receive feedback on their 
communication skills with families, including reviewing video recordings of conversations with family 
members, and identifying models and mentors to emulate. 
During the workshop, a number of participants emphasized that an organizational culture that 
prioritizes communication skills and training is necessary to affect positive changes for the health care 
team and individual health care professionals.  Examples of how the hospital culture can promote 
improved communication includes supporting continuous learning and quality improvement, setting 
expectations for communication competency, and holding physicians accountable for their 
communication errors.  A family member expressed her concerns regarding the need for accountability: 
I think this is a huge topic in medicine, about mistakes, and mistakes come in all different types, 
and communication errors are huge, and I really feel like that is a huge gap…being able to circle 
back and have that accountability and personal reconciliation between the people who are 
involved and – that’s a huge cultural thing in medicine…but I think that accountability piece and 





Just the thought of not knowing, and not know if he’s dying, is he going to be okay. You know, I 
didn’t know. So I just prayed about it, and I didn’t know what else to do.  (FM, interview) 
With one exception, similar emotional needs were expressed in both the interviews and the workshop.  
It was important to family members to receive assurance that members of the health care team 
genuinely cared for their loved one, expressed by frequent checking in with updates, being respectful 
and attentive, addressing questions, and being empathetic and compassionate. 
I never felt like they were giving up on him. I never felt like anyone was giving up hope. I just 
overall feel like since it was all so sudden (laughs) so unexpected and no one…could tell me 
because they had no idea. So generally, I never felt like anyone was not going to give him the 
care he needed. I really, really felt like everyone was doing everything they could to help him…  
(FM, WS) 
The hospital staff also expressed an understanding of the emotional needs of family members and how 
they responded with compassion during this stressful period, particularly to assure them that their loved 
one is receiving the best care and treatment.  As expressed by a health care professional at the 
workshop: 
So we try to portray that we are [providing] very aggressive care, and you have come to the right 
place, and anything is possible. Anything is out there that works for your patient – or for your 
loved ones, it will be available here, and we will make everything possible to do it.  (Professional, 
WS) 
During this critical period, it can be challenging to maintain a sense of control while managing distress 
and attempting to process information about the loved one’s care.  Family members struggled to stay 
“present” in order to be receptive to information coming from different sources and to take care of their 
personal needs.  Family members utilized a range of strategies, such as seeking information from the 
internet or friends and family in the healthcare field, keeping a daily journal, and seeking solace through 
prayer.  The hospital staff recognize the challenges experienced during this time of intense worry about 
the loved one’s prognosis: 
And when they are ready, they can realize not only that they are not alone in this experience, 
because families feel so alone when this has happened to them. They think they are the only 
person in the world that this has happened to…Blogging, when they’re ready for it to read about 
other people’s experiences. (Professional, WS) 
Social support from friends and family, as well as the support services offered at the hospital, also 
helped family members deal with the emotional overload during this time period.  The presence of close 
friends and other family members was also comforting for some, whereas others preferred to not be 
distracted by others.  As one family member expressed, “I felt very alone when I was there. I mean, [the 
social worker] helped me to keep a little bit calm, but still, it’s a lot to process by yourself without having 
a family member there with you.”  (FM, interview) 
With regard to support from the hospital, family members appreciated knowing what was available as 
soon as possible upon arrival to the ED or ICU, though this information may need to be repeated as the 
family copes with the shock of the event.  It was particularly helpful when there was consistency over 
time in the support person, who understood the family’s needs and was accessible to provide guidance.  
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While some did not recall the details, they expressed awareness of the impact on their experience and 
their emotional self-regulation, as one family member explained:  “I don’t even remember what she was 
called. I think she was there as a spiritual advisor. I didn’t need the spiritual advice, but I needed her 
support, and I got it.”  (FM, WS) 
The value of clear delineation of roles in relation to the balance of providing both clinical care and 
emotional support was expressed this way by a hospital physician:   
And I think that it’s really important to have roles delineated and have that – have that type of 
emotional support, really have a plan in place where folks on the team can provide that. Because 
if every emotional need has to come back to me as an attending physician, I’m probably going to 
do a poor job in meeting that in addition to all my other responsibilities. (Professional, WS) 
The need to have closure with the care team that treated the loved one was a unique theme expressed 
by several family members at the workshop.  The opportunity to make this connection to express 
gratitude was described as part of the healing process for family members.  As expressed by two 
workshop participants:  “It's vitally important for survivors, family members and the care team to 
reunite months later. Our hospital facilitated a reunion tour at our request. It was amazing for all... and 
very healing.”  (FM, WS – Chat)  
So that helped me, and it really helped my wife, to go back and actually meet some of those 
people that – you know, they – especially the nurses, to be honest with you. They had such an 
impact on our family for a very intense but short period of time, and then they’re gone. You leave 
and you never see them again, and it’s like we really do – it makes us feel better when we can be 
grateful.  (FM, WS) 
Several topics related to hospital-level strategies to meet family members’ emotional needs emerged 
through the interview and workshop data collection, including observing family members and 
responding to their distress, validating their feelings regarding uncertainty and personal guilt, and 
clearly communicating when they can be at their loved one’s bedside.  Per a family member at the 
workshop: “I was so relieved when someone told me I could be with him as long as there wasn't a sterile 
procedure, etc.” (FM, WS – Padlet) 
Views on tailoring approaches to helping families manage emotions were explored in the interviews, 
during which both family members and health care professionals expressed the importance of taking 
time to assess the particular situation, including the family member’s emotional state and capacity to 
absorb information at that time.  Responses and interactions should be appropriately adapted, taking 
into account observations of family members’ reactions and body language under these circumstances.  
In some instances, participants reported simply being present in silence as the best approach to 
providing emotional support and comfort. 
Other support strategies that bridge the range of emotional and communication needs included keeping 
the family member apprised on the loved one’s condition, expectations for next steps, and when more 
definitive information may be available.  Finding the proper balance in expressing what is known and 
unknown may depend on the family member’s informational processing capacity, prior history and 
background, and preference for knowing the full range of potential or likely outcomes.  The often long 
and uncertain passage of time can be draining for family members, who in their distress often fail to 
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consider their own needs, which can contribute to the emotional anguish.  Hospital staff provide 
practical information and suggestions to help occupy the family member and regulate their feelings 
during this time. 
Families want something to do, so I often will tell families bring in your favorite music – I mean, 
this is a little bit past that initial period, but talk to people. Have a conversation. A lot of families 
in this situation need to do something and something concrete as a way of both distraction and 
feeling part of the care. (Professional, WS) 
Underlying the emotional reaction of family members is the challenge of managing uncertainty and the 
need to wait as treatment of the loved one unfolds and the prognosis becomes clearer.   This theme was 
particularly salient at the workshop as it was the topic of one of the breakout sessions.  Family members 
generally desire information to know what to expect, but may differ in preference for and ability to cope 
with a poor prognosis.  Some expressed that they wished to hear the range of possible outcomes, so 
that they can prepare for the worst, and several indicated being unaware that death or poor quality of 
life were possible outcomes for their loved one.  Reflecting on their own experience, the observation 
was made that such information received earlier in the course of treatment may have led them to make 
different decisions about their loved ones’ care, such as allowing more time for family and friends to 
visit and grieve, or removal from life support to end suffering.  A clinician offered this perspective on 
family member resiliency: 
…uncertainty is the most powerful human emotion actually. I mean, it’s what I say to the families 
in that moment is that what’s amazing about human nature is the capacity to process bad news. 
And we obviously understand how to process good news in large measure, but we also 
understand how to process bad news. It is actually more powerfully impactful to receive 
uncertainty than to receive bad news from a psychological and human nature perspective. 
(Professional, WS) 
Managing the emotions associated with uncertainty can be challenging for both family members and the 
health care team.  Physicians also discussed the challenge of timing the delivery of information as well 
as expression of confidence in what was conveyed.   
But I think I’d be disingenuous if I said we just have absolutely no idea, because that’s not really 
discussing and preparing the family for the situation in which – what you’re facing...having done 
this for a very long time, I’m coming from a place where I’ve been disappointed at the level of 
certainty that physicians have had when they’re wrong over time. And that’s been the biggest 
concern that I’ve seen over my 25 year career as a neuro intensivist, is that physicians have 
overestimated their ability to precisely prognosticate poor outcomes early after injury. 
(Professional, WS) 
Institutional strategies to address the emotional needs of families emphasized the provision of capable 
and compassionate staff to help the family members cope, including social workers, counselors, and 
pastoral care.  The workshop participants elaborated on the need for this support to be available as 
early as possible.  Another strategy was to have the capacity for family members to have time with their 









the challenge of constraining responses to the first 48 hours after the loved one’s arrival to the 
hospital, a relatively arbitrary timeframe given the enormity of their experience.   
• Participant recruitment.   The case study design, utilized in Stage I, situated the experiences of 
both families and professionals in a highly regarded Level 1 trauma center, which likely resulted 
in a higher representation of positive experiences for the case study exploration than would be 
typical. The intention, therefore, was to validate and elaborate on the findings through the 
workshop deliberations per the project design. The recruitment strategy employed was 
successful in identifying health care professionals in diverse roles at the case study site, who 
then assisted in reaching out to individuals whose loved one received care at the case study site 
to assess their interest in participating in an interview.  Workshop participants’ loved ones, in 
contrast, received care at various hospitals across the United States, and the health care 
professionals were also from regions outside of the case study site.  Recruitment approaches 
used in both stages yielded highly interested health care professionals, as well as those more 
engaged in research, which may not be representative of providers in most emergency care 
settings.  Although the institutional perspective is highly relevant, no institutional administrators 
or representatives were included either in the interview sample or as a workshop participant.  
With regard to family members, despite the intention to recruit those whose loved one’s injury 
was fairly recent (within the last two years), attendees reported that the traumatic events 
occurred between 2008 and 2019, potentially introducing a recall bias.   
• Diversity of participants.   Engaging participants with diverse social and demographic 
characteristics - both family members and professionals - was challenging to achieve for both 
stages of the project.  The implications of this lack of diversity is the likely underrepresentation 
of the sociocultural needs of family members, as well as less confidence that the workshop goals 
– to validate and elaborate on the findings from the case study interviews with more diverse 
groups – were achieved.   Similarly, whereas the aim was to explore scenarios with different 
outcomes to represent a fuller range of experience, in most cases the family member’s loved 
one survived the traumatic event.  
• Conduct of the workshop.  Achieving the objectives of the workshop was challenging for several 
reasons.  Original plans to conduct the workshop at a conference facility were deemed 
infeasible due to the COVID-19 pandemic restrictions.  Thus, some of the options and 
opportunities to more effectively engage family members were not possible in the virtual 
conference setting.  There were also some associated challenges that contributed to delays in 
finalizing the discussion topics for the breakout groups.  Ideally, there would have been more 
time to crystalize these topics and develop the tailored discussion guides for the breakout 
sessions, including with family member involvement as mentioned above.  Finally, the agenda 
was designed to be respectful of attendees’ time and attention (especially given the virtual 
format); thus, sessions for small-group reporting back to the larger assembly were excluded.  
These challenges likely limited the opportunities for bidirectional learning between the family 
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Family Member Interview Guide Preamble 
Thank you for agreeing to participate in this interview.  I am [NAME] and will be leading today’s 
call.  [NAME] is also on the call.  We are part of the team working on this project together with 
Dr. Jonathan Elmer at the University of Pittsburgh and Dr. Robert Silbergleit at the University of 
Michigan. This work is paid for by SIREN, an Emergency Care Research Network.  
 
The purpose of this research is to better understand the experiences of family members and 
companions after a loved one’s severe brain injury or cardiac arrest.  What we learn from you 
and others will help inform a workshop planned for this fall focusing on improving family 
member experience and engagement.  We are interested in your experiences. Nothing you say 
will affect the ongoing care your loved one may be receiving.  
 
Before we get started, I’d like to go over a few “housekeeping” guidelines.  
• We hope you’re comfortable sharing your thoughts and opinions, especially about this 
difficult experience. There are no right or wrong answers.  
• I want to remind you that participation is completely voluntary. If you would like to 
stop at any time, please tell me and we will stop immediately. If there are any 
questions you do not want to answer, let me know and we can skip them.  
• We will be recording today’s call. Everything you say will be kept confidential and not 
linked to your name in any report. The recording will be destroyed after we finish the 
project.  If at any time you do not want your comment to be recorded, please let me 
know and we will turn off the recorder. 
 
Are there any questions before we get started? Answer any questions.  
 
Do you agree to participate in this interview, and do I have your permission to record our 
discussion? Obtain verbal agreement. Turn on recorder. 
 
Today is [DATE]. Now that the recorder is on, I will ask you again-- do you agree to participate 
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Thanks again for talking with us today about [your loved one’s event]. We understand discussing 
these experiences may be upsetting and really appreciate your willingness to talk with us.   
 
We want to focus on your experiences early on, specifically in the first 48 hours after [patient’s 
name] arrived to the hospital following [his/her] brain injury/cardiac arrest. 
 
1. Before we begin, I would like to make sure I understand more about your experience, 
starting from the beginning. How did you first find out that something happened to 
[patient’s name]?   




We’ll now talk more about the information you received about [loved one] during this 
time, including conversations you may have had with doctors, nurses, social workers, and 
other hospital staff. 
 
2. Can you tell me what it was like when you first arrived to the hospital? 
a. Who did you speak to or interact with? What was the nature of the 
conversation(s)? What did you learn? Where did this take place? 
b. How was this information communicated to you (e.g., written material, verbal 
communication, meeting, etc.; by doctor, nurse, social worker, etc.)?   
c. What did you think about the information you initially received about 
[patient’s name] and the way it was communicated? 
d. Thinking about what you were told when you first arrived to the hospital, 
is there any other information that would have been helpful to receive? 
 
3. One thing people in these situations have a hard time with is not knowing what will 
happen to their loved one.  At any point in the first 48 hours, did the health care team 
tell you that they did not know how [loved one] would recover?  
a. Who shared this information with you?  How was this uncertainty 
communicated to you? When and where? Did anyone else talk with you about 
the uncertainty of [loved one’s] condition?  
b. What did you think about the way [that person] shared this information with 
you (e.g., communications style, approach)? 
c. During the conversations about the uncertain trajectory of [loved ones’] care or 
condition, did you feel the [providers] communicated this in a way to you that 
was easy to understand? Can you say more. 
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d. When you had questions about the uncertain nature of [loved ones] care, did 
you know whom to ask?  What sources, other than hospital staff, did you draw 
on for information during this time? 
 
4. In thinking about the first 48 hours, what aspects of the communication were most 
important to you? Why?   
 
5. Family and companions may be asked to make decisions about their loved one’s 
care.  Prior to this event, had you and [patient’s name] discussed his/her wishes if 
something like this were to happen?    
a. Did the team ask for your input about decisions for [patient’s name]? [IF 
ANSWER IS NO: Would you have liked to have been more involved in 
decisions regarding [patient’s name] care? IF YES: Tell me more.] 
b. Can you say more about how they involved you in decisions for your loved one 
when there were options? When and where did this decision making take place 
(e.g., bedside, waiting room, by phone, etc.)? Who (else) was involved in these 
decisions? 
c. What helped you make decisions for your loved one?  
d. What did you think of the way [that person/team] discussed different options 
with you (e.g., communications style, approach)? How did you feel about the 
level of involvement you had in making decisions about [patient’s name] care?  
 
Emotional Needs 
Now, we’ll transition to discussing the emotions you experienced and the social-emotional 
support you may have received. Again, I would like you to think back from when you first 
found out something had happened until about 48 hours after [patient name] arrived to the 
hospital.  
  
6. Can you tell me how/what you were feeling during this time period? How did you 
feel when you first found out about [patient name]?  How did those feelings change 
over time? 
 
7. How did you cope during this time?  
a. What, if anything, gave you comfort or reassurance during this early 
period? 
b. What types of emotional support did you receive?  
i. Who provided this emotional support? When, where, and how? 
ii. What did you think about the emotional support provided by the 
hospital?  
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c. Did you feel that your needs for things like food, rest, and privacy were 
addressed? Can you say more about that? What support, if any, did hospital staff 
offer to address these things?  
d. Is there anything else that could have been helpful? 
 
8. Did you ever feel that medical providers or hospital staff treated you differently because 
of your personal characteristics, like gender, age, religion, race or ethnicity? How so? 
 
9. Based on your experience, how do you feel hospital staff and healthcare providers can 
best support family members during this difficult time?  
 
 
Participation in Emergency Research/Clinical Trials 
 
10. Now I would like to learn your thoughts about research study participation following a 
loved one’s cardiac arrest/severe brain injury.  Did the topic of [patient’s name] being in a 
research study come up? 
  
IF YES:   
a. How did it come up and how did you feel about it?   
b. Were you asked to make a decision about [patient’s name] being in a study? 
What information was helpful to you to decide whether [patient’s name] 
should participate in the research study or not? 
 
IF NO:  
a. One way that emergency research can happen is by asking next of kin for 
permission to enroll the patient in a research study.  I know it might be 
difficult to imagine now, but how do you think you would have felt if you 
had been asked about having [patient name] participate in a research 
study? 
 
11. Can you tell me more about what information would be important to help you 
decide whether your loved one should participate in a research study or not? 
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Thank you for participating in this discussion today.  Before we close, is there anything else you 
would like to share?   
 
We appreciate that you have taken the time to share your thoughts and personal experience.  
Should you have any questions about this project, you may contact Dr. Jonathan Elmer at 
elmerjp@upmc.edu or 412-647-3078.
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Professional Interview Guide Preamble  
Thank you for agreeing to participate in this interview.  I am [NAME] and will be leading today’s 
call.  [NAME] is also on the call.  We are part of the team working on this project together with 
Dr. Jonathan Elmer at the University of Pittsburgh and Dr. Robert Silbergleit at the University of 
Michigan. This work is supported by SIREN, an Emergency Care Research Network.  
 
The purpose of this project is to better understand the experiences of family members and 
companions after severe brain injury or cardiac arrest.  What we learn from you and others will 
help inform an NIH workshop planned for this fall. 
 
Before we get started, I’d like to go over a few “housekeeping” guidelines.  
• Your participation in this discussion is voluntary and you can end the interview or 
choose not to respond to a question at any time. Everything you say will be kept 
confidential and not linked to your name in any report. 
• We will be recording today’s call. The recording will be destroyed after we finish the 
project.  If at any time you do not want your comment to be recorded, let me know and 
we will turn off the recorder.  
 
Are there any questions before we get started? Answer any questions  
 
Do you agree to participate in this interview, and do I have your permission to record our 
discussion? Obtain verbal agreement. Turn on recorder.  
 
Today is [DATE]. Now that the recorder is on, I will ask you again-- do you agree to participate 
in this interview today, and do I have your permission to record?  
 
Introduction 
Thinking about family members’ experiences in the first 48 hours after severe brain injury or 
cardiac arrest, our discussion will explore how you and others’ address the communication 
and emotional needs of family members early in the clinical course during their time in the 
emergency department and the ICU.  
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We understand that you will be discussing these topics from your role as [role here], and 
will be drawing on your experience with many patients and family members over time.  We 
recognize that some questions may not be relevant to your work, and those we can feel 
free to skip.    
   
I’d like to start with getting a better understanding of how you interact with family 




The next questions focus on your approach to communicating with families during the first 
48 hours after the patient’s arrival to the hospital. 
 
1. What is your typical approach to communicating with families when you first talk 
with them?   
a. When and where does this take place? 
b. What influences your approach? How do family members’ preferences 
have an influence? 
c. How can you tell if your approach is effective?  
d. What other approaches do you observe [variations]? 
 
2. What about any other times [during the first 48 hours after the patient’s arrival] 
you speak with the family (e.g., communicating updates about the patient’s 
condition, care, treatment)? How does your approach differ at these times, if at 
all? 
a.  In general, how well do you feel family members’ communication or 
information needs are met during this time?  
 
3. I know that prognosis or the anticipated clinical course early after severe brain injury or 
cardiac arrest is often uncertain. In your experience interacting with families in the first 
48 hours following the patient’s hospital arrival, how does talking about the uncertainty 
of the patient’s clinical course come up?   
a. When and where is this brought up? By whom? What is your typical approach 
for communicating uncertainty about the patient’s clinical course with families?  
b. What variations do you see? What seems to work? What doesn’t seem to work?  
c. What are the challenges? What helps? 
 
4. How do potential long-term implications [prognosis] for the patient come up? 
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a. When and where is this brought up? By whom? What is your typical approach 
for communicating potential long-term implications?  
b. What variations do you see? What seems to work? What doesn’t seem to work? 
c. What are the challenges? What helps? 
 
5. Family members seem to fall on a spectrum between wanting to be part of all the 
decisions and leaving the decision to the doctor. What has been your 
experience/what have you observed with families wanting to be involved versus 
leaving decisions with the doctor? 
 
6. Likewise, clinical providers seem to fall on a spectrum between involving the family 
in most decisions and excluding the family from any decision making by telling 
them what to do. What is your typical approach/what have you observed with 
providers involving family members in decisions early in the clinical course?  
a. When and where does this take place? Who is involved? 
b. What variations do you see? What seems to work? What doesn’t seem to 
work?  
 
7. [PHYSICIAN ONLY] When there are different treatment options, how do you 
handle situations when family members express a preference for an option that 
differs from your own?  
a. Under what circumstances do you find it most challenging to go along with 




Now we are going to focus on the emotional needs of family members during this critical 
period and how they are addressed.   
 
8. What do you feel are common emotional needs of family members during this 
time?   
 
9. How are family members’ emotional needs typically addressed?  
a. When, where, by whom? 
a. In general, how well do you feel family members’ emotional needs are met 
during this time?  
b. How, if at all, is this influenced by family members’ characteristics such as race 
or ethnicity, age, gender, etc.?   
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c. In what way do you feel your own personal identity (e.g., age, gender, 
cultural affiliation, and minority status) influences your experience with 
families? Can you share (other) examples where it did? 
 
10. From your perspective, how could the emotional needs of family members during this 
time period be better identified and addressed?  
 
Participation in Emergency Research Clinical Trials 
Now we will briefly cover your experience and views on patient participation in emergency 
research studies. 
  
11. Can you tell me briefly about your experience with emergency research enrollment 
[INTERVIEWER NOTE: Can probe on “observations”. If No experience, go to 
Demographics] 
 
a. From your experience, what are families’ reactions to the enrollment of their family 
members (the patients) into a clinical trial?   
 
Demographics 
As we wrap up, I have a few questions about  you and your background.  
 
12. How many years have you been in your profession? 
 
13. Which gender do you identify with? 
 
14. Are you of Hispanic or Latino origin or descent? 
 
15. What is your race? [INTERVIEWER NOTE: PROBE AS NEEDED USING LIST BELOW] 
 White 
 Black or African American 
 Asian 
 Native Hawaiian or Other Pacific Islander 
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Thank you for participating.  Before we close, do you have any other comments or additional 
information that you would like to share about the experiences of family members and 
companions after severe brain injury or cardiac arrest?   
 
[INTERVIEWER NOTE: Turn recorder off. Follow-up on family member referrals] 
 
We appreciate that you have taken the time to share your thoughts and personal experience.  
Should you have any questions about this project, you may contact Dr. Jonathan Elmer at 
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SIREN AIM 3: Family Member Experience Interviews 
 
Should the participant become uncomfortable or distressed while discussing their experience, 
the following actions will be taken: 
1. The interviewer will suggest that it is acceptable for the interview to be terminated. 
2. If the participant would like the interview to end, the interviewer will thank the 
participant and terminate the interview. Before ending the call, the interviewer will offer 
resources to the participant (see possible resources below).  
3. If the participant wishes to continue, the interviewer will carry-on with the interview and 
check-in with the participant, as needed.  
4. For any participant whose interview was terminated because of distress, the interviewer 
will notify the participant that they will call over the next 1-2 business days to ensure that 
the participant is okay. During the follow-up call, the interviewer will provide contact 




• UPMC: resolve Crisis Services (24-hour, 365-day crisis service that’s free to all 
Allegheny County residents) 
o 1-888-7-YOU-CAN (1-888-796-8226) 
 
• Crisis Services at UPMC Western Behavioral Health at Safe Harbor 
o 814-456-2014 or 1-800-300-9558 
 
• National Helpline 
o 1-800-662-HELP (4357) 
o Treatment referral and information, 24/7 
 
•  UPMC Presby – Speak with a Physician 
o A 24-hour phone number that you may call to speak with a physician after 
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Family Experience after Cardiac 
Arrest and Severe Neurotrauma:  
Virtual Workshop 
November 19, 2020 





Meeting password: Nov2020 
 
                    






This workshop is supported by funding from the National Institutes of Health. 
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Agenda 
 
I. Welcome & Objectives  (10:00 – 10:15 am ET)  
 
II. Housekeeping & Introductions (10:15 – 10:30 am ET)  
 
III. Overview of the Field & Findings from Qualitative Interviews  (10:30 – 12:05 pm ET) 
a. Presentation 1: Family Involvement in the Early Phase of Cardiac Arrest and 
Traumatic Brain Injury (TBI)  
b. Presentation 2: Preliminary Interviews: A Single Hospital’s Experience 
c. Q&A  
d. Reflection Session: Participant reflections on interview findings  
 
IV. Breakout Session #1 (12:05 – 1:05 pm ET)  
Topics: Family needs in the first 48 hours; provider training and care team approach 
 
V. Break (1:05 – 1:40 pm ET)  
 
VI. Breakout Session #2 (1:40 – 2:45 pm ET) 
Topics: Uncertainty and information processing  
 
VII. Break (2:45 – 3:00 pm ET) 
 
VIII. Takeaways & Closing (3:00 – 4:00 pm ET) 
a. Synthesis/Key Themes 
b. Prioritization Activity  







NOTE: This workshop will be recorded for notetaking purposes. Only members of the study 
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Dr. Clifton Callaway 
Dr. Callaway is a professor of emergency medicine at the University of 
Pittsburgh, whose clinical practice includes management of patients 
hospitalized after cardiac arrest.  He has served as an investigator 
enrolling patients in clinical trials and studies after cardiac arrest, 
traumatic brain injury, and other emergency conditions.  He has worked 
with paramedics and other emergency providers on trials conducted in 




Gail Delfin MSN RN. With 35 years of experience in cardiac critical care, 
I served as a bedside nurse and Clinical Nurse Specialist at the Hospital 
of the University of Pennsylvania. In addition, I was a nurse researcher 
in the Center for Resuscitation Science at Penn. My expertise includes 
post-cardiac arrest care, with an emphasis on Targeted Temperature 
Management (TTM); with Dr. Benjamin Abella as my mentor, I have co-
authored publications, and presented at both American Heart 




Dr. Claude Hemphill 
Dr. Claude Hemphill is Professor of Neurology at the University of 
California, San Francisco and Chief of Neurology at Zuckerberg San 
Francisco General Hospital. His research focuses on advanced 
neuromonitoring, clinical treatment trials, and prognostication for 
acute neurological emergencies such as traumatic brain injury and 
stroke. He is the current co-chair of the Neurocritical Care Research 




Dr. Karen Hirsch 
Karen Hirsch is an Associate Professor of Neurology and Neurosurgery 
at Stanford University. She specializes in neurocritical care, caring for 
patients in the intensive care unit with critical brain, spine, and nervous 
systems injuries and illnesses. Dr. Hirsch's research focuses on 
neuroimaging, prognostication, and critical care management of 
patients with traumatic brain injury and brain injury after cardiac arrest. 
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Paula Kovanic Spiro 
Paula Kovanic Spiro, LMSW, MPH is the program coordinator for the 
BRAVE (Buffalo Rising Against Violence at Erie County Medical Center) 
which is a federally funded hospital based violence injury program. 
Prior to this, she worked as the unit social worker in both the neuro 





Dr. Christos Lazaridis 
Dr. Christos Lazaridis is a neurointensivist at the University of Chicago. 
His interests include neurotrauma critical care, multimodality 





Dea Mahanes has been a neuroscience nurse for over 25 years. She is 
currently a Clinical Nurse Specialist in the intensive and intermediate 
care units at the University of Virginia Health System. In this role, Dea 
works directly with patients and families and is also a resource for 





As a scholar practitioner, Nick has been a paramedic, paramedic 
executive, and health system consultant for over 20 years in rural, 
suburban, and urban settings. He has participated in over 150 cardiac 
arrest resuscitations in both hospital and out-of-hospital settings as a 
team leader and a provider. 
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Dr. Muehlschlegel is an Associate Professor of Neurology, 
Anesthesiology and Surgery at the University of Massachusetts 
Medical School in Worcester, MA. She is Director of Neurocritical 
Care Research at UMASS with a research program in Shared Decision 
Making and neuroprognostication in severe acute brain injury, in 
particular traumatic brain injury and stroke. Her clinical research lab 
focuses on designing and testing shared decision making 
interventions in critically ill neurologic patients as well as 
understanding and improving the way doctors communicate with 
and prognosticate to families. She is the co-chair of a large 
international guideline on “Neuroprognostication”, a joint guideline 
between the Neurocritical Care Society, and the German Society for 
Neuro-Intensive Care Medicine (Deutsche Gesellschaft für 
Neurointensivmedizin). She leads the NIH “Curing Coma” Common 
Data Elements working subgroup “Goals of Care Decisions / Family 




Dr. Sarah Perman 
Dr. Perman, MD MSCE, is an Associate Professor of Emergency 
Medicine at the University of Colorado School of Medicine.  She 
obtained her medical degree from Temple University in 2007, 
general emergency medicine residency at the University of 
Pennsylvania in 2011 and a Resuscitation Research fellowship at the 
University of Pennsylvania Center for Resuscitation Science in 2013.  
Dr. Perman’s clinical interests are focused on post-cardiac arrest 
therapies and acute critical care in the emergency department.  Her 
research is focused on post-cardiac arrest neuro-prognostication and 
decision-making, in addition to sex/gender differences in cardiac 
arrest outcomes.  Dr. Perman is an active member of the American 
Heart Association and a member of the Emergency Cardiovascular 




Dr. Robert Silbergleit 
Robert Silbergleit MD is a Professor of Emergency Medicine at 
University of Michigan.  His research focuses on clinical trials of 
acute interventions for neurological emergencies including status 
epilepticus, cardiac arrest, stroke, and traumatic brain injury.  He is a 
key investigator in the leadership of the NIH funded NETT and SIREN 
clinical trial networks.  Dr. Silbergleit is dedicated to improving the 
structure, efficiency, and accountability of the clinical trial 
enterprise.  He has been a co-investigator on a regulatory science 
grant from the NIH and FDA to investigate adaptive clinical trial 
methods in confirmatory phase trials, and is Principal Investigator on 
an NIH funded empirical ethics research project to study local 
context review by individual and centralized Institutional Review 
Boards.  He has published and presented on issues relating to 
emergency research, consent, and exception from informed consent 
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Distress Protocol 
11/19/20 SIREN AIM 3 Virtual Workshop 
 
Discussion during the November 19, 2020 workshop, Family Experience after Cardiac Arrest and 
Severe Neurotrauma, may cause emotional distress for participants as they reflect on their 
experiences. The following actions will be taken to protect participants: 
1. Before the workshop 
a. Participants will be emailed the workshop agenda and alerted to the sensitive and 
potentially distressing nature of topics 
b. Participants will be emailed a crisis support resource (e.g., 
https://www.crisistextline.org/).  
 
2. During the workshop 
a. During the opening segment, participants will be informed that it is acceptable for 
them to step away for a moment or turn their camera off if the participant needs a 
break. Participants will be asked to inform Renee Kasperek-Wynn by email, phone, 
or Zoom chat if they will be stepping away for more than 20 minutes at any point 
during the workshop. Breakout room facilitators and Renee will be observing 
participation throughout the entire workshop. Breakout room facilitators will let 
Renee know if a participant unexpectedly leaves the workshop for more than 20 
minutes. If a participant has unexpectedly left the workshop for more than 20 
minutes or does not return within 30 minutes of when they said they would, Renee 
will call the participant to check in on them. 
 
b. Should a workshop participant become noticeably distressed during the workshop, 
the PI (Robert Silbergleit) will send a private chat message to the participant to 
check on him/her.13 
Breakout room facilitators and Renee Kasperek-Wynn will be monitoring 
participants’ distress and alert Robert by email or Zoom chat if someone is very 
distressed. 
c. Should a workshop participant express homicidal or suicidal thoughts, Renee 
Kasperek-Wynn will call the participant’s local police and inform them of the 
participant’s contact information so they may visit the participant to check in on 
them. 
 
Breakout room facilitators will be monitoring participants and alert Renee by emnail 
or Zoom chat if any participant expresses homicidal or suicidal thoughts. 
 
3. After the workshop 
a. Participants will be provided with the crisis support resource once again via email. 
                                                          
13 Family member participants will be informed that workshop organizers may check-in with them by phone or Zoom 
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SIREN Subproject #3 
Reflection Sessions Guide – Care Team Groups 
Total time:  1 hour 
11/19/2020 
 
Reflection Session Preamble – 5 min 
Hi everyone and welcome to the Reflection Session of our workshop.   As Jonathan 
previously mentioned, we’re in this breakout room to discuss our reflections on the 
interview findings. I am [facilitator name], and I will be starting today’s discussion.  [Co-
chair] may also ask a few follow-up questions or provide additional insight during the 
session.  But most of the conversation will come from you all, as we’d like to learn more 
about your thoughts about the interview findings. 
All of you participating in this discussion are members of a care team that see patients 
with cardiac arrest or traumatic brain injury in the ED or ICU.  There are several others in 
the breakout room who are either members of the SIREN team or from NIH.  They are only 
observing and will not participate in the discussion. 
Jonathan mentioned that one of the limitations of the findings is that the interviews were 
conducted with care team members that service one hospital in Pittsburgh, PA.  These 
providers then referred family members that had a loved one admitted to this hospital. 
We’d like to take the time during this session to understand if our findings also resonate 
with those that are not affiliated with this hospital, or if we are missing any information. 
It’s important to express yourself openly during our discussion today.  There are no right or 
wrong answers. We simply want to know what you think.  I would like everyone to be a 
part of this conversation. You do not need to wait for me to call on you to talk, but only 
one person should speak at a time. Also, we ask you keep what we discuss today within this 
group and not share what we discussed with others who did not participate in the 
workshop. This is to make everyone feel comfortable sharing their honest opinions with 
the group.  
As we stated earlier, we are recording the workshop, including this reflection session.  
What you say will not be linked to your name in any of our reports, and the recording will 
be destroyed after we have analyzed the discussions.   
Lastly, before we begin, I want to note that if you anticipate leaving the session for more 
than 20 minutes, please send a chat to [backup.]  We just want to make sure that we 
haven’t lost or overlooked anyone during the session. 
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Practice Padlet – 5 min 
For this session, we will use Padlet, which is a website that allows several people to 
collaborate and share ideas in real time.  We’ll post some initial ideas of our feedback on 
the interview findings and then discuss further.  First, let’s walk through a practice Padlet 
so that we can understand how to use it. 
I’m adding a link to Padlet in the breakout room chat. Please click on that link, which will 
take you to the Padlet website. 
Once you are in Padlet, you’ll see that there is a question on the top of the page. [Read the 
practice Padlet question] Click on the plus sign to add in your response.  Everything is 
reported anonymously.  You can also vote if you agree or disagree on someone’s 
response, and comment on it as well.  [Allow a few minutes to play around with the 
features, demonstrate some features, and respond to any questions.] 
Great. Now that we have the hang of Padlet, let’s review the findings that Jonathan 
presented and then hear your thoughts about these findings. We’ll group the findings by 
information, communication, emotional, and sociocultural needs and go through them 
one by one. 
 
Information Needs – 10 min 
First, let’s review the information needs and strategies to address these needs that were 
discussed during the interviews. 
[Present slide by sharing screen and review bullets] 
• Both family members and care team participants expressed the need for clear 
expectations for the progression of illness/injury.  
• Family members emphasized the need for procedural information to navigate the 
hospital environment. 
• From your perspective, what other information is important to provide to 
family members in the first 48 hours after their loved one has been admitted to 
the hospital?   
I’m now adding a link to another Padlet in the chat.  Please click on that link, which will 
take you to the Padlet website.  Here, you can add your response for additional 
information under the “Information Needs” column.  Click on the plus sign under that 
column to add in your responses. We’re just focusing on information needs at this time. 
Discuss common responses, clarify differing responses, ask if the findings resonated, and 
generate discussion 
 
Communication Needs – 10 min 
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Now, let’s review the communication needs and strategies to address these needs that 
were discussed during the interviews. 
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[Present slide by sharing screen and review bullets] 
• Both family members and care team participants expressed the need for effective 
communication strategies when conveying health information about the loved one.  
• Family members emphasized the need for the care team to assist with information 
processing:  
o Give direct, understandable information 
o Use repetition to assist with understanding 
o Provide opportunities to ask questions 
o Receive contact information for care team 
• The care team spoke about specific strategies used to assist with information 
processing: 
o Suggest taking notes 
o Recommend key terms to search in Google 
o Offer translation services 
o Provide time for questions 
• From your perspective, what communication strategies are missing from this list?   
Please click on the link to Padlet again, where you can add your response under the 
“communication needs” column.   
Discuss common responses, clarify differing responses, ask if the findings resonated, and 
generate discussion 
 
Emotional Needs – 10 min 
Families and care team members also discussed emotional needs and strategies to address 
these needs throughout the interviews. 
[Present slide by sharing screen and review bullets] 
• Both family members and care team participants expressed the importance of: 
o Displaying compassion in all interactions 
o Encouraging support from other family and friends 
o Utilizing social/religious support services 
o Engaging in self-care activities (e.g., sleep, eating, walking, etc.) 
o Being with the loved one as much as possible 
• Family members expressed the need to: 
o Personally help their loved one (e.g., internet searches, journaling, praying) 
o Receive continued support (after ICU transfer, after death or hospital 
discharge) 
• The care team emphasized the need to address uncertainty in clinical course and 
outcomes:  
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o How to convey; how much to convey 
o Balancing communication of uncertainty with clarity 
o Emotional toll on overwhelmed families 
o Need for time to observe course of illness 
o Effect on shared decision-making 
o Consistency of messaging across teams 
o Perils of using statistics 
• From your perspective, what additional strategies are used to address emotional 
needs?   
Please click on the link to Padlet again, where you can add your response under the 
“emotional needs” column.   
Discuss common responses, clarify differing responses, ask if the findings resonated, and 
generate discussion 
 
Sociocultural Needs – 10 min 
[Present Slide by sharing screen and review bullets] 
Now we’ll talk about sociocultural needs, or the needs family members may have based on 
their background including but not limited to their culture, race and ethnicity, religious 
beliefs, geographic location, and family structure.  
• Both family members and care team participants emphasized the need for equitable 
treatment and socioculturally appropriate communication 
• From your perspective, what strategies are used to address the needs families may 
have based on their background?  
If participants don’t respond to the above questions, ask:  What does equitable treatment 
and socioculturally appropriate communication mean to you?  
 
Please click on the link to Padlet again, where you can add your response under the 
“Sociocultural Needs” column.   
Discuss common responses, clarify differing responses, ask if the findings resonated, and 
generate discussion 
 
Other Needs – 5 min 
[Present Slide by sharing screen and review bullets] 
• Thinking about the first 48 hours, are there any other family needs or strategies that 
we haven’t addressed in the interview findings or in this reflections session? 
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Please click on the link to Padlet again, where you can add your response under the “Other 
Needs” column.   
Discuss common responses, clarify differing responses, and generate discussion  
 
Closing – 5 min 
Thanks so much for all of your feedback!  Your comments are extremely helpful for us to 
understand FMs’ needs in various types of settings. Do you have any last minute comments 
to add? 
If you have time, summarize main points and reflect back to the group for confirmation.   
Now, we’ll go back to the main meeting room in a few moments. When you see the prompt 
that we’ll return to the main room in a few seconds, please don’t click on it yet, as it will 
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SIREN Subproject #3 
Reflection Sessions Guide – FM Groups 
Total time:  1 hour 
11/19/2020 
 
Reflection Session Preamble – 5 min 
Hi everyone and welcome to the Reflection Session of our workshop.   As Jonathan 
previously mentioned, we’re in this breakout room to discuss our reflections on the 
interview findings. I am [facilitator name], and I will be starting today’s discussion. [Co-
chair] may also ask a few follow-up questions or provide additional insight during the 
session.  But most of the conversation will come from you all, as we’d like to learn more 
about your thoughts about the interview findings.   
All of you participating in this discussion are family members of a loved one who suffered 
from a cardiac arrest or traumatic brain injury.  There are several others in the breakout 
room who are either members of the SIREN team or from NIH.  They are only observing 
and will not participate in the discussion. 
Jonathan mentioned that one of the limitations of the findings is that the interviews were 
conducted with care team members that service one hospital in Pittsburgh, PA.  These 
providers then referred family members that had a loved one admitted to this hospital. 
We’d like to take the time during this session to understand if our findings also resonate 
with those that are not affiliated with this hospital, or if we are missing any information. 
It’s important to express yourself openly during our discussion today.  There are no right or 
wrong answers. We simply want to know what you think.  I would like everyone to be a 
part of this conversation. You do not need to wait for me to call on you to talk, but only 
one person should speak at a time. Also, we ask you to keep what we discuss today within 
this group and not share what we discussed with others who did not participate in the 
workshop. This is to make everyone feel comfortable sharing their honest opinions with 
the group.  
As we stated earlier, we are recording the workshop, including this reflection session.  
What you say will not be linked to your name in any of our reports, and the recording will 
be destroyed after we have analyzed the discussions.   
Lastly, before we begin, I want to note that if you anticipate leaving the session for more 
than 20 minutes, please send a chat to [backup.]  We just want to make sure that we 
haven’t lost or overlooked anyone during the session. 
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Practice Padlet – 5 min 
For this session, we will use Padlet, which is a website that allows several people to 
collaborate and share ideas in real time.  We’ll post some initial ideas of our feedback on 
the interview findings and then discuss further.  First, let’s walk through a practice Padlet 
so that we can understand how to use it. 
I’m adding a link to Padlet in the breakout room chat. Please click on that link, which will 
take you to the Padlet website. 
Once you are in Padlet, you’ll see that there is a question on the top of the page. [Read the 
practice Padlet question] Click on the plus sign to add in your response.  Everything is 
reported anonymously.  You can also vote if you agree or disagree on someone’s 
response, and comment on it as well.  [Allow a few minutes to play around with the 
features, demonstrate some features, and respond to any questions.] 
Great. Now that we have the hang of Padlet, let’s review the findings that Jonathan 
presented and then hear your thoughts about these findings.  We’ll group the findings by 
information, communication, emotional, and sociocultural needs and go through them 
one by one. 
 
Information Needs – 10 min 
First, let’s review the information needs that family members discussed during the 
interviews. 
[Present slide by sharing screen and review bullets] 
• Both family members and care team participants expressed the need for clear 
expectations for the progression of illness/injury.  
• Family members emphasized the need for procedural information to navigate the 
hospital environment. 
• From your perspective, what other information would have been helpful to 
receive during the first 48 hours after your loved one was admitted to the 
hospital?   
I’m now adding a link to another Padlet in the chat.  Please click on that link, which will take 
you to the Padlet website.  Here, you can add your response for additional information 
under the “Information Needs” column.  Click on the plus sign under that column to add in 
your responses. We’re just focusing on information needs at this time. 
Discuss common responses, clarify differing responses, ask if the findings resonated, and 
generate discussion 
 
Communication Needs – 10 min 
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Now, let’s review the communication needs that family members discussed during the 
interviews. 
 
[Present slide by sharing screen and review bullets] 
• Both family members and care team participants expressed the need for effective 
communication strategies when conveying health information about the loved one.  
• Family members emphasized the need for the care team to assist with information 
processing:  
o Give direct, understandable information 
o Use repetition to assist with understanding 
o Provide opportunities to ask questions 
o Receive contact information for care team 
• From your perspective, what communication needs are missing from this list?   
Please click on the link to Padlet again, where you can add your response under the 
“communication needs” column.   
Discuss common responses, clarify differing responses, ask if the findings resonated, and 
generate discussion 
 
Emotional Needs – 10 min 
Family members also discussed several emotional needs throughout the interviews. 
[Present slide by sharing screen and review bullets] 
• Both family members and care team participants expressed the importance of: 
o Displaying compassion in all interactions 
o Encouraging support from other family and friends 
o Utilizing social/religious support services 
o Engaging in self-care activities (e.g., sleep, eating, walking, etc.) 
o Being with the loved one as much as possible 
• Family members expressed the need to: 
o Personally help their loved one (e.g., internet searches, journaling, praying) 
o Receive continued support (after ICU transfer, after death or hospital 
discharge) 
• From your perspective, what emotional needs are missing from this list?   
Please click on the link to Padlet again, where you can add your response under the 
“emotional needs” column.   
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Sociocultural Needs – 10 min 
[Present Slide by sharing screen and review bullets] 
Now we’ll talk about sociocultural needs, or the needs you may have based on you and your 
family’s background including but not limited to your culture, race and ethnicity, religious 
beliefs, geographic location, and family structure.  
• Both family members and care team participants emphasized the need for equitable 
treatment and socioculturally appropriate communication 
• From your perspective, what other needs based on you and your family’s 
background, are missing?  
If participants don’t respond to the above questions, ask:  What does equitable treatment 
and socioculturally appropriate communication mean to you?  
Please click on the link to Padlet again, where you can add your response under the 
“Sociocultural Needs” column.   
Discuss common responses, clarify differing responses, ask if the findings resonated, and 
generate discussion 
 
Other Needs – 5 min 
[Present Slide by sharing screen and review bullets] 
• Thinking about the first 48 hours after your loved one arrived to the hospital, are 
there any other needs that we haven’t already addressed in the interview findings or 
in this reflection session? 
Please click on the link to Padlet again, where you can add your response under the “Other 
Needs” column.   
Discuss common responses, clarify differing responses, and generate discussion  
 
Closing – 5 min 
Thanks so much for all of your feedback!  Your comments are extremely helpful for us to 
understand FMs’ needs in various types of settings. Do you have any last minute comments 
to add? 
If you have time, summarize main points and reflect back to the group for confirmation.   
Now, we’ll go back to the main meeting room in a few moments. When you see the prompt 
that we’ll return to the main room in a few seconds, please don’t click on it yet, as it will 
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SIREN Subproject #3 
Breakout Session #1 – Care Team Groups 
Total Time:  50 minutes 
11/19/2020 
 
Breakout Session Preamble – 5 min 
Hi everyone and welcome to the first Breakout session of our workshop.   As Sarah 
mentioned, we’re in this breakout session to have a more in-depth discussion about the 
needs identified in the qualitative interviews.   
I am [facilitator name] and just as in the Reflections Session, I’ll facilitate and start the 
discussion, but most of the conversation will come from you all.  Also, just as in the last 
session, all of you participating in this discussion are members of a care team that see 
patients with cardiac arrest or traumatic brain injury in the ED or ICU.  There are several 
others in the breakout room who are either members of the SIREN team or from NIH.  
They are only observing and will not participate in the discussion. 
The same ground rules for the Reflections Session also apply here. It’s important to 
express yourself openly; there are no right or wrong answers. You do not need to wait for 
me to call on you to talk, but only one person should speak at a time. Also, we ask you to 
keep what we discuss today within this group and not share what we discussed with 
others who did not participate in the workshop. We will also record this breakout session. 
Lastly, before we begin, I want to note that if you anticipate leaving the session for more 
than 20 minutes, please send a chat to [backup.]  We just want to make sure that we 
haven’t lost or overlooked anyone during the session. 
For this Breakout Session, we’d like to hear more about provider communication training 
and care team approaches.  Throughout our project, care team members brought up these 
topics, and we’d like to hear more about this from your perspective. 
 
Understanding Provider Communication Trainings and Gaps– 20 min 
During the interviews, we heard family members and care team members speak about the 
importance of being able to convey information about patients in a compassionate, clear 
and appropriate way to family members.  We’d like to hear more about the communication 
skills that providers need in order to effectively and compassionately communicate with 
family members.  
1. What types of communication training does your institution provide?  
o Probe:  What do you think about the trainings that are offered?  
o Probe:  If not offered, how would a training benefit you and your health care 
team? What types of team members should be included in the training?  
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2. In lieu of formal training, how can providers improve their family-centered 
communication/emotional intelligence? 
o Probe:  Have you been able to use these strategies (e.g., continuing 
education, finding mentors, modeling after others)?  How have they affected 
your communication style?  
o Probe: Are these strategies widely used by your colleagues? 
3. What tools or strategies have been helpful to you or your organization in 
communicating with families? 
o Probe:  Use of specific care team members, technology 
4. What are some of the challenges with training providers in family-centered 
communication/empathic communication? 
o Probe:  What are potential solutions to address these challenges? 
 
Care Team Approach– 20 min 
We also heard several family members and providers speak about the care team, including 
variations in the composition of care teams and specific roles and responsibilities of each 
member (e.g., physicians, nurses, social worker, hospital chaplains.)  We learned that family 
members found certain care team approaches helpful to address their communication and 
emotional needs. 
5. What care team configurations and approaches do you think are best for meeting 
family members’ needs during the first 48 hours after a loved one’s cardiac arrest or 
TBI? Why? 
o Probe:  Are there specific roles and responsibilities that are important to 
include in the care team (e.g., mediator, liaison between providers and 
families)? 
6. What challenges does your organization have in its care team approach? 
o Probe:  What are potential solutions to address these challenges? 
 
Closing – 5 min 
Thanks so much for all of your feedback!  Your comments are extremely helpful for us to 
further understand how the care team can best address FMs’ needs, especially during this 
challenging time. Do you have any last minute comments to add? 
If you have time, summarize main points and reflect back to the group for confirmation.   
Now, we’ll have a break for 35 minutes.  Please come back to the Workshop at [time].  We’ll 
then reconvene and hear reports from each of the Breakout Sessions. Thank you! 
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SIREN Subproject #3 
Breakout Session #1 – FM Groups 
Total Time:  50 minutes 
11/19/2020 
 
Breakout Session Preamble – 5 min 
Hi everyone and welcome to the first Breakout session of our workshop.   As Sarah 
mentioned, we’re in this breakout session to have a more in-depth discussion about the 
needs identified in the qualitative interviews.   
I am [facilitator name] and just as in the Reflections Session, I’ll facilitate and start the 
discussion, but most of the conversation will come from you all.  Also, just as in the last 
session, all of you participating in this discussion are family members of a loved one who 
suffered from a cardiac arrest or traumatic brain injury.  There are several others in the 
breakout room who are either members of the SIREN team or from NIH.  They are only 
observing and will not participate in the discussion. 
The same ground rules for the Reflections Session also apply here. It’s important to 
express yourself openly; there are no right or wrong answers. You do not need to wait for 
me to call on you to talk, but only one person should speak at a time. Also, we ask you to 
keep what we discuss today within this group and not share what we discussed with 
others who did not participate in the workshop. We will also record this breakout session. 
Lastly, before we begin, I want to note that if you anticipate leaving the session for more 
than 20 minutes, please send a chat to [backup.]  We just want to make sure that we 
haven’t lost or overlooked anyone during the session. 
For this Breakout Session, we’d like to hear more about the logistical needs for FMs for the 
first 48 hrs after their loved one has been admitted to the hospital.  Throughout our 
project, FMs brought up this topic, and we’d like to hear more about this from your 
perspective. 
 
Navigating the Hospital and Logistical Support – 15 min 
During the interviews, we heard many family members speak about having to navigate 
through the hospital and the importance of receiving logistical information, especially when 
they arrived at the hospital. This can include things like how to get to the cafeteria, the 
hours of the cafeteria, where to park, and options for lodging. Please think back to when 
you first arrived at the hospital when your loved one was admitted. 
1. When you first spoke to someone from the hospital or arrived at the hospital, what 
information related to navigating the hospital and logistical information did you 
expect to receive?  
o Probe:  What would have been helpful for you to receive? 
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2. What information related to navigating the hospital should be communicated to 
families during the first contact? 
3. How did your needs related to navigating the hospital and logistics change over the 
first 48 hours? 
o Probe:  Were you able to find the information or resources that you needed?  
If you can recall, who provided you with this information/resource? For 
example, if your loved one moved to another department, did you require 
new or different information? 
4. Did you need help from someone to manage your logistical needs during the first 48 
hours?  What are some examples? 
 
Interactions with the Care Team – 15 min 
We also heard several family members speak about their loved one’s care team and how 
they communicated with the team, particularly within the first 48 hrs after hospital 
admission.   
5. Were the roles and responsibilities of your loved one’s health care team clear to 
you? 
o Probe:  If the roles and responsibilities were not clear, what specifically was 
not clear? Were you able to get clarification about this? 
6. What was your experience with connecting to your loved one’s health care team 
when you had questions or concerns?  
o Probe:  What would have helped you to get in touch with the health care 
team? 
 
Support Services – 15 min 
The interviewees also spoke about several types of support services they received from the 
hospital during the first 48 hrs after their loved one was admitted to the hospital.   
7. What types of support services (e.g., discussions with a social worker, meeting with 
the hospital chaplain) did you find helpful during this time? 
8. What other support or services should be offered to families during this time?  
o Probe: In hindsight, what do you now wish you had in the first 48h that you 
did not have then? 
9. What recommendations do you have for hospital staff communicating available 
support services with families during such a hectic and emotional time? 
 
Closing – 5 min 
Thanks so much for all of your feedback!  Your comments are extremely helpful for us to 
further understand FMs’ needs, especially during this difficult time. Do you have any last 
minute comments to add? 
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If you have time, summarize main points and reflect back to the group for confirmation.   
Now, we’ll have a break for 35 minutes.  Please come back to the Workshop at [time].  We’ll 
then reconvene and hear reports from each of the Breakout Sessions. Thank you! 
SIREN Subproject #3 
Breakout Session #2 – Mixed FM and Care Team Groups 
Total Time:  50 minutes 
11/19/2020 
 
Breakout Session Preamble – 5 min 
Hi everyone and welcome to the last Breakout Session of our workshop.   Just as before, 
we want to have an in-depth discussion about the needs identified in the qualitative 
interviews.  This time, those of you participating in the discussion are either family 
members of a loved one who suffered from a cardiac arrest or traumatic brain injury, or 
are members of a care team who see patients with cardiac arrest or traumatic brain injury 
in the ED or ICU. Again, there are others in the breakout session who are either members 
of the SIREN team or from NIH; these individuals are only observing and will not 
participate in the discussion. 
Similar to the previous Reflection and Breakout Sessions, the same ground rules apply 
about speaking one at a time and not sharing what we discuss with others who did not 
participate in the workshop.  We will also record this session.  As before, if you anticipate 
leaving the session for more than 20 minutes, please send a chat to [backup.]   
For this Breakout Session, we’d like to hear more about how family members experience 
and manage their feelings after they are notified that their loved one’s prognosis is 
uncertain. We’d also like to hear how providers help manage family members’ discomfort 
with uncertainty, including how they help family members process technical information 
during this highly emotional time.   
 
Uncertainty and Emotional Needs – 20 min 
For family members, please think back to the first 48 hrs when your loved one was admitted 
to the hospital and if there were any discussions of uncertain prognosis, or if there were any 
unknowns or areas of uncertainty about your loved one. For providers, please think of a 
time when you’ve had to convey information to families about uncertain prognosis and how 
you responded to their questions or concerns.   
1. If you are a family member who had discussions of an uncertain prognosis with your 
loved one’s provider (that is, the care team was not sure how your loved one’s 
illness or injury would progress or what the outcomes might be), how did you react 
to this information?   
o Probe: Emotional responses, need for information, need for support 
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2. For those whose loved one’s prognosis was known, did you experience any feelings 
of uncertainty in other areas (e.g., treatment, procedures, discharge)? 
o Probe:  If yes, in what areas? How did you react to this information? 
 
3. Were there any activities or tasks that you did to manage your feelings and 
emotions about the uncertain prognosis or other areas of uncertainty? 
o Probe:  Gather information, seek emotional or spiritual support  
 
4. For providers, what are some ways that you have responded to family members’ 
emotional needs when they are experiencing uncertainty?   
o Probe: From your experience, how was this received by family members?  
 
5. For both family members and providers, are there additional suggestions about how 
to manage family members’ emotional needs during this time of uncertainty?   
o Probe:  Strategies for both FMs and providers to help manage their needs  
 
Uncertainty and Information Processing– 20 min 
6. For family members, thinking about your experience, what information did you 
receive from your provider to help you understand the uncertain prognosis (e.g., 
percentages, statistics, data tailored for loved one) or other areas of uncertainty? 
o Probe:  Is there any type of information that you didn’t receive that would 
have been helpful for you to better understand the situation? 
 
7. For providers, what types of information are you comfortable sharing with families 
when there is uncertainty for their loved one? (e.g., percentages, statistics, data 
tailored for loved one)? 
o Probe: What makes this information appropriate to share with families?  
How are these types of information helpful to family members? Or not 
helpful? 
 
8. For providers, how do you help families understand this information?   
o Probe:  From your experience, how are these strategies viewed by family 
members? How have they been helpful? Or not helpful? 
 
9. For both family members and providers, are there any additional thoughts about the 
types of information that families need to understand uncertain prognoses or other 
areas of uncertainty?   
o Probe:   Strategies for how providers can help family members better 
understand information related to uncertain prognosis?   
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Closing – 5 min 
Thanks so much for all of your feedback!  Your comments from this breakout session as well 
as the earlier sessions have been extremely helpful. Do you have any last minute comments 
to add? 
If you have time, summarize main points and reflect back to the group for confirmation.   
We’ll now take a 15 minute break.  Please come back to the Workshop at [time.]  We’ll then 









[End of Report] 
 
 
 
